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EPEC   Enteropathogenic Escherichia coli 
  
ER   Endoplasmic reticulum 
Esp   Escherichia coli secreted protein 
FACS   Fluorescent-activated cell sorting 
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Stat6   Signal transducer and activator of transcription 6 
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1. Introduction 
 
Shiga toxin-producing Escherichia coli (STEC) infections are a major cause of bloody 
diarrhoea, hemorrhagic colitis and haemolytic uremic syndrome in humans (23). Following 
initial major outbreaks (321, 413), STEC are considered as human pathogens of significant 
public health concern. E. coli Shiga toxins (Stx, consisting of two major groups, Stx1 and 
Stx2) are heteromeric toxins (1A:5B) and were identified as main STEC virulence factors 
(287), that principally target endothelial cells (222), leading to vascular damages in human 
kidneys, brain, pancreas and intestine. After binding of the B-subunit(s) to the 
glycosphingolipid Gb3/CD77 (109), Stx is retrogradly transported (332) and the A1-subunit 
translocates to the cytosol, where it exerts its cytotoxicity and rapidly kills the affected cells 
(334). Stx are ribosome-inactivating toxins that inhibit the protein synthesis by removing the 
adenine residue A-4324 in the 28S rRNA of the 60S ribosomal subunit (88, 90) and 
eventually block the eEF-1 and eEF-2 dependent elongation process (290). Additionally, 
cross-linking of Gb3/CD77 by Stx1 on the cell surface activates the BCR-signaling cascade 
and induces apoptosis of human B cells (240, 261). An increasing body of evidence suggests, 
however, that Stx1 also modulates the expression of certain cytokines (IL-1, TNF-α, IL-6) 
and chemokines (IL-8 and MCP-1) in epithelial cells (392, 393), mesangial cells (354) and 
monocytes and macrophages (139, 140, 390, 401) in mice and man. Remarkably, peritoneal 
murine macrophages resist the cytolethal effects of Stx1 but produce large amounts of 
cytokines in response to the toxin (390). 
In cattle, representing the main source of human infections (137), intestinal STEC-infections 
are mostly asymptomatic (356) but result in a high percentage of animals shedding STEC for 
prolonged periods (69, 77). It was hypothesized (247) that STEC have evolved strategies to 
limit intestinal inflammation and the mucosal immune defense in cattle, thus permitting a 
commensal-like lifestyle as suggested by Smith (356). Indeed, Stx1 suppresses bovine 
lymphocyte functions (250, 254) and presumably represents a STEC virulence factor even in 
cattle (252). In contrast to human lymphocytes, bovine B and T cell subsets both express 
functional Stx-receptors and are affected by the toxin (363). Stx1 blocks the activation and the 
proliferation of these cells in vitro (103, 250, 254) and in vivo (151). Intestinal intraepithelial 
lymphocytes (IEL), the first immune cells that gain contact to the toxin, likely represent the 
main targets for Stx1 in the bovine gut (247). Stx1 inhibits the activation of certain subsets of 
Gb3/CD77-expressing IEL in vitro and depletes the ileal mucosa of CD8α
+ T IEL in an ileal 
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loop model of STEC infections (247, 252). However, since Stx1 neither induces cellular death 
nor affects the NK activity of IEL in vitro (247) and in vivo (252), the consequences of this 
effect of Stx1 for mucosal immune responses remained to be elucidated. 
IEL represent effector cells against bacterial (277) and viral infections (125, 268). While 
TCR αβ IEL participate in immune reactions to lumenal antigens, TCR γδ IEL mainly secrete 
cytokines (e.g. TGF-β and IL-4) involved in the surveillance and regulation of the epithelial 
homeostasis (19, 110, 156). IEL are also a potent source of chemokines (e.g. IL-8, MIP-1α 
and -1β) (35, 227). Based on the hypothesis that Stx1 modulates the local immune response 
during STEC infections in cattle, the objectives of this study were to investigate whether Stx1 
binding to or internalization by bovine ileal IEL (iIEL) changes the cellular expression of 
selected cytokine and chemokine genes on the transcriptional and translational level. These 
investigations aimed at helping to elucidate the mechanisms by which Stx1-producing E. coli 
colonize the intestine and persist in cattle in a commensal-like lifestyle. 
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2. Literature review 
 
2.1. Mucosal immune system 
 
The immune system is defined as the molecules, cells, tissues, and organs that function to 
provide a protection against foreign organisms (1). This system is composed of several 
compartments as the blood, the mucosal tissues, the thymus, the bone marrow, the body 
cavities and the skin. The mucosa-associated lymphoid tissue (MALT) is the largest and the 
most complex compartment of this system. The intestinal mucosa is a huge surface of 
exchange and is consequently more exposed to microorganisms. The gut-associated lymphoid 
tissue (GALT), which is a part of the MALT, comprises four distinct compartments: the 
Peyer’s patches (PPs) and other lymphoid follicles associated with the follicle-associated 
epithelium (FAE), the lamina propria (LP), the intraepithelial lymphocytes (IEL), and the 
mesenteric lymph nodes (MLN). The small intestinal epithelium of ruminants contains large 
populations of lymphocytes (298), comparable, in number, to the pool in the spleen. The 
GALT is a sophisticated system in which food antigens have to be ignored (tolerance) while 
antigens of pathogenic microorganisms have to induce both strong innate and adaptive 
immune responses to protect the organism and to prevent further dissemination of the 
pathogens. Specialised systems such as secretion of immunoglobulin (Ig) A, certain TH-type 
cell responses and induction of tolerance are essential mechanisms of the mucosal protection 
(265). The presence of several compartments and the association of inductive (PPs and MLN) 
and effector (LP lymphocytes [LPL] and IEL) sites allow a very efficient sampling of 
antigens from the mucosa, draining towards the lymph nodes and an adequate immune 
response (40). In addition to cell subsets and lymphoid structures of the immune system, 
several types of cells are present in the mucosa and constitute a well-integrated network with 
intense cell-to-cell and cytokine-mediated communication allowing a physical protection of 
the mucosa of the host (enterocytes [or intestinal epithelial cells, IEC], Paneth cells, and 
goblet cells). The surveillance of the mucosa and the sampling of exogenous antigens are 
performed by M cells and dendritic cells (DCs) present in the epithelial monolayer and in the 
lamina propria, respectively. Effective immune responses toward pathogens mounted in the 
mucosa are mediated by IEL and LPL. A highly-regulated control of the infected IEC and 
activated IEL during and after the clearance of the infection allow an efficient homeostasis of 
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the mucosal immune system. The anatomy of the small intestine is considered as prototype of 
a mucosal immune tissue and therefore represents a model for studying infectious processes. 
 
2.2. Functions of the intestinal epithelium 
 
2.2.1. Barrier function 
 
The lumen of the small intestine is lined by a monolayer of microvilli-folded epithelial cells, 
called enterocytes, forming tight junctions (230, 231), which play different structural and 
functional roles (physical barrier, exchange of molecules, immune response). The enterocytes 
are first covered by a layer of negatively charged mucin-like molecules and carbohydrates 
called the glycocalyx which protect them from chemical injuries (243). The enterocytes are 
then covered by several layers of mucus produced by the goblet cells. The main functions of 
this viscous fluid are to protect the epithelium against chemical damages and to trap and 
eliminate particles and micro-organisms by peristalsis in the lumen of the intestine. 
 
2.2.2. Immunological functions 
 
Secretion of antimicrobial peptides 
Paneth cells are part of the epithelial layer in the small intestine. Their main function is to 
produce lysozyme, phospholipase A2 and antimicrobial peptides. Epithelial cells can as well 
produce antimicrobial peptides to ensure the protection of the mucosa. In vertebrates, the 
defensins and the cathelicidins are the main products with antibacterial activity (83). Three 
subfamilies of defensins have been described (α, β and θ). Alpha-defensins, called “cryptdins” 
in mice, are produced by phagocytes in human, primates and rodents and by Paneth cells of 
the small intestine in human, mouse, and rat in response to stimulation by bacterial antigens 
(12). Alpha-defensins are processed to their active form by the matrix metalloproteinase 7 
(MMP-7 or matrilysin)(422) and were shown to be involved in clearance of E. coli infection 
in the small bowel. The β-defensins were first described in the tracheal epithelium of cattle 
and are produced after activation of the Toll-like receptor (TLR) -2 pathway (342). In contrast 
to β-defensins, the α- and θ-defensins are constitutively expressed. In addition to defensins, 
the cathelicidin LL-37 which is constitutively produced in the human intestinal tract by 
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colonic epithelial cells but not in the small intestine (141), binds to LPS and can efficiently 
attract monocytes and neutrophils (213). 
 
Antigen presentation by IEC and regulation of IEL activation 
IEC are considered effective antigen presenting cells (APC) as they express both MHC class I 
and II molecules like professional APC do (179), and produce the co-stimulatory molecule 
B7H (ICOS-L) (272) to activate T cells in vitro (175). The presence of the HLA-G, -H, (32) 
and CD1d antigens (33) on the surface of IEC suggests that these cells can also present 
antigens in the context of MHC class I-like molecules rather than conventional MHC 
antigens. IEC are thought to maintain and regulate the immune homeostasis in the intestine by 
selectively activating or suppressing IEL functions (29, 30). In one hand, IEC induce the 
proliferation of lamina propria lymphocytes without any classic MHC restriction (296). On 
the other hand, IEC can downregulate functions and inhibit activation of both αβ- and γδ-TCR 
intraepithelial lymphocytes subsets (335, 430). 
A possibility of antigen sampling in the intestine of humans and porcine, described recently, 
implicates the transport of IgG through the intestinal epithelial barrier using the Fc receptor as 
a shuttle service (373, 436). 
 
Cytokine and chemokine production by IEC 
In addition to the secretion of antimicrobial peptides and the presentation of antigens, IEC 
have a very important immune function as they can produce large amounts of cytokines and 
chemokines, including TGF-α, TGF-β, IL-15, IL-6, TNF-α, GM-CSF, IL-8, and MCP-1 
(211). In response to bacterial invasion of the mucosa, the production of such mediators is up-
regulated (84) and is a critical factor for the regulation of the innate immune response of the 
mucosal epithelium (85). In addition to the production of cytokines during an infection, the 
production of chemokines is an important process in physiologic conditions (absence of 
infection with pathogens) leading to the homing of IEL and will be addressed in another 
section (see 2.3.4.3). 
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2.3. Gut-associated lymphoid tissues (GALT) 
 
2.3.1. Peyer’s patches (PPs) 
 
Peyer’s patches are specialised complex and well-organised lymphoid structures located in the 
small intestinal wall containing IgA-producing B lymphocyte follicles with T cell areas 
surrounding the germinal centres. PPs contribute to the local and systemic immunity against 
intestinal antigens. Consequently, all types of cells necessary for initiating, regulating, and 
performing immune responses are present in PPs (macrophages, dendritic cells, and 
polymorphonuclear cells). After stimulation by TGF-β and IL-10 produced by DCs and T 
cells, B cells undergo Ig class switch from IgM to IgA (245). Fifty percent of the B cells from 
the lymphoid follicles express surface IgA. Although IgA are very important in the 
mammalian gastrointestinal immune response, IgG play a part in immune response to foreign 
antigens as well. T cells are found in the T-dependent interfollicular areas and are intercalated 
with B cells in the dome overlying the follicles (92). 
In ruminants, two different categories of PPs exist in the small intestine. The ileal and jejunal 
PPs contain functionally distinct B-cell populations. While ileal PPs mainly produce CD5+ 
sIgM+ B-cells, jejunal PPs contain IgA-producing plasma-cells. Moreover, ileal PPs’ follicles 
can be repopulated by circulating B-cells if necessary (128, 129). 
One specificity of the GALT (and more generally of the MALT) is the constant recirculation 
of lymphocytes. Naïve lymphocytes originating from the bone marrow, can be activated in the 
PPs, migrate through the lymphatic draining of the intestine, via the mesenteric lymph nodes 
and the thoracic duct to the blood, and can finally re-enter the MALT in the lamina propria 
using specific adhesins. This mechanism allows the spread of the protection all along the 
whole length of the intestinal immune system (9). 
There are evidences that the intestinal immune response is initiated in PPs because they are 
covered by a specialised follicle associated epithelium (FAE) containing M cells involved in 
antigen uptake and processing (293). In the epithelial monolayer of the FAE (dome), 
enterocytes are interrupted by large cells without well-shaped villi, called M cells, that cover 
small and large intestinal PPs (280). M cells present in the specialised FAE are characterised 
by the absence of glycocalyx seen on enterocytes, by the lack of a well-organized brush 
border on their apical surface, and by the presence of a cavity (or pocket) where B and T 
lymphocytes and small numbers of macrophages are stored. Most of T cells are CD4+ 
expressing the typical antigen of memory cells CD45RO (99). M cells take up antigens, via 
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endocytosis by uncoated or clathrin-coated pits and vesicles, and transport them across the 
FAE. M cells can as well make direct contact with lymphocytes or APC (122). Although 
MHC class II molecules have been reported on the surface of M cells, no evidence have 
confirmed their implication in the presentation of antigens yet (6). M cells can also be used as 
a way of infection by bacteria and contribute to infection of other cells (279). Viruses 
(reovirus, poliovirus, HIV) and bacteria (V. cholerae, E. coli, S. thyphimurium, Y. 
enterocolotica, S. flexneri, and C. jejuni) can adhere to M cells and then infect the mucosal 
tissues (171). A rabbit pathogenic E. coli strain was found to intimately bind to M cells, to 
induce effacement of M cell villi, and to trigger the formation of pedestals (161, 162). The 
capacity to transfer different materials distinguishes M cells from typical enterocytes and 
underlines both their antigen-sampling function and their vulnerability to infection by 
pathogens. Consequently, M cells represent attractive candidates for drug and vaccine 
delivery (169). 
 
2.3.2. Lamina propria 
 
The intestinal lamina propria (LP) is a connective tissue located between the epithelium and 
the muscularis mucosae. The LP, an effector site of the mucosal immune response, contains 
several types of cells of various functions and states of activation. Large numbers of B cells 
are present in the intestinal LP and are a major source of IgA that enter the lumen of the 
intestine to neutralize bacteria or antigens. Locally synthesized by plasma cells in the LP, IgA 
can bind pathogens and lead to their excretion through the epithelium into the lumen, or 
directly bind the antigens in the lumen of the intestine. During their intraepithelial transport to 
the lumen, IgA are able to bind to viral particles and then inhibit viral production inside IEC 
(203). 
In addition to B cells, both CD4+ and CD8+ T cells are present in the LP at a high level of 
activation, and can mediate cytotoxicity or produce helper and suppressor cytokines (183). 
LPL are predominantly of TH2 phenotype (50 to 70 %) and many CD4
+ T cells stimulate the 
production of antibodies by B cells. The LP contains a smaller proportion of LPL bearing the 
CD8 antigen (20 to 30 %) capable of cytotoxic-T-lymphocyte (CTL) activity (209). In several 
species, the LP is a reservoir of memory cells (142, 143), suggesting the LP as a site of 
secondary responses. Both CD4+ and CD8+ T cell populations of memory phenotype are 
phenotypically different from peripheral blood memory cells. LPL express CD45 (tyrosine 
phosphatase) and CD58 (= LFA3, ligand of CD2) antigens at high level (337) but relatively 
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few adhesion molecules like CD18 (integrin β2), CD29 (integrin β1), and CD44 (142, 337), 
indicating a lack of functional properties. In addition, CD4- CD8- and CD4+ CD8+ T cell 
subsets have been observed in the LP of pigs. LPL generally show a high degree of activation 
by expressing IL-2 mRNA, IL-2Rα, and surface expressed MHC class II antigen (183). 
The presence of macrophages in the LP also underlines the possibility of primary responses 
(234). The LP contains as well DCs which process antigens and become mature cells capable 
of driving a T cell response in the LP. 
 
Dendritic cells (DCs) 
The main function of DCs is to capture antigens and to present them to lymphocytes. Three 
stages of development of DCs have been reported: 1) precursor DCs patrol through the blood 
and the lymph, 2) tissue-residing immature DCs capture antigens, 3) mature DCs present 
these antigens locally to LP T cells or within secondary lymphoid organs. Immature DCs are 
characterized by the expresion of mannose receptors, Fc receptors, and by the absence of 
molecules involved in T cell activation. Immature DCs express CCR6 and are then attracted 
by the chemokine CCL20 (MIP-3α)(13) produced by IEC in response to infection by enteric 
pathogens (281). DCs are able to sample the lumenal antigens directly by extending dendrites 
across the epithelial cell layer and by expressing tight junction proteins without disturbing the 
integrity of the monolayer (320). By this mechanism DCs can transport extracellular bacteria 
from the apical to the basolateral side of the epithelium. Mature DCs do not express Fc or 
mannose receptors anymore but high level of MHC class II and T cell activation molecules 
(CD86, ICAM-1, and IL-12). DCs process and present antigens and then orientate the 
response of T cells and drive their differentiation into helper, regulatory or cytotoxic T cells. 
For that purpose, DCs may migrate to T cells zones, mesenteric lymph nodes, or interact with 
memory cells. 
 
2.3.3. Mesenteric lymph nodes (MLN) 
 
Mesenteric lymph nodes, the largest lymph nodes in the body, contain B and T lymphocytes 
and some APC, such as macrophages and DCs. MLN are divided into a peripheral cortex 
composed of B lymphocyte-rich follicles and a central medulla. When responding to an 
antigenic stimulation, B lymphocytes of the follicles are activated, start to proliferate and 
produce antibodies. T cells expressing CD49d (α4β7 integrin) also accumulate in the follicles, 
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multiply, differentiate after contact with an antigen, and migrate to the medulla. Cytotoxic and 
helper T cells then leave the node via efferent vessels towards other nodes and circulate to 
spread the protection specific for pathogens among the lymphatic net. MLN are considered 
crossroads between peripheral and mucosal recirculation pathways (265). Under physiological 
conditions, the presentation of food antigens in MLN leads to the induction of tolerance 
mediated by the induction of TH3-type cells secreting TGF-β and IL-10 (58). 
 
2.3.4. Intraepithelial lymphocytes (IEL) 
 
2.3.4.1. General characteristics of IEL 
 
In contrast to Peyer’s patches and lamina propria, the small intestinal epithelium contains 
small amounts of B lymphocytes (271) and relatively few CD4+ T cells. Newborn calves’ 
small intestines have relatively fewer IEL than adult animals. In addition, the B cell number is 
significantly increased in the ileum of calves compared to adult animals (299). One 
lymphocyte per approximately five to ten epithelial cells is present in the small intestine, 
representing 10 to 15 % of the cells in the adult bovine intestinal epithelium. In cattle, IEL 
often co-express the αβ TCR with a CD8 molecule or the γδ TCR without any co-receptor 
(427, 428). The IEL, located on the basolateral side of the mucosa between epithelial cells, 
occupy a unique location at the interface between the epithelium and the gut lumen and are 
the first lymphoid population that encounter exogenous pathogens/antigens (441) and/or 
associated toxins in the whole body (266). IEL are distinct from systemic T cells and 
represent an unusual T cell compartment characterized as a large and heterogeneous 
population of lymphocytes containing resting, activated and memory cells derived from a 
limited number of T cell clones (34, 144). 
In contrast to spleen, blood and lymph lymphocytes which are subdivided into MHC-class II 
restricted CD4+ αβ TCR T cells and MHC-class I restricted CD8αβ+ αβ TCR T cells, IEL 
comprise mainly CD8+ T cells. Other parameters are required to classify the IEL. For this 
purpose, most of the investigations were performed in mice. Following a classification based 
on gene expression profiles and on TCR and co-receptors expression proposed by Hayday 
et al. (144), two major subsets of IEL can be segregated. The “type a” and “type b” IEL can 
be distinguished functionally as these populations become differently activated. While 
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“type a” IEL are activated by conventional MHC restriction, the “type b” IEL do not 
recognize these classical MHC molecules (144). 
In addition to activation segregation, the “type a” mucosal T cells express αβ TCR together 
with CD4 or CD8αβ co-receptors. Relatively little is known about the functions of CD4+ IEL 
which can be also divided into two subsets possessing both pro- and anti-inflammatory 
functions (CD4+ CD45Rbhigh TH1-like and CD4
+ CD45Rblow TH2-like populations)(310, 311). 
Additionally, double positive (DP) CD4+CD8αα+ IEL were reported in the small intestine 
(110, 111, 206). The “type b” subset includes αβ TCR CD8αα+ IEL and also contains 
γδ TCR CD8αα+ and γδ TCR double negative (DN, CD4-CD8-) T cells. DN T cells can 
represent as 10 % of small intestinal IEL (144). 
The bovine IEL population is composed of 3 to 5 times more CD8+ than CD4+ T cells (409). 
In cattle, IEL are predominantly “type a” cells expressing the αβ TCR and preferentially the 
CD8αβ heterodimer co-receptor in contrast to other species (31, 60). A high proportion of 
cells also expresses the bovine activation marker ACT2 (ACT2+ CD8+ αβ TCR and 
ACT2+ γδ TCR cells)(10, 427). Most of IEL are activated mature T cells expressing CD3 
(61.0 %), and CD6 (48.6 %)(248). Bovine IEL also express the MHC class II molecule (271) 
characteristic of activated cells pointing to an effector function of IEL in vivo. 
Human IEL also express CD45RO or CD45RB and co-express CD11a, CD29 and CD58 
constantly (168), suggesting a previously activated or memory phenotype. Moreover, high 
expression of Bcl-2+ and the absence of CD95 (Fas) on human small intestinal IEL is 
supposed to render the cells relatively resistant to the activation-induced cell death (350). 
Freshly isolated murine IEL have a high level of MAP kinase-2 pointing to an in vivo 
activation state independent of exposure to bacteria (381). Investigations in mice revealed that 
the generation of the IEL repertoire is random and not governed by viable microbial flora, 
although certain food antigens could play a role (319). In other terms, all intestinal IEL 
subpopulations display characteristics of 'activated yet resting' immune cells (60). 
 
2.3.4.2. Gammadelta (γδ) TCR intraepithelial lymphocytes 
 
Described in the past as non-classic T cells, γδ TCR lymphocytes have gained in 
consideration in the recent years. A characteristic of mucosal surfaces is the relative 
abundance of “type b” IEL bearing the γδ TCR. This TCR is expressed by more than 37 % of 
human IEL, 30 to 50 % of murine IEL (309, 437), and the bovine intestinal IEL compartment 
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contains 13.4 to 25.1 % of γδ TCR bearing cells (248)(Moussay et al., submitted). The great 
majority of these γδ TCR cells express the co-receptor CD8 in calves (427). Analysis of 
CD8+ γδ T cells demonstrated that they are involved in promoting quiescence, consistent with 
a role of sentinel in the mucosa. More generally, γδ TCR cells are highly conserved and are 
the first T cells to develop (104). They can differentiate from late foetal liver and adult bone 
marrow precursors and require the presence of IL-7, which has been shown to be a critical 
factor for the rearrangement and the expression of the TCRγ genes in mice and for survival of 
γδ TCR cells in the periphery (202). In cattle, γδ TCR cells generally do not express CD2, 
CD4, and CD6 (229) but are the only cell type in the organism to express the WC1 antigen, a 
member of the scavenger receptor cysteine rich (SRCR) family (418). WC1+ γδ TCR cells 
have a TH1-like cytokine profile characterised by production of IFN-γ and the lack of IL-4 
(16). 
Functionally, γδ TCR IEL respond to a relatively small range of stimuli, do not significantly 
proliferate, and do not recognize antigens presented in the context of classical MHC (62, 264). 
However, they can directly interact with self-MHC molecules not loaded with processed 
antigens (MHC class I-related molecules)(366). 
Bovine blood γδ TCR WC1+ cells stimulated 24 hrs by concanavalin A produce mRNA for 
multiple cytokines (IL-2, -4, -6, -7, -10, -12, -15, IFN-γ, TNF-α, TGF-β and GM-CSF)(297) 
and some cytokine proteins (IFN-γ and TGF-β)(324). Recently, bovine and human γδ TCR T 
cells of adults and neonates were shown to strongly respond to Pathogen-Associated 
Molecular Patterns (PAMPs) and to produce large amounts of cytokines (MIP-1α, 1-β, 
TNF-α, IFN-γ) and chemotactic factors for activated neutrophils, thus confirming the 
implication of γδ T cells in innate immunity. The TLR2 and 4, Nucleotide-binding 
oligomerization domain (NOD), in cooperation with CD11b/CD18, have been proposed to be 
at the origin of this strong response of γδ T cells (146). In addition, the interpretation that 
γδ TCR IEL use their TCR as a pattern recognition receptor led to suggest that these IEL act 
as a bridge between the innate and the adaptative immune systems (152). 
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2.3.4.3. Origin of IEL 
 
Thymic and extra-thymic origin of IEL 
After the migration of IEL precursors (TCR-CD8-) from the foetal liver and later the bone 
marrow, the process of IEL maturation is not fully understood. Several studies, performed in 
mice, underlined both thymic and extra-thymic origin of gut IEL subsets (134, 212, 218, 323). 
Most of αβ TCR DP IEL (CD4+CD8αα+) and αβ TCR CD8αα+ IEL subsets appear to be of 
thymic origin (219). “Type a” IEL seem to be the progeny of circulating conventional T cells 
that had been positively selected in the thymus and already exposed to antigens in the GALT 
(9). Moreover, in absence of MHC class I, these IEL are not produced since the positive 
selection is blocked (115). Because the adult intestine is not a significant site for 
αβ TCR T cell development in normal conditions (81), αβ and some γδ  IEL precursors from 
thymic origin were found to mature in the periphery and then home in the gut (208). Even if 
the majority of IEL is antigenically distinct from peripheral blood lymphocytes (PBMC)(350, 
409), some “type a” IEL are phenotypically identical to mature thymus-derived T cells. In 
addition, T cell subsets of the ileal mucosa of naïve neonatal calves are different from those of 
adult cattle (300). Calf IEL also produce mRNA for the recombinases RAG-1 and RAG-2, 
which are critical for DNA recombination events that form functional Ig and TCR (228), 
indicating that a postnatal maturation of the gut mucosal IEL occurs in vivo. In any case, the 
development of intraepithelial T lymphocytes is regulated by the cytokines IL-2, IL-7, and IL-
15, which bind to their respective receptors sharing the common gamma-chain (γc). The 
different activities of these cytokines assure the development of phenotypically diverse 
subsets of intestinal IEL (307, 308). 
In chicken, only the thymus is an effective source of αβ and γδ TCR intestinal IEL and 
“type b” IEL originate in the thymus but acquire the expression of CD8αα homodimers in the 
gut microenvironment. The negative selection might occur in the intestine and then IEL 
colonize the gut where they are able to survive for months (157). 
 
Murine and human small intestine IEL and rat γδ TCR IEL were reported to develop from 
cells of extrathymic origin (226, 315). Murine CD8+ IEL can undergo selection in the absence 
of thymus as well. Interestingly, studies about the effects of stress, aging and thymus 
involution have shown that the extra-thymic production of αβ TCR IEL can supplant the 
thymic cell production in certain conditions. However, even if γδ TCR IEL are from extra-
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thymic origin, they need to undergo a self-antigen β2 microglobulin-dependent selection 
process. A recent report indicated that the differentiation and maturation of γδ TCR IEL 
requires the presence of immature αβ TCR thymocytes (351). 
The epithelium has been early proposed as a primary lymphoid organ (105) and to be a site of 
development for γδ TCR and CD8αα lymphocytes in adult animals (134). In fact, all 
prerequisites for cell development, maturation, and activation can be produced by IEC. 
Several hints reinforce the existence of distinct IEL origins. Epithelial cells produce the stem 
cell factor (SCF), express MHC-class I and II molecules (179), and the co-stimulatory 
molecule B7H (272). SCF binds to the tyrosine kinase membrane receptor c-Kit expressed 
only by the “type b” IEL (γδ TCR IEL and αβ TCR CD8αα+ IEL)(201, 313). IL-7, produced 
by IEC, is also absolutely required for the development of all γδ TCR IEL. 
In contrast to αβ TCR CD8αβ IEL, the development of murine αβ TCR CD8αα IEL in the 
intestine is promoted, following a Gram-negative bacteria infection, by the production of 
IL-15 by IEC in a TLR4-dependent manner (177). 
A distal site to the intestine, such as the bone marrow, cannot be excluded from the list of 
potential site of extra-thymic T-cell development (210). Specifically reported in mice, the 
lamina propria can contain cryptopatches, clusters of lymphoid cells in the basal LP, rich in 
IL-7R+ cells supposed to be progenitor T cells for extra-thymic descendants which can 
migrate to the IEL compartment (176, 327). In contrast to cryptopatches, lymphoid 
aggregations such as isolated lymphoid follicles (ILF) and Peyer’s patches (PP) are not 
indispensable for the generation of IEL (294). 
 
IEC chemokine secretion and IEL homing 
IEL are thought to reside in the LP and MLN and to be attracted by epithelial-produced-IL-8 
or MCP-1 in response to injury and bacterial or parasitic infections. Moreover, cultured 
intestinal IEL migrate into a polarized human epithelial monolayer while PBMC are incapable 
to do so (345). IEC are capable of producing a large panel of chemokines in order to attract 
IEL (434). In parallel, IEL are known to express several chemokine receptors (CCR1, CCR2, 
CCR5, CXCR3), mainly in the ileum (224). However, due to the redundancy of ligand-
receptor, both α- and β-chemokines commonly use a limited number of receptors expressed 
by IEL (322). Consequently, IEL migrate upon antigen stimulation (186), and are attracted to 
the site of infection in response to both α- and β-chemokines produced by IEC. Alpha (α)-
chemokines (IL-8, GRO family) are characterised by a C-X-C sequence while β-chemokines 
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have a C-C motif (MCP-1, MIP family, and RANTES). IEC also produce the chemokine 
CXCL10 (10 kDa-IFN-γ inducible protein, IP-10) and the monokine induced by IFN-γ (MIG) 
CXCL9 (79) which bind to CXCR3 expressed by freshly isolated IEL (349). In addition, 
CCR5 is an important component of the migration of intraepithelial CD8+ T cells in response 
to parasite infection (224). Virtually, all IEL co-express the αEβ7 integrin (CD103) and the 
CCR9 (receptor for CCL25, or thymus-expressed chemokine [TECK] produced by IEC of the 
small intestine)(380, 425, 440). The association CCR9/CCL25 promotes the expression of 
CD103 on CD8+ cells (91). 
IEL can reside in the MLN where they express the αEβ7 integrin. After activation by PPs or 
MLN DCs (170, 260, 362), IEL down-regulate the expression of the αEβ7 integrin and then 
migrate towards the epithelium, via the bloodstream, by using the α4β7 integrin. The α4β7 
heterodimer binds to an Ig-like domain in the mucosal addressin cellular adhesion molecule-1 
(MAdCAM-1) expressed by the endothelium in PPs and LP (25). After homing in the 
epithelium, IEL express αEβ7 again which then binds to E-cadherin expressed by IEC (56). 
Integrins are primordial components of IEL behaviours. After the migration, the interaction of 
IEC and IEL is important for the maintenance of IEL in the epithelium. More than 90 % of 
IEL express αEβ7 (55) and the intercellular adhesion molecule-1 (ICAM-1). The expression of 
the integrin αEβ7 is another marked difference between IEL and PBMC. In fact, 95 % of 
intestinal IEL express this heterodimer while only 5 % of PBMC bear this integrin. This 
molecule is significantly up-regulated on IEL following the production of TGF-β by IEC 
(348, 379). Similarly, the homing of IEL into the epithelium induces an up-regulation of 
MHC class I and II, ICAM-1, CD44, and increases the production of IL-8 and IP-10 by IEC 
(347). After homing, IEL are thought to be closely bound to epithelial cells and this cell-to-
cell interaction down-regulates the proliferation of both αβ and γδ TCR IEL which stay in the 
mucosa as resting cells. In addition, the interaction with IEC down-regulates both TH1- (IFN-γ 
and IL-2) and TH2- (IL-4 and IL-5) cytokine production of IEL. In contrast, co-incubation of 
IEC has no effect on splenic αβ T cell proliferation, indicating very specific cell-to-cell 
interactions between IEC and IEL (430). 
 
2.3.4.4. Principal functions of IEL 
 
The several subsets of IEL express different surface antigens and possess special features in 
order to maintain homeostasis and to develop an adequate immune response in the gut. While 
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some IEL are dedicated to perform the immune surveillance of the epithelium (166) and to 
mount efficient immune response against pathogens, other contribute to the regeneration of 
the epithelial monolayer (homeostasis, tumor surveillance) and to the removal of damaged 
epithelial cells and/or cells exposed to toxic agents (257, 291)(Natural Killer (NK) 
properties). 
 
IEL as effector cells of the immune response 
Even if IEL are considered as part of the adaptative immune system, αβ TCR IEL are thought 
to be involved in the development of innate immune response to lumenal antigens (383). All 
the diverse populations of IEL show a phenotype of antigen-experienced lymphocytes (61, 
204) characterized as “activated yet resting” immune cells (60). Mucosal CD4+ T cells mainly 
secrete TGF-β and IL-10 (116). In addition to regulatory functions of αβ TCR CD4+ and 
γδ TCR IEL, several studies confirmed that αβ TCR CD8αβ IEL possess cytolytic functions, 
have a memory function and are protective against bacterial (277, 306), viral (125, 187) and 
parasitic infections (133, 216). IEL from the small intestine have a more pronounced cytolytic 
activity in vitro than IEL from the large intestine (49). Through an enhanced cytotoxicity, IEL 
are more involved in protection against a challenge infection than against primary infection of 
Cryptosporidium (133). Alphabeta TCR CD8αβ IEL are also more potent cytolytic cells than 
CD8αα, exert an efficient protective activity in vivo against acute viral infection, and produce 
perforin and granzyme B mRNA in the small bowel 6 days post-infection (268). 
Similarly to other species, bovine intestinal IEL possess cytotoxic activity against bovine 
coronavirus (BCV)-infected target cells and are able to inhibit the viral replication. This 
activity was enhanced by IL-2 and TNF-α. Ileal IEL (iIEL) have a better cytotoxic activity 
than lymphocytes isolated from other sites in the GALT or systemic immune system (124, 
125). As murine IEL, bovine iIEL respond to Cryptosporidium parvum antigen in vitro and 
are then important in the host’s response towards enteric infections (408). 
Gammadelta TCR IEL of several species have cytolytic activity and are involved in the host 
response against a variety of intracellular pathogens (2, 167, 270). Gammadelta TCR IEL 
activation is not restricted by classical MHC molecules but can be induced by small bacterial 
antigens, MHC-class I-like molecules and several other ligands (174). 
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Soluble factors produced by IEL  
An important feature of IEL is to locally produce cytokines and chemokines. In opposition to 
cytolytic functions, some IEL subsets possess suppressive functions. By producing IL-10, 
CD4+ CD8αα+ intestinal IEL can suppress a TH1-induced intestinal inflammation (66). 
Activated γδ TCR IEL can secrete a large array of cytokines (IFN-γ, TNF-α, IL-2, IL-3, TGF-
β, IL-4, IL-5, and IL-10)(19, 442). They perform surveillance and regulate the epithelium 
homeostasis (158) by producing keratinocyte growth factor (KGF), which stimulates 
proliferation (36) and regulates differentiation of epithelial cells (198). Moreover, γδ IEL 
regulate autoimmunity (267) and are a significant protective T cell population against colitis 
in a mouse model by aggregating at sites of epithelial cell damage, by producing TGF-β and 
IL-4, and by down-regulating CD4+ CD8αβ+ cells (suppression of TH1-type immune 
response)(57, 158). Human small intestinal IEL spontaneously secrete the cytokines IFN-γ 
and IL-4 (53). These cytokines are probably involved in the normal homoeostasis of the 
intestinal mucosa. Disturbances in their secretion could play a role in the pathogenesis of 
gastrointestinal diseases. 
Freshly isolated normal human IEL express mRNA encoding IL-1β, IL-2, IFN-γ, TNF-α and 
approximately 10 % of IEL produce IFN-γ protein, suggesting that IEL are immunologically 
active in vivo. Human IEL could be stimulated in vitro to secrete IL-10, TNF-α, and TGF-β 
proteins pointing to suppressive and cytolytic functions for IEL (19, 227). 
Ileal IEL of neonatal calves express TNF-α and IFN-γ mRNA but no transcripts for the anti-
inflammatory cytokines IL-4 and IL-10 were found (428). As PBMC, iIEL of 4-week old-
calves produced IFN-γ in response to mitogens. Ileal IEL and especially γδ T cells also 
produced TH1-type cytokines at the early steps of infection with Listeria monocytogenes in 
mice and rats, underlining the important role of iIEL in the host immune response. 
Ileal IEL are also a potent source of chemokines (IL-8, MIP-1α, -1β, RANTES and 
lymphotactin) (35, 227) and are consequently thought to act as sensors to infections and to 
induce attraction of both cells of the innate immune response (monocytes, neutrophils) and 
lymphocytes. 
 
Natural killer (NK) properties of IEL 
Representing around 15 % of intestinal IEL in mice, some IEL subsets have natural killer 
activities. These cells are not restricted by the classical MHC system (52), and become 
cytolytic in vivo after exposure to antigens (207). Both murine αβ and γδ TCR IEL express 
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NK receptors and mediate cytotoxicity through perforin and Fas (135) against enteric murine 
coronavirus infected cells (52) and against enterocytes in a model of graft versus host disease 
(328). The rat IEL compartment harbours a large population of CD3- cells that function as NK 
cells, but display an activated phenotype and an unusual cytokine profile that clearly 
distinguishes them from splenic NK cells. In fact, all NK IEL express CD25 and 
spontaneously secrete IL-4 or/and IFN-γ whereas splenic NK cells do not (394). Several 
groups already reported the presence of a CD3- CD7+ subset of IEL in the human small 
intestine representing around 10 % of the cells and expressing the NK markers CD161 
(P-selectin glycoprotein ligand, PSGL-1) and CD122 (IL-2Rβ) (87, 168). Variable percentage 
of IEL express CD94, CD56 (cell adhesion), CD16 (Fcγ RIII), and contain perforin granules. 
However, these IEL do not express CD18 (integrin β2) and CD44 (cell adhesion) indicating 
limited capacity of migration (86). Similarly to other species, bovine iIEL have NK activity 
against the bovine lymphoma cell line BL-3 (248).  
 
Implication of IEL in the regeneration of the epithelium 
In contrast to αβ TCR IEL, γδ TCR IEL perform regulation of the homeostasis of the 
epithelium (106, 158, 166), but as well tumor surveillance, and removal of epithelial cells 
exposed to toxic agents (257, 291). Ileal IEL promote the repair of epithelial lesions to 
maintain intestinal integrity. Gammadelta TCR IEL possess electron-dense granules and are 
closely associated with apoptotic enterocytes in the small intestine of cattle (229). Damaged 
or infected intestinal epithelial cells express the MHC-like molecules MIC-A and MIC-B 
(131) which are ligands for the type C lectin NKG2D expressed on the surface of γδ TCR IEL 
in the GALT. Thereafter IEL lyse damaged cells in the mucosa (22, 131). 
Several other types of IEL are involved in regeneration of the epithelium. CD4+ CD8αα+ IEL 
are able to respond to self-MHC class I expressed on epithelial cell surface, and to express 
CD178 (Fas ligand) which induces apoptosis of IEC via Fas-dependent pathway (159, 437). 
Both αβ and γδ TCR IEL were also recently described as a potent source of angiotensin 
converting enzyme (ACE)(419), which is known to have a significant role in promoting 
apoptosis in epithelial cells (355, 407). 
After induction of apoptosis by IEL, epithelial cells are eliminated by LP dendritic cells to the 
mesenteric lymph nodes. However, the induction of IEC apoptosis implies to maintain the 
selective permeability of the epithelium. A recent study reported a novel function of IEL 
which contribute to the barrier function of the epithelial surface (160). Murine IEL from the 
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small intestine express junctional molecules like IEC. Zonula occludens (ZO)-1, occludin and 
junctional adhesion molecule (JAM), β-catenin and E-cadherin mRNA were found in IEL, 
which constitutively expressed occludin and E-cadherin at the protein level (160). 
Activated γδ TCR IEL regulate the homeostasis of the epithelium by producing the 
keratinocyte growth factor (KGF, also known as SDGF-3 in cattle (378)) and TGF-β. KGF is 
a specific mitogen for many epithelial cells but not for fibroblasts and endothelial cells. KGF 
stimulates the proliferation (36) and regulates the differentiation (198) of epithelial cells. 
TGF-β is a well-known growth factor for intestinal epithelial cells (18). The proliferation of 
IEC in vivo is reduced in the absence of γδ TCR IEL (198). 
 
2.3.4.5. IEL apoptosis 
 
The intestinal mucosa is chronically exposed to an abundance of dietary antigens and 
exogenous pathogens, and this continuous antigen challenge should constantly activate IEL 
and provide a constant state of inflammation. As IEL are activated in situ, the homeostasis of 
the mucosal immune system is strongly regulated (263). A high level of apoptosis contributes 
to maintain IEL homeostasis by limiting the proliferation of activated T cells and clearing 
primed lymphocytes. In physiological conditions, 25 % of human duodenal IEL were 
quantified as apoptotic (71). 
Investigations relative to IEL functions are further complicated by the high apoptosis rate of 
freshly isolated and in vitro cultured cells. The close association of IEL with epithelial cells 
appears to be the key mechanism of IEL survival in vivo. In absence of any stimulation, 
60 ± 16 % of IEL were apoptotic (annexin-V+) after 6 hrs of incubation and very few cells 
survived overnight (70). Cytokines, such as IL-7 and IL-15, produced by epithelial cells are 
known to enhance IEL survival in vitro (159), and to regulate IEL-TH1 cytokine production 
and cytotoxicity (70). However, stimulation of IEL by mitogens or activation through the 
TCR can compensate the lack of these survival promoters by increasing the expression of 
Bcl-×L. In addition, the induction of IEL death has been shown in mice to be regulated, at 
least partially, by endogenously produced glucocorticoids (46). 
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2.4. Shiga toxin-producing Escherichia coli (STEC) 
 
The STEC denomination for Shiga-toxin-producing Escherichia coli (E. coli) was adopted 
following the proposed classification of Calderwood et al. (47), due to the biological relation 
of the E. coli Shiga-like toxin to the Shiga toxin (Stx) produced by Shigella dysenteriae 
type 1. More than 400 serotypes of E. coli can produce Shiga toxins and are called Shiga 
toxin-producing E. coli (STEC) or Verocytotoxin-producing E. coli (VTEC) due to a high 
toxicity of the Shiga toxin to Vero cells (199, 284, 439). The term EHEC (enterohemorrhagic 
E. coli) denotes a subset of STEC and includes a clinical connotation. EHEC is used to denote 
strains, as E. coli O157:H7, that cause haemolytic uremic syndrome (HUS) and hemorrhagic 
colitis (HC), express Stx1 or 2, and cause Attaching and Effacing (A/E) lesions on epithelial 
cells (273). In contrast to STEC, all EHEC strains are believed to be pathogens for humans. 
STEC strains are found in the intestinal and faecal flora of several animals including sheep, 
cattle, goats, pigs, cats, dogs, chickens, and gulls (273, 301), and are often at the origin of 
food or waterborne infections of humans. 
 
2.4.1. STEC infections in humans 
 
STEC infections are a major cause of bloody diarrhoea, HUS, and HC in humans. HUS is 
characterised by an acute renal failure and a risk of persistent kidney damage (23) but other 
organs can be affected such as the brain and the pancreas. Due to lack of curative therapy to 
these diseases (395), diarrhoeagenic E. coli have been recently included on the Biodefense 
Research Priority Pathogens Category B list of the National Institute of Allergy and Infectious 
Disease (NIAID, USA) and are so considered to be of important public health concern. STEC 
were categorized as human pathogens following two major outbreaks (321, 413). The 
dominant STEC type most commonly implicated in large outbreaks in the United States, 
Canada, and the United Kingdom is O157:H7 but the serogroups 026, O103, O111, and 0145 
are also prominent in many european countries (42, 178, 416). STEC strains can be 
transmitted by water, vegetables or directly from person to person. Fruits (apples and 
cider)(343), vegetables (melon, lettuce, radish sprouts) and drinking water were also reported 
as causes of infections in humans. Person-to-person and contamination after farm and zoo 
visitations are common causes of EHEC infections as well (178). A potential airborne 
transmission after exposure to a contaminated building was also recently reported by Varma 
et al. (402). Due to the relative long time of E. coli survival in the environment (more than 10 
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months), there is still a significant risk of infection for humans even a long time after the 
initial contamination of an environment. In addition, it has been shown that E. coli 0157:H7 
can multiply within house-flies, which can then spread the bacteria in the environment (194, 
336). However, most of the cases reported are caused by ingestion of unpasteurized milk and 
undercooked contaminated meat, mainly of bovine origin (273). 
 
2.4.2. STEC infections in cattle 
 
2.4.2.1. Epidemiology 
 
Cattle appear to be the main reservoir of Stx-producing O157:H7 (37) and is the most 
important source of STEC strains pathogenic for humans (27, 114, 233). More than 120 
different O:H types have been isolated in cattle. A recent survey of healthy cattle in 
Switzerland reported that the majority of bovine STEC strains isolated (90 %) belonged to 
five serotypes previously reported in association with HUS, including the O157:H7 serotype 
(28). In addition, Ont:H- and ONT:H25 (non-typable) are present at high frequency in healthy 
cattle in Australia and North America (346). 
In adult ruminants, STEC are part of the normal gastrointestinal flora of healthy cattle, sheep, 
and deers. A high prevalence of STEC in cattle herds is reported from different countries 
worldwide (69, 77, 214). The reasons of the wide distribution of STEC in ruminants are not 
known but eventual benefits arising from colonisation by STEC are possible. Ferens and 
Hovde (103) reported that STEC strains, by producing Shiga toxins, can slow down the 
Bovine Leukemia Virus (BLV) -induced proliferation of bovine PBMC. Additionally, Stx1 is 
implicated in diarrhoea of calves (233)(see also 2.5.5.). 
 
2.4.2.2. Tropism, persistence and shedding 
 
O157 and non-O157 strains appear to have strikingly different tropisms. After an 
experimental challenge by STEC strains, of whom O26, bacteria could be recovered from all 
intestinal sites (399). In opposition, the initial binding of E. coli O157:H7 occurs in the 
follicle-associated epithelium of PPs within the small bowel in humans (302) and at the recto-
anal junction in cattle (274). This tropism for the mucosal epithelium of lymphoid follicles of 
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the recto-anal junction enables a longer colonization and a prolonged duration of shedding in 
the faeces (223, 274). 
STEC infections in cattle show two different age-dependent patterns. The infection of calves 
or neonates by STEC strains (O5, O26, O111, 0123, O157) may lead to development of 
diarrhoea (256), production of mucopurulent exudate in calves’ ileum and colon (331), and 
enterocolitis with formation of A/E lesions in small and large intestines (68, 374). STEC O5, 
O26, and O118 strains are often found to attach to the epithelium of the large intestine (372) 
(extensive adherence and A/E lesion), in part explaining the implication of these strains in 
diarrhoea in farm animals (399). However, O157:H7 strains are not pathogenic in adult 
animals in which the infection is persistent but mostly asymptomatic. In addition to A/E 
lesions observed in the intestine of experimentally infected calves (68, 69), E. coli O157:H7 
adhere to and form A/E lesions on the intestinal mucosa of adult bovine biopsies in vitro 
(302) and of naturally colonized adult animals in vivo (274, 275). 
Three different patterns of shedding were observed in ruminants: 1 week, 1 month, and 2 
months or more, suggesting that O157:H7 can persist a long time in the gastro-intestinal tract 
of ruminants (127). STEC serotypes involved in human diseases, including O26, O91, O103, 
and O111, can survive a long time in bovine faeces after shedding too and are a possible 
source of further contamination (113). 
 
2.4.2.3. Colonization factors 
 
Virulence factors differentially utilized by O157:H7 and O26 
STEC strains from different serotypes possess different virulence factors involved in the 
colonization. Non-O157 STEC strains (i.e. O26) utilize different virulence factors but 
apparently no type I fimbriae to colonize the intestine of calves (399). In contrast to O157 
strains in which the removal of the large plasmid containing the enterohemolysin EhxA and 
the E. coli secreted protein EspP has no effect on the pathogenesis of O157 in piglets (396), 
EhxA plays a role in O26 infection of calves (399). O26 strains interact with IEC, inducing an 
acute inflammatory response. In order to resist to the immune cells, O26 strains produce 
type III secreted proteins (EspA, EspD) and cytotoxins (EhxA, serine protease PssA) to 
inactivate the host immune response (399). 
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Several genes were recently reported to be commonly used by E. coli strains and to be 
particularly important for STEC colonization and survival in the bovine intestinal tract and 
persistence in water. In fact, mutations of ecf operon (E. coli attaching and effacing gene-
positive conserved fragments) and lpxM gene (lipid A myristoyl transferase) altered the 
motility and the survival of the bacteria in the bovine intestine (435). The putative structural 
component of the type III secretion apparatus (EscN), the non-LEE-encoded type III secreted 
effector D (NleD), and EspI/NleA (non-LEE-encoded effector A) were identified as essential 
for intestinal colonization (80, 132, 269). The locus of enterocyte effacement (LEE) is a 
pathogenicity island (PAI) located on a 35-45 kb fragment of the chromosomal DNA. LEE 
possesses more than 50 genes and ORF coding for translocated proteins and a type III 
secretion system and associated chaperones and is highly controlled by the quorum sensing-
regulated protein Ler (360). 
The E. coli factor for adherence (Efa1) is then required for an efficient colonization of the 
bovine intestinal tract by O26 STEC, since efa1 deletion and insertion mutants are shed in the 
faeces in significantly lower numbers (372). The efa1 gene is identical in size and 99.9 % 
identical in nucleotide sequence to the lymphostatin lifA gene of enteropathogenic E. coli 
(EPEC). The EPEC lifA and STEC efa1 genes encode predicted proteins of 366 kDa that are 
97.4% identical at the amino acid level. The EPEC LifA inhibits the proliferation and the 
mitogen-induced cytokine synthesis (IL-2, IFN-γ, IL-4) of human PBMC (192) and of human 
and murine IEL, indicating an influence in intestinal colonization by modulating mucosal 
immunity in the gut. 
While E. coli O157:H7 lacks the full-length efa1 gene, a large gene (toxB/l7095) with 
significant homology to efa1 also exists on the E. coli O157:H7 pO157 virulence plasmid. 
Efa-1 and ToxB indirectly influence the adherence by modulating the production and 
secretion of LEE-encoded type III secreted proteins EspA and Tir (372) that are required for 
the formation of A/E lesions. 
 
2.4.2.4. Establishment of Attaching and Effacing (A/E) lesions 
 
The initial step of the infection is the adherence of the bacteria to the surface and to the 
microvilli of the host epithelial cells followed by the development of the characteristic 
Attaching and Effacing (A/E) lesion. STEC are considered extracellular pathogens which 
intimately attach to the epithelial cell surface. The colonisation of the gut, formation of A/E 
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lesions and establishment of the disease in calves require the presence of a bacterial protein, 
the intimin. O157:H7-infected calves developed watery diarrhoea after 18 hrs and the enteritis 
could lead to the death of animals. The primary factors required for the initial adhesion to the 
cells of the mucosa are still unknown (233) but trigger the expression of several genes located 
on the LEE on the chromosome. The type III secretion system induces rearrangement of the 
cytoskeleton of the target cell, then leading to effacement of the microvilli, and 
polymerisation of actin. The bacteria create a more intimate adhesion to the epithelial cells by 
expressing and injecting specific proteins into host cells. STEC then induce the activation of 
the phosphatidylinositol (IP3) cascade in epithelial cells leading to an increased concentration 
of intracellular Ca2+, an important second messenger in cell signalling (163). The intimin 
encoded by the LEE gene eae is the major factor of this tight attachment (74) and is required 
to allow the persistence of a non-toxigenic O157:H7 E. coli strain in the bowel of sheep (424). 
The intimin is a type II outer membrane protein (OMP) binding to its receptor Tir 
(Translocated intimin receptor), a bacterial protein injected into the host cells by the type III 
secretion system. STEC translocate both their own receptor (Tir) and an Nck-like protein 
called TccP (Tir-cytoskeleton coupling protein) to facilitate the polymerization of actin (117). 
The binding intimin-Tir amplifies cell cytoskeleton modifications leading to the formation of 
a pedestal enabling the settlement of the bacteria. 
The A/E lesion caused by EHEC is not directly responsible for the diarrhoea in humans. 
However, the cytokine-induced inflammation, the opening of the tight junctions, the increase 
of paracellular permeability, or modification of ions absorption have been showed in vitro as 
consequences of bacterial adherence and proposed as more potent causes of the diarrhoea 
in vivo. 
 
 
2.5. Shiga toxins (Stx) 
 
Even if an asymptomatic carriage of STEC O157:H7 was eventually found in specific cases 
of farmers or their relatives (352), STEC strains are pathogenic for humans due to the 
presence of the Shiga toxins (Stx), which are the main virulence factors of STEC. The E. coli 
Stx was first identified in 1983 by Karmali et al. (181) in stools of sporadic HUS patients. 
STEC can produce several toxins designated Stx1, Stx1c, Stx1d, Stx2, Stx2c, Stx2d, Stx2e, 
Stx2f. A total of 11 variants of Stx2 have been described yet. Several subvariants of Stx2d 
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have also been identified. In particular, E. coli Shiga toxin 1 (Stx1) has been identified as a 
virulence factor both in human (287) and in cattle (251). 
 
2.5.1. stx genes structure 
 
The stx1 and stx2 A and B subunits genes exist as a tandem Open Reading Frame (ORF) 
coding for A and B subunits transcribed from a 5’ iron-regulated promoter to the stxA gene 
(339, 412) in the central position of lambdoid bacteriophages in E. coli STEC strains (153, 
164, 276, 288). These phages are present in two different states, alternatively “lysogenic” and 
“lytic”, and possess transcription units for various functions, such as replication and lysis. 
During the lysogenic period, the genome in incorporated into the bacterial chromosome and is 
replicated by the host machinery. In contrast, during the lytic phase, the phage excises itself, 
replicates and produces the Shiga toxin. The entry into the lytic phase induces the death of the 
bacteria spreading Stx in the lumen of the intestine. The toxin production is coupled with the 
phage release during lytic growth because stx genes are found in the late operons of the 
phages (305) along with lysis genes downstream of the Q transcription activator which 
modifies  transcription complexes initiating at the late promoter pR‘ (276). In addition, several 
promoters can contribute to stx1 transcription, such as the iron-regulated promoter pStx1 and 
the phage promoters pR regulated by prophage induction (404). Phage-inducing agents such as 
mitomycin C are known to increase Stx production by E. coli (4). 
 
 
2.5.2 Stx 1 protein structure 
 
Shiga toxin 1 from E. coli is part of a family of heterodimeric toxins composed of the Heat-
labile enterotoxin of E. coli, the cholera toxin of Vibrio cholerae, ricin, and several other plant 
toxins. Stx1 and Stx from Shigella dysenteriae are the most similar members of the family 
(99 %)(286). Their B subunit is identical (48, 67) and only one amino acid in their A subunit 
differs between these two toxins (Ser45 for Stx vs Thr45 for Stx1)(375). Stx1 and Stx2 
proteins have been reported to be 56 % identical in amino acid sequence and are 
immunologically distinct (286). 
Each molecule of Stx is composed of one A subunit (315 amino acids) non-covalently linked 
to a doughnut-shaped pentamer of B subunits (89 amino acids each)(67). Studies to 
understand the regulation of the stoichiometry of Stx subunits (1A:5B) revealed that this 
Literature review 
 - 25 - 
regulation takes place on both transcriptional and translational levels. A second promoter for 
the B subunit, a Ribosome Binding Site (RBS)(136), and secondary structures in the mRNA 
surrounding the RBS lead to the over-expression of the B-subunit. 
The StxA subunit (32 kDa) is, after cleavage, enzymatically active in the cytosol of the target 
cells. The processing of StxA is performed by a serine protease, the enzyme furin (118, 119) 
which is located in the Golgi apparatus and the endosomes. The proteolytic cleavage of Stx is 
important for the activation of the toxin and facilitates rapid intoxication of target cells (334). 
StxA is processed into a 27.5 kDa A1 fragment (enzymatically active) and a small 
A2 fragment (3 kDa) that blocks the catalytic centre in the intact A subunit and mediate the 
A-B association (11). 
Each B subunit of Stx1 (7.5 kDa) is composed of two three-stranded anti-parallel β-sheets 
which are linked together through hydrogen bonds and form a β-barrel. This β-barrel is then 
capped by an α-helix located between β-strands 4 and 5 of each monomer (365). The B 
subunit of Stx1 is responsible for the binding of the toxin to the glycosphingolipid Gb3/CD77. 
The affinity of binding of Stx is related to the presence of a phenyl ring of phenylalanine-30 
in the StxB subunit and to the presence of a terminal galactose in Gb3/CD77 (221). 
Ling et al. (220) and Bast et al. (20) showed that three biologically relevant Gb3-binding sites 
are present on each StxB monomer (3 × 5 for the holotoxin). Even if the site 1 and 2 are more 
physiologically significant, this multiplicity enhances the avidity of the B pentamer for the 
cell membrane surface (358). Functional studies confirmed that the uptake of the toxin 
mediated by sites 1 and 2 is important for both toxicity and cytokine production, while site 3-
mediated uptake plays an auxiliary role (423). 
The release of Stx by the bacteria happens in the lumen of the intestine. However, StxA1 has 
the same toxic effect on bacterial ribosomes (Inhibitory concentration for 50 % of the 
ribosomes IC50 = 0.8 nM) than on eukaryotic ribosomes (IC50 = 1 nM)(377). Consequently, 
Stx is found in vesicles released by Shigella dysenteriae (78). Similarly, E. coli 0157:H7 
produce spherical vesicles (20-100 nm) composed of an intact membrane bilayer carrying 
DNA and proteins (197). This way of secretion of Stx1 allows a protection of other bacteria, 
from exogenous proteases, and can be an effective mechanism for the transfer of the toxin 
directly to target cells of the mucosa. Consequently, Stx can be detected in faecal samples of 
STEC-infected human (180, 386) and cattle (17, 156). After being released, the toxin is 
absorbed through the mucus and the intestinal epithelial barrier. 
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2.5.3. Gb3/CD77 as a receptor and cellular processing of the toxin 
 
The toxin binds to the globotriaosylceramide Gb3/CD77 (αGal(1-4)βGal(1-4)βGlc-ceramide), 
a neutral glycosphingolipid without a cytoplasmic domain (195) expressed on the surface of 
different types of mammalian cells (109). Gb3/CD77 is a marker for the germinal centre stage 
of B cell development (14) and is also a Burkitt’s lymphoma associated antigen (285). The 
expression of glycosphingolipids and consequently the susceptibility to Stx occur as a 
function of the cell cycle. Pudymaitis and Lingwood showed that stationary phase cells are 
resistant to the toxic effects of Stx (314). 
All the physiological functions of Gb3/CD77 in vivo are not yet known. However, 
glycosphingolipids are involved in signal transduction pathways and cell surface-associated 
mechanisms. Gb3/CD77 seems to be specifically required for the interferon-induced inhibition 
of B cell growth (236). It has also been suggested that Gb3/CD77 may act in the intracellular 
transport of proteins such as CD19 (185), a member of a complex involved in modulating the 
signal transduction through the BCR. CD19 possesses StxB-like regions potentially 
explaining the interaction with Gb3/CD77 (220, 237) and the retrograde transport into the 
cells (185). As a Stx-like amino acid sequence was found on the β-chain of human and murine 
MHC class II molecules, Gb3/CD77 is thought to be involved in the interaction of the antigen 
and the MHC molecule. Gb3/CD77 could therefore play a functional or regulatory role in 
MHC class II-mediated functions specifically related to antigen presentation by B-cells to T 
helper cells in humans (121). 
In humans, Stx mainly exerts its cytotoxicity on renal glomerular and vascular endothelial 
cells (289). Both cell types express the toxin receptor Gb3/CD77 on the cell surface (38). The 
Stx-induced damage of renal endothelial cells and the induction of apoptosis by decreasing 
the expression of anti-apoptotic protein (93, 94) are the central steps of the pathogenesis. To 
reach target cells so far from the primary site of infection, Stx can circulate in the human 
blood bound to B-cells, monocytes, polymorphonuclear leukocytes (PMN), and erythrocytes 
(318). The potential implication of PMN was suggested by an increase in PMN number 
during the HUS. Stx bind to PMN and can be then transferred to human glomerular 
endothelial cells (389). 
Stx are also able to cross through human intestinal epithelial Caco-2 and T84 cell lines 
without destroying or altering the functions of the thigh junctions (3, 154, 155). However, Stx 
can indirectly increase the permeability of the tight junctions by inducing chemokine 
production by IEC leading to intense migration of PMN. Other bacterial strains are able to 
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induce such a trafficking of PMN across polarized intestinal epithelial cells. Shigella flexneri 
increases the migration of PMN and this plays an important role in the early stages of 
infection by opening the paracellular pathway (244). 
In cattle, the Stx receptor is present on the surface of intestinal epithelial cells, kidney cells 
(tubules and collecting ducts)(148), bovine peripheral lymphocytes, and intestinal IEL (248, 
254). However, bovine endothelial cells from kidney glomeruli and intestine and bovine 
granulocytes lack Gb3/CD77 expression (312)(Menge et al., submitted). This observation 
contributes to explain the discrepancies between human and cattle concerning the disease and 
the absence of vascular damages due to the toxin during STEC infections in adult cattle. 
The presence of cholesterol in the lipid bilayer significantly enhances the binding of Stx1 to 
Gb3/CD77. Interestingly, human intestinal epithelial cells which lack Gb3/CD77 can still take 
up Stx1. Then a transcellular mode of transport was confirmed by observation of the toxin in 
endosomes and associated with specific targets including the trans-Golgi network (TGN), the 
endoplasmic reticulum (ER), and the nuclear membrane (303). Thus, a Gb3/CD77-
independent retrograde transport route exists in T84 cells for Stx1 that does not induce cell 
damage (340). 
After binding to Gb3/CD77, Stx can be endocytosed by the clathrin-coated pits pathway (333) 
or independently of clathrin (98) and can reach the Golgi apparatus by a non-conventional 
retrograde transport via the endocytic early/recycling compartment and then through 
structures containing the γ-adaptine AP-1 (235). By this mechanism, Stx avoid to cope with 
the degrading environment of the late endosomes. Stx was the first molecule to be shown to 
be transported from the cell surface to the Golgi apparatus and the endoplasmic reticulum by 
retrograde transport (332) related with cholesterol-rich microdomains (lipid rafts) in HeLa 
cells (98). 
The StxB subunit can also use a Rab6-dependent COP-I-independent retrograde transport to 
be delivered from the TGN to the ER (123). Once in the ER, Stx binds to HEDJ (Hsp40 
chaperone), Sec61 (central core of the ER translocation channel), and to BiP (ER-localized 
chaperone), composing the translocon which is involved in retrotranslocation of proteins to 
gain access to the cytoplasm (97, 438). 
However, in some resistant cells, Stx1 can be differently processed. In contrast to what is 
observed in human IEC which lack Gb3/CD77, bovine crypt epithelial cells of the small and 
large intestine express Gb3/CD77 on the cell surface (148) but escape Stx-mediated cell 
toxicity by routing the endocytosed toxin to the lysosome rather than to the endoplasmic 
reticulum (149). 
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2.5.4. Mode of action of Stx 
 
2.5.4.1. Damage of nucleic acids 
 
Using the transmembrane protein complex, Stx is released from the ER in the cytosol, cellular 
compartment in which the StxA1 subunit exerts its cytotoxic activity by catalysing the same 
depurination reaction as ricin does (90). Stx target the 28S rRNA of the 60S ribosomal 
subunit (89) by cleaving the N-glycosidic bond and by specifically removing the adenine 
A-4324 in ribosomal RNA (90). In addition, Stx inhibit the elongation factor (eEF-1 and 
eEF-2) -dependent binding of aminoacyl-tRNA to ribosomes (in particular of Phe-tRNA), and 
consequently irreversibly inhibit the protein elongation (290). 
Recent evidences also indicate that Stx can directly damage DNA (removal of adenine 
moieties), inhibit the DNA repair, and can sometimes cause transformation-like changes in 
mammalian cells (344). 
 
2.5.4.2. Induction of apoptosis 
 
Apoptosis is very important physiological process indispensable to allow a coherent 
development and to maintain the homeostasis of the organism. This highly regulated process 
is first composed of three manifestations as the loss of mitochondrial membrane potential, the 
activation of the caspases, and the internucleosomal DNA fragmentation. Then the so-called 
“flipping” of phospatidylserine from the internal to the external side of the cellular membrane 
happens. The last steps of the apoptotic process are the permeabilization of the nuclear 
membrane, the vacuolation of the cytoplasm, the collapse of the cytoskeleton, the blebbing of 
the cell membrane, and the final formation of apoptotic bodies (59). 
In contrast to necrosis, no inflammation is observed during apoptosis. Consequently, some 
pathogenic agents or associated toxins can specifically induce apoptosis of target cells to 
decrease or slow down the immune response in order to ease the bacterial infection. Stx1 
shares this ability with several toxins from bacteria. These toxins are part of the large group of 
RIPs (ribosome inactivating proteins) which share similarities in cell processing (entry and 
transport) and mode of action to exert their cytotoxicity. 
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The ability of Stx1 holotoxin or StxB1 subunit to induce apoptosis has already been 
extensively studied on several cell lines as Burkitt’s lymphoma cell lines (182, 189, 240, 241, 
261, 382, 391), ACHN, THP-1, and astrocytoma cells (8, 196, 384). In Ramos cells, Stx1 
holotoxin induced a caspase-dependent apoptosis very efficiently after 18 hrs of incubation 
(241). Stx1-mediated apoptosis is Fas- and TNFR-independently mediated. Anti-Fas antibody 
or TNF-α do not affect the Stx1 mediated apoptosis of Ramos cells. Stx1 can induce apoptosis 
by triggering the signaling cascade linked to Gb3/CD77 (189) in a caspase and mitochondria-
dependent pathway (391). StxB1 and the cross-linking of Gb3/CD77 with antibody trigger as 
well apoptosis in Burkitt’s lymphoma B cells (240) but not in Vero cells (420). 
Stx also induce apoptosis in a dose- and time-dependent manner of the human epithelial cell 
lines Hep-2, Caco-2, HeLa expressing Gb3/CD77 (63, 112, 172). Apoptosis was shown to be 
induced by the caspase 3 and the activation of stress-activated kinase cascade JNK/SAPK and 
p38 (357). 
Stx induce apoptosis of endothelial cells isolated from various sites, which appear to be very 
sensitive to low amounts of toxin (10-100 fM). The Stx holotoxin inhibits the expression of 
the anti-apoptotic FLICE-like inhibitory protein (FLIP, inactive homologous of caspase 8) 
and of Mcl-1, a member of the anti-apoptotic Bcl-2 family (93, 94). The Stx-induced cell 
death also involves the pro-apoptotic Bak factor (421). The StxB subunit also induces 
apoptosis of endothelial cells in the nanomolar range of concentration (304). 
Human endothelial cells are resistant to LPS-induced apoptosis. However, a pre-treatment 
with reduced amounts of Stx1 increases the sensitivity of the cells to apoptosis mediated by 
LPS (94). In addition, the fact that pro-inflammatory cytokines such as TNF-α also contribute 
to the vascular damages (304, 316) suggests that cytokines, Stx1 and LPS may act in concern 
in vivo to induce endothelial cell death in humans. 
 
2.5.4.3. Induction of ribotoxic stress response and cytokine expression 
 
Stx1 treatment of monocytic THP-1 cells induced a ribotoxic stress response and the 
activation of the transcriptional factors NF-κB and AP-1 (329). IL-1β and TNF-α are 
produced by macrophages when stimulated with purified Stx in vitro (317, 390, 401). Without 
inducing apoptosis, Stx enhances the production of TNF-α and GM-CSF from human 
peripheral blood monocytes in a p38 MAP kinase (mitogen-activated kinase) and ERK 
(extracellular-regulated kinase) dependent pathway. Investigations with the 
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monocyte/macrophage THP-1 cell line in vitro revealed that the enzymatic activity of Stx1 
was required (140). Several chemokine mRNAs were induced by Stx1 in THP-1 cells but a 
poor correlation was found with the amount of secreted proteins (IL-8, MIP-1α, -1β, and 
GRO-β) confirming a post-transcriptional regulatory effect (139). Stx1 increased both TNF-α 
mRNA and protein production in vitro by triggering the transcription factors NF-κB and AP-1 
complex pathways (329) but was a poor inducer in vivo in mice (423). 
Human vascular endothelial cells are the main targets of Stx1 in the course of the disease in 
humans. The surface expression of the receptor Gb3/CD77 can be increased by endogenous 
cytokines including TNF-α, -β and IL-1β (398). However, renal and intestinal endothelial 
cells do not produce TNF-α themselves. 
As Stx does not induce apoptosis in human PMN (356), activated PMN and monocytes 
produce cytokines (IL-1, TNF-α) inducing the expression of Gb3/CD77, VCAM-1, and 
ICAM-1 by glomerular endothelial cells (262), then leading to the adhesion of PMN to the 
endothelium and inflammation. Similarly to Stx1, Stx2 triggers leukocytes’ adhesion and 
transmigration via a NF-κB dependent up-regulation of IL-8 and MCP-1 (443). An enhanced 
adhesion to endothelial cells and degranulation of PMN has also been described in vivo in 
HUS patients, associated with increased levels of IL-6, IL-8 and TNF-α in serum. Stx increase 
the formation of superoxide in PMN but fail to increase the formation of oxygen radicals. 
Moreover, PMN exposed to Stx1 have both reduced bacterial phagocytosis and 
responsiveness to mitogens (188). 
In addition to endothelial cells and PMN, glomerular epithelial cells are early targets of Stx 
and release pro-inflammatory cytokines, vasoactive factors and enzymes contributing to 
spread the damages in humans (258). Stx induce the production of the chemokine IL-8, GRO- 
(α, β, γ) mRNA, and both ENA-78 mRNA and protein by intestinal epithelial cell lines (393). 
The interaction between Stx and its receptor induces the activation of the protein kinase p38 
(392), and expression of the primary stress response genes c-jun and c-fos in IEC (357), 
indicating the importance of the ribotoxic stress response pathway. Stx1 also induces the 
stabilization of IL-8 and GRO-α mRNA in epithelial cells and this induction by Stx require 
the enzymatic activity of the toxin (432). 
Taken together, in addition to clearly inducing cytotoxic effects on target cells, Stx1 triggers 
other cell types to produce mediators which then participate to up-regulate the endothelial 
expression of Gb3/CD77 (259) and to spread the vascular damages. 
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2.5.5. Effects of Stx in cattle 
 
The majority of strains isolated from calves with diarrhoea are positive for stx1 (233). Several 
reports confirmed that Stx is produced in the intestine of cattle and can be recovered in faeces 
from bovine (17, 156) and is consequently thought to influence the colonization of the 
intestine by STEC strains (148). In opposition to the implication of Stx in the development of 
diarrhoea observed in humans, pigs, and rabbits, the significance of Stx in the intestine of 
cattle is different. In fact, Stx is not indispensable for the ability of STEC strains to colonize 
(399) and to induce diarrhoea in neonatal calves (69). Moreover, Stx-negative O157:H7 
strains could induce diarrhoea and colonic oedema in neonatal calves independently of A/E-
lesion, intimin, or Stx1 (368). In addition, cattle lack the vascular receptor for E. coli Shiga 
toxins and this leads to a lack of vascular damage in adult cattle (312). Stx1 does not bind to 
blood vessels of intestinal organs and viable E. coli O157:H7 or Stx-containing bacterial 
extracts are not enterotoxic in ligated ileal loops in newborn calves in vivo. 
Nevertheless, Stx1 has been confirmed as a virulence factor in adult cattle (251) and to 
suppress functions of bovine lymphocytes which express a functional receptor (249, 253, 
363). In fact, Stx1 holotoxin and B subunit bind to stimulated bovine PBMC (B and CD8+ T 
cells) which are highly sensitive to Stx1 (363). In contrast to human, both B and T cells are 
affected by the toxin in cattle, suggesting a more broad impact of Stx on the bovine immune 
system. Stx1 blocks the mitogen-induced activation and proliferation of bovine lymphocyte 
subpopulations without inducing apoptosis (254), independently of IL-2, TNF-α and IFN-α  in 
vitro (249), and in vivo (151). Stx1 also specifically blocks bovine leukaemia virus (BLV) -
dependent initiation of bovine lymphocyte proliferation in culture (103). BLV-infected B cells 
are selectively eliminated from cultures and this effect of Stx1 requires the enzymatic activity 
of StxA1 (102) which reduces the viral protein synthesis, interrupts virion assembly, and 
induces cell death (21). Stx1A inhibits the production of the viral p24 protein by bovine 
PBMC. Both Stx1 and 2 exert an antiviral activity and limit the BLV infection in cattle by 
slowing the progression of the infection to its malignant end stage (21). 
Recently, intestinal intraepithelial lymphocytes, the first immune cells to gain contact with the 
toxin in the whole body, have been shown to express Gb3/CD77 and to be the main target of 
Stx1 in the bovine gut (248, 251). Ileal IEL are strongly affected by Stx1 which reduces the 
percentage of mitogen-induced-transformed blast cells within all subpopulations identified. 
An in vivo model of ligated ileum (calf) revealed that Stx1 specifically depletes the ileal 
mucosa of a certain subset of CD8α+ Gb3/CD77 expressing T lymphocytes (251). The rStxB1 
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subunit binds to iIEL ex vivo and in particular to CD8α+ iIEL and to iIEL co-expressing 
TcR1-N12, a pan γδ TCR cell marker in cattle. However, the consequences of this effect on 
bovine iIEL for the mucosal immunity remain to be elucidated since Stx1 does not affect the 
NK activity of iIEL in vitro and in vivo against a bovine lymphoma cell line (BL-3 
cells)(248). 
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3. Materials and methods 
 
3.1. Isolation of bovine ileal intraepithelial lymphocytes (iIEL) 
 
Ileal IEL were isolated following the procedure described by Menge et al. (248) with slight 
modifications. Briefly, the isolation was based on incubation of ileal mucosa with EDTA and 
mechanical detachment followed by density gradient centrifugation. Gut specimen (distal 
ileum) were obtained from freshly slaughtered adult cattle older than 24 months from the 
local slaughterhouse (Giessen, Hessen, Germany). The ileum was incubated for 25 min in 
erlenmeyer flask with phosphate-buffered saline (PBS; see 8.2. for all recipes of buffers and 
cell culture media) supplemented with 1 mM of 1,4-Dithiotreitol (DTT, Carl Roth GmbH, 
Karlsruhe, Germany) at 37°C under constant shaking (100 rpm). After the examination of the 
mucosal surface and the removal of eventual parasitic nodules, specimen were cut into strips 
(0.5 - 1 cm), transferred to 50-ml centrifugation tubes (Greiner, Frickenhausen, Germany) 
containing 35 ml of PBS-EDTA-AB (PBS supplemented with 2 mM of Ethylenediamine 
Tetraacetic Acid [EDTA], 100 IU/ml of penicillin, 100 µg/ml of streptomycin [PAA 
Laboratories GmbH, Pasching, Austria] and 50 µg/ml of gentamicin [Biochrom AG, Berlin, 
Germany]), and incubated for 20 min at 37°C under constant shaking (100 rpm). The tissues 
were vortexed for 2 min at full speed and supernatants were passed through nylon wool 
(Biotest AG, Dreieich, Germany) disposed into 50 ml-Multistepper tips (Eppendorf, 
Hamburg, Germany). The cells were collected by centrifugation (250 × g, 8 min, 20°C), 
resuspended in 25 ml of Percoll solution (Sigma-Aldrich Chemie, Steinheim, Germany, 
density adjusted to δ=1.0500 g/ml with PBS-EDTA 1X (PBS supplemented with 5.4 mM 
EDTA), and layered on 10 ml of Percoll solution (δ=1.0816 g/ml). After centrifugation 
(652 × g, 20 min, 20°C, Ominifuge 2.0 RS, rotor type 2251, Heraeus Holding GmbH, Hanau, 
Germany), the cells were carefully recovered from the Percoll-Percoll interface, washed once 
with 20 ml of PBS-EDTA 1X (202 × g, 7 min, 20°C) and once with 20 ml of PBS 1X. The 
cell number was estimated by live-dead exclusion in a Neubauer chamber after a dilution 1:20 
with trypan blue solution. The iIEL (2 × 107) were transferred to reaction tubes (Eppendorf), 
centrifuged (350 × g, 5 min, 20°C) and directly lysed in 600 µl of RLT buffer (RNeasy® Mini 
Kit, QIAGEN, Hilden, Germany) supplemented with 1 % of β-mercaptoethanol (Fluka, 
Taufkirchen, Germany), or were resuspended and cultured in IEL-medium (78 % RPMI 1640 
with 2 mM stabilized L-glutamin and 2.0 g/l NaHCO3 [PAN™ BIOTECH GmbH, 
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Aidenbach, Germany], supplemented with 20 % of heat-inactivated foetal calf serum [FCS, 
Biowest, Essen, Germany], 100 IU/ml of penicillin, 100 µg/ml of streptomycin, 2.5 µg/l of 
amphotericin B [PAA Laboratories GmbH] and 2.5 µg/ml of gentamicin [Biochrom  AG]). 
 
 
3.2. Immunophenotyping of iIEL 
 
Ileal IEL were immunolabeled and analysed by flow cytometry to control the quality of the 
preparation. Freshly isolated iIEL were washed twice by centrifugation with 10 ml of PBS 1X 
(202 × g, 7 min, 20°C) and transferred into wells of a V-shaped microtiter plate (Greiner) at 
the density of 4 × 105 per well, and centrifuged (400 × g, 3 min, 20°C, in Eppendorf 5403 
centrifuge [rotor type 16 M2-MT, Hamburg, Germany]). Ileal IEL were stained for several 
surface-expressed antigens by incubation 20 min in the dark with the antibodies listed in 
table 1, as previously described (248). Some of the antibodies used in this study were 
produced by hybridoma cell lines kindly provided by J. Naessens (International Livestock 
Research Institute [ILRI], Nairobi, Kenya). Some antibodies were also purchased from 
VMRD, Inc. (Pullman, WA, USA)(see table 1). The anti-human CD77 antibody (clone 38.13) 
was purchased from Beckman-Coulter GmbH (Krefeld, Germany). 
The cells were next centrifuged (400 × g, 3 min, 20°C) and washed once with PBS 1X and 
resuspended 20 min in the dark in 50 µl of secondary antibody. A goat anti-mouse IgG 
(Heavy and Light chains) conjugated with fluorescein isothiocyanate (FITC) was purchased 
from Dianova (Hamburg, Germany) and was used diluted 1:400 in PBS 1X. An anti-rat IgM 
conjugated with phycoerytrin (PE) was purchased from Beckman-Coulter GmbH (Krefeld, 
Germany) and was used diluted 1:200 in PBS 1X. One microgram of 7-amino actinomycin D 
(7-AAD, Sigma) was added per ml of secondary antibody suspension. The staining with 
7-AAD, which is capable to bind DNA, indicates an increased permeability of the cell 
membranes and can be used as a death stain (338). The cells were next centrifuged (400 × g, 
3 min, 20°C), washed twice with PBS 1X, resuspended into 100 µl of PBS 1X and transferred 
into 5 ml-FACS tubes containing 200 µl of PBS 1X. Five thousand events were acquired by a 
FACSCalibur™ flow cytometer (Becton-Dickinson [BD], Heidelberg, Germany) using the 
acquisition software Cell Quest Pro (BD). 
The analysis of the data was performed with the software FCS express 2 (De Novo software, 
Thornhill, Ontario, Canada). The gating of the cell populations allowed the exclusion of 
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apoptotic/necrotic cells which took up the death dye 7-AAD and to analyse the expression of 
antigens on viable iIEL only. 
 
Table 1. Antibodies specific for bovine antigens used for iIEL immunuphenotyping 
 
Antigen 
specificity 
Hybridoma cell line Isotype 
Cell 
distribution Supplier Condition of use 
CD4 IL-A11  IgG2a T helper ILRI 50 µl, pure 
1) 
CD8α IL-A105 IgG2a T cytotoxic ILRI 50 µl, pure 
1) 
CD8β BAT82A IgG1 T cytotoxic VMRD 50 µl, 1:800 
2) 
CD21 IL-A65 IgG2a B ILRI 50 µl, pure 
1) 
CD25 IL-A111 IgG1 T and B ILRI 50 µl, pure 
1) 
CD77 4) 38.13 IgM various Coulter 50 µl, 1:20 3) 
TcR-N12 CACT61A IgM γδ T VMRD 50 µl, 1:200 2) 
WC1 IL-A29 IgG1 γδ T CD2
- ILRI 50 µl, pure 1) 
CD = Cluster of Differentiation, WC = Workshop Cluster, ILRI = International Livestock Research 
Institute, VMRD = Veterinary Medical Research & Development. 1) hybridoma cell line supernatant,       
2) diluted in PBS + 1 % BSA, 3) diluted in PBS, 4) anti-human CD77 antibody. 
 
 
3.3. Isolation of bovine peripheral blood mononuclear cells (PBMC) 
 
Bovine PBMC were isolated following the method of Bøyum (39) modified as described by 
Menge et al. (254). PBMC were isolated by density gradient centrifugation using Ficoll-
Paque™ Plus (Amersham Biosciences Europe GmbH, Freiburg, Germany). Blood was 
obtained from healthy cows of the dairy herd of the Teaching and Research Farm of the 
University (“Oberer Hardthof”) with 60 ml syringes pre-filled with 12 ml of citrate solution 
(20 % of 3.8 % sodium-citrate and 80 % of blood). Twenty millilitres of citrated blood were 
diluted with 17 ml of PBS-EDTA 1X in a 50 ml-centrifugation tube in order to reduce the 
tendency of erythrocytes to aggregate and to trap lymphocytes. The diluted blood was then 
carefully layered onto 12 ml of Ficoll-Paque™ Plus that was previously placed at room 
temperature for an optimal cell separation (density of Ficoll-Paque™ Plus is 1.077 g/ml). A 
centrifugation was performed during 45 minutes at 800 × g, and 20°C with smooth 
deceleration to keep the different phases separated. The plasma was then removed and the 
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interphase PBMC-Ficoll-Paque™ Plus was recovered and transferred to a 50 ml-
centrifugation tube. PBS-EDTA 1X was added up to 50 ml to disrupt the gradient and a 
centrifugation was performed to pellet the cells at 249 × g during 8 minutes at 20°C. In order 
to remove the eventual contaminating erythrocytes, the cell pellet was then resuspended in 
10 ml of erythrocyte-lysis buffer (8.26 g NH4Cl, 1.09 g NaHCO3, and 0.037 g Na3EDTA per 
1 litre of distilled water) and incubated for 5 minutes at room temperature. Ten millilitres of 
PBS-EDTA 1X were added to restore the osmolarity and the cells were centrifuged at 202 × g 
during 7 minutes at 20°C. The PBMC were next washed once with 10 ml PBS-EDTA 1X and 
once with 10 ml PBS 1X. The pellet of PBMC was resuspended in 3 ml of PBMC-medium 
containing RPMI 1640 with stabilized L-glutamine and 2.0 g/l NaHCO3 (PAN™ BIOTECH 
GmbH), 10 % fetal calf serum (Biowest) and 3 µM β-mercaptoethanol (Fluka, Taufkirchen, 
Germany). The cell number was estimated by live-dead exclusion in a Neubauer chamber 
after a dilution 1:10 with a trypan blue solution. 
 
 
3.4. Cultivation of bovine lymphocytes for RNA isolation 
 
Freshly prepared iIEL were seeded in 6-well plates in IEL-medium (2 × 107 in 9 ml). For 
lymphocytes’ stimulation, the medium was supplemented with phytohemaglutinin-P 
(2.5 µg/ml, PHA-P, Sigma-Aldrich). The cells were then incubated in absence or presence of 
purified Stx1 (7, 15, 22, 30, 66, 90, 180, or 200 CD50/ml, as determined on Vero cells (254) 
with an equivalence of about 1 CD50/ml to 1 pg/ml (292). The Shiga toxin 1 was purified in 
our institute by Dr. Menge and Dr. Stamm, and the methods for Stx1 preparation and 
purification were published by Menge et al. (254). Briefly, Stx1 was obtained from the STEC 
strain 2403 (rough, H-), purified by affinity chromatography (FPLC®, Amersham Biosciences 
Europe GmbH) (resin Cibacron blue 3G-A linked to agarose beads), dialyzed against 10 mM 
sodium phosphate buffer, and purified by immunoaffinity chromatography (MAb 13C4 anti-
StxB1 coupled to protein A/G agarose). Finally, the preparation was passed through a Detoxi-
Gel™ column (Pierce) to reduce the amount of endotoxin, and analysed by SDS-PAGE. The 
titration of the preparation by a cytotoxic assay using Vero cells (ATCC CRL 1587) 
established the concentration at 65,000 CD50 per ml. The Limulus amoebocyte lysate assay 
indicated a concentration of 0.17 ng of endotoxin per ml. The iIEL were incubated for 4, 6, 8, 
18 or 24 hrs at 37°C in 5 % CO2 and 95% humidity, and then resuspended in the wells, 
transferred to 50 ml-centrifugation tubes, washed once with PBS (202 × g, 7 min, 20°C) and 
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lysed in 1.5 ml-reaction tubes with 600 µl of RLT buffer (RNeasy® Mini Kit, QIAGEN) 
supplemented with 1 % β-mercaptoethanol and stored at -70°C. Supernatants of 8 and 18 hrs 
cultures were recovered, aliquoted in 2 ml-reaction tubes and immediately frozen at -20°C. 
These supernatants were later used for ELISA and neutrophil migration assays. 
Based on previous results that the effect of Stx1 on iIEL could not always be neutralized by 
the anti-StxB1 antibody 13C4 (31), iIEL (2 × 107 in 9 ml) were stimulated with PHA-P 
(2.5 µg/ml), and several concentrations of Stx1 were applied to the cultures (7.5, 15, 30, 90, or 
180 CD50/ml Stx1, as determined on Vero cells) with a fixed concentration of 1.5 µg/ml of 
anti-StxB1 monoclonal antibody 13C4. As controls, the cells were incubated only with either 
a) IEL-medium (= visualized as 100 %), b) Stx1 (180 CD50/ml), c) an anti-StxB1 antibody 
13C4 (1.5 µg/ml). The iIEL were harvested after 6 hrs of cultivation, transferred to 50 ml-
centrifugation tubes, washed twice by centrifugation with PBS 1X (202 × g, 7 min, 20°C), 
and lysed in 600 µl of RLT-buffer (Qiagen). 
The monoclonal antibody 13C4 (376) was used at the concentration of 1.5 µg per ml to 
neutralize the effect of Stx1 on the different types of cells used in this study. The 13C4-
containing supernatant was obtained by culturing the hybridoma cell line. The preparation 
was then purified by affinity chromatography (Protein G, FPLC®) and titrated by 
neutralization of the cytotoxic effect of Stx1 on Vero cells (363). 
Bovine PBMC were seeded in 6-well plates in PBMC medium (2 × 107 in 9 ml) supplemented 
with 5 µg/ml PHA-P, incubated for 6 or 20 hrs at 37°C in the absence or presence of purified 
Stx1 (33 CD50/ml) or with Stx1 pre-incubated at 37°C with the anti-StxB1 antibody 13C4 
(f.c. 1.5 µg/ml) during 90 minutes. The PBMC were then resuspended, washed twice in PBS, 
and lysed as described for iIEL in 600 µl RLT buffer and stored at -70°C. 
 
 
3.5. Quantitation of cytokine/chemokine mRNA in vitro from bovine lymphocytes 
 
3.5.1. Isolation of total RNA from lymphocytes 
 
The samples (lymphocytes lysed in RLT buffer) were thawed 5 min at 37°C and homogenized 
by passing through a 20 Gauge-needle fitted to a 5 ml-syringe. For RNA extraction, the 
RNeasy® Mini Kit (QIAGEN, Hilden, Germany) was used following the instructions of the 
manufacturer (RNeasy® Mini Handbook, Third Edition, June 2001) with slight modifications. 
Six hundred microlitres of ethanol 70 % (Merck, Darmstadt, Germany) were added to each 
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sample which were then loaded onto the QIAGEN columns and centrifuged for 30 sec at 
16,000 × g (MIKRO 20, rotor type 2073, Hettich ZENTRIFUGEN, MAGV, Rabenau-
Londorf, Germany). Briefly, the RNA extraction was done by using a column containing a 
silica-gel membrane which trapped total RNA. All the next centrifugations were performed 
30 sec at 16,000 × g, except when noted. Several washes and treatments were required to 
eliminate DNA, proteins and others elements that would be contaminants for the next steps. A 
first DNA digestion was made in the QIAGEN column with 70 µl of RDD buffer (RNase-
Free-DNase Set, QIAGEN) and 10 µl of DNase I (27 units, RNase-Free-DNase Set, 
QIAGEN) during 20 min at room temperature. After a wash by centrifugation with 350 µl of 
RW1 buffer (QIAGEN), RNA was eluted twice by centrifugation with 2 × 40 µl of RNase-
free DEPC-treated water (Carl Roth GmbH, Germany). A second DNA digestion was 
performed in the reaction tubes with 30 units of DNase I (Amersham Biosciences Europe 
GmbH) for 20 minutes at 37°C. RNA was then protected by 80 units of Ribonuclease 
Inhibitor (RNasin, Fermentas GmbH). The volume of the reaction was adjusted to 100 µl by 
addition of 10 µl of DNase buffer and 5 µl of DEPC-treated water. The DNase was then 
inactivated by chemical (10 µl of 3 M sodium acetate, pH 4.6) and physical denaturations 
(repeated vortexing). 
Total RNA was precipitated with 200 µl of 99 % ethanol two hours at -70°C. After 
centrifugation (12,000 × g, 60 min, 4°C, Eppendorf centrifuge 5804R, rotor type F45-30-11), 
the RNA was washed twice with 250 µl of ethanol 70 %, air-dried and finally resuspended in 
40 µl of DEPC-treated water supplemented with 40 units of RNasin. 
 
The nucleic acid content was then estimated spectrophotometrically. For this purpose, 5 µl of 
RNA solution were diluted 1:20 in Tris-EDTA and the absorbance (Abs) was measured 
against Tris-EDTA (blank) at 260 nm and 320 nm by using a spectrophotometer (DU® 640, 
Beckman). RNA quantity was calculated by using the following formula:  
(Abs260 nm – Abs320 nm) * 40 * 20 = ng of RNA / µl of sample 
 
The quality of the isolated RNA was checked by agarose gel electrophoresis. Depending on 
the amount of RNA harvested, 200 or 400 ng of RNA were mixed in a final volume of 10 µl 
with DEPC-treated water and 2 µl of loading-dye (Fermentas GmbH), and loaded into an 1 % 
agarose gel (Serva Electrophoresis GmbH, Heidelberg, Germany, in 40 mM Tris, 40 mM 
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glacial acetic acid, 1 mM EDTA, 10 ng/ml ethidium bromide) and the migration was 
performed 45 min at 90 volts. 
The figure 1 shows RNA of 6 and 24 hrs mitogen-stimulated iIEL after electrophoresis in an 
1 % agarose gel. RNA appears in the characteristic 3-bands-shape: the upper band 
representing the 28S rRNA, the middle band the 18S rRNA and the lower band representing 
the 5.8S rRNA. The mRNA, representing only 1 % of total cellular RNA, cannot be 
visualized as a single band because the different transcripts are of variable sizes. 
 
 
 
 
Fig. 1. Electrophoresis of 400 ng of RNA isolated from 6 and 24 hrs PHA-P stimulated ileal IEL. 
 
Legend of the figure 1: 
Lanes 1 and 5: Lambda DNA/Eco RI + Hind III marker (Fermentas GmbH) 
Lane 2 : RNA from 6 hrs-stimulated iIEL incubated with medium 
Lane 3 : RNA from 6 hrs-stimulated iIEL incubated with 200 CD50/ml of Stx1 
Lane 4 : RNA from 6 hrs-stimulated iIEL incubated with 200 CD50/ml of Stx1 and  
1.5 µg/ml of anti-StxB1 antibody 
Lane 6 : RNA from 24 hrs-stimulated iIEL incubated with medium 
Lane 7 : RNA from 24 hrs-stimulated iIEL incubated with 200 CD50/ml of Stx1 
Lane 8 : RNA from 24 hrs-stimulated iIEL incubated with 200 CD50/ml of Stx1 and 
1.5 µg/ml of anti-StxB1 antibody 
 
 
The absence of genomic DNA in the RNA preparation was checked by Polymerase Chain 
Reaction (PCR) for a housekeeping gene encoding the glyceraldehyde-3-phosphate 
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dehydrogenase (GAPDH) performed with the reagents listed in the table 2. The primers 
purchased from MWG Biotech AG (Ebersberg, Germany) are listed in the table 5. 
After successive addition of the reagents, the tubes were vortexed, centrifuged 10 sec at 
10,000 × g, and placed in a Perkin Elmer gene Amp PCR System 2400 thermocycler. After a 
denaturation step of 2 min at 94°C, the amplification was performed in 40 sequential cycles 
(94°C, 15 sec; 60°C, 30 sec; 72°C, 30 sec) followed by a post-elongation step for 2 min at 
72°C. PCR products were mixed with 2.5 µl of loading dye, loaded into a 2 % agarose gel 
(Serva Electrophoresis GmbH, in 40 mM Tris, 40 mM glacial acetic acid, 1 mM EDTA, 
10 ng/ml ethidium bromide), and the migration was performed 60 min at 100 volts. 
 
Table 2. Reagents used to perform the GAPDH control PCR 
 
Reagent Volume (in µl) 
Quantity or final 
concentration 
Supplier 
Bi-distilled water 11.6 -  
10 X PCR buffer II 2.0 1 X Applied Biosystems 
25 mM MgCl2 1.2 1.5 mM Applied Biosystems 
5 µM Forward primer 1.0 0.25 µM MWG Biotech AG 
5 µM Reverse primer 1.0 0.25 µM MWG Biotech AG 
dNTP (4 mM each) 1.0 0.2 mM PAN Biotech GmbH 
AmpliTaq® DNA 
polymerase 
0.2 1 unit Applied Biosystems 
RNA (1:4 in water) 2.0 ≈ 50 ng  
Final Volume 20.0   
 
 
3.5.2. Reverse transcription (RT) of mRNA 
 
Complementary DNA (cDNA) was obtained from mRNA by reverse transcription of 1 µg of 
total RNA per sample by using an oligo d(T) primer (Table 3) in a 40 µl reaction volume 
according to the instructions of the manufacturer of the reverse transcriptase (Promega, 
Mannheim, Germany). This reaction was performed following a two-step method. In a first 
step, 1 µg of RNA was diluted in 23 µl of DEPC-treated water and 2 µl of 50 µM oligo d(T)16 
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primers were added (corresponding to 0.5 µg; Applied Biosystems, Darmstadt, Germany). 
The annealing was performed during 5 min at 70°C in a thermocycler (Perkin Elmer gene 
Amp PCR System 2400). In a second step, each sample (1 µg RNA) was reverse transcribed 
by 200 units of Moloney-Murine Leukemia Virus (M-MLV) Reverse Transcriptase RNase H 
Minus purchased from Promega (Mannheim) at 40°C for 60 min, followed by 94°C for 2 min. 
The cDNA was then stored at -20°C or used immediately for real-time PCR. 
 
Table 3. Reagents used to perform the reverse transcription 
 
Reagent Volume (in µl) 
Quantity or final 
concentration 
Supplier 
RNA (in water) 23.0 1 µg - 
Oligo d(T)16 2.0 0.5 µg Applied Biosystems 
5X M-MLV buffer 8.0 1 X Applied Biosystems 
dNTP (5 mM each)  4.0 0.5 mM each PAN™ Biotech GmbH 
Bi-distilled water 1.0 - - 
RNasin 1.0 40 units Fermentas GmbH 
M-MLV RTase 1.0 200 units Promega 
Final volume 40.0   
 
 
3.5.3. Cytokine/chemokine-specific semi-quantitative or real-time PCR 
 
For freshly isolated iIEL, a semi-quantitative PCR was performed to establish a cytokine and 
chemokine mRNA profile that indicates which mRNA are harboured by iIEL in vivo. RT-
PCR were performed to detect mRNA encoding the following cytokines: Interleukine (IL) -2, 
IL-4, IL-10, interferon-γ (IFN-γ), transforming growth factor-β (TGF-β), and the three 
chemokines CXCL8 (syn. IL-8), CXCL10 (syn. 10 kDa-Interferon-Inducible Protein or 
IP-10), and CCL2 (syn. Monocyte Chemotactic Protein-1 or MCP-1). The presence of the 
Tumor-Necrosis Factor-α (TNF-α) mRNA was also investigated. The conditions of the 
amplification were the same as described for GAPDH (see 3.5.1 and Table 2). The 
housekeeping gene GAPDH was used as a control for constitutive gene expression. The 
primers purchased from MWG Biotech AG are listed in Table 5. 
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For mitogen-stimulated iIEL and PBMC a real-time PCR was performed (Table 4); primers 
(purchased from MWG Biotech AG) and probes (purchased from Eurogentec, Liège, 
Belgium) are shown in Table 5. The qPCR™ Mastermix purchased from Eurogentec 
(Seraing, Belgium) already contains dNTP, MgCl2, and a Hot Goldstar DNA polymerase. The 
TaqMan® probes were labelled at the 5’-end with the reporter dye FAM (6-
carboxyfluorescein) and at the 3’-end with the quencher dye TAMRA (6-carboxytetramethyl-
rhodamine). For real-time PCR, 1.5 µl of cDNA (corresponding to 37.5 ng of total RNA) was 
used in a 25 µl PCR reaction mixture containing 12.5 µl qPCR™ MasterMix (Eurogentec), 
300 nM of each primer and 200 nM of probe. Twenty-three microlitres of this mix were 
transferred to the 96-well optical reaction plates (Micro Amp Optical Reaction Plate, Applied 
Biosystems) which was then closed with an adhesive cover (ABI PRISM Optical Adhesive 
Cover Starter Kit, Applied Biosystems). The PCR amplification was performed on an 
automated fluorometer (ABI PRISM™ 5700 Sequence Detection System, Applied 
Biosystems). Each sample was analysed in duplicates. 
Amplification conditions were the same for all targets assayed: one cycle at 50° C for 2 min, 
one cycle at 95°C for 10 min and 40 cycles at 95°C for 15 sec and at 60° C for 60 s.  
 
Table 4. Reagents used to perform the real-time PCR 
 
Reagent Volume (in µl) 
Quantity or final 
concentration 
Supplier 
Bi-distilled water 7.0 - - 
2 X qPCR™ MasterMix 12.5 1 X Eurogentec 
5 µM TaqMan® probe 1.0 0.2 µM Eurogentec 
5 µM Forward primer 1.5 0.3 µM MWG Biotech AG 
5 µM Reverse primer 1.5 0.3 µM MWG Biotech AG 
cDNA 1.5 ≈ 37 ng  
Final Volume 25.0   
 
 
In order to compare the mRNA expression of one cytokine in iIEL incubated in medium in 
the absence or presence of Stx1, quantitative analyses were used (comparative Ct method 
[∆∆Ct method]) according to the instructions of the manufacturer of the ABI PRISM™ 5700 
Sequence Detection System and reported as differences in comparison to the medium control  
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Table 5. Sequences of primers and probes used for the amplification of cDNA by semi-
quantitative RT-PCR and real-time PCR 
 
Specificity Primers (5´- 3´) and probes (5´- 3´) 
Size of 
products   
(in bp) 
Reference 
IL-2 Forw GGA TTT ACA GTT GCT TTT GGA GAA A 
IL-2 Rev GCA CTT CCT CTA GAA GTT TGA GTT CTT 
TaqMan® probe CGT GCC CAA GGT TAA CGC TAC AGA ATT GAA 
165 (217) 
IL-4 Forw CAT GCA TGG AGC TGC CTG TA 
IL-4 Rev AAT TCC AAC CCT GCA GAA GGT 
TaqMan® probe TGC TGC CCC AAA GAA CAC AAC TGA GAA G 
83 (405) 
IL-8 Frow CAC TGT GAA AAA TTC AGA AAT CAT TGT TA 
IL-8 Rev CTT CAC CAA ATA CCT GCA CAA CCT TC 
TaqMan® probe AAT GGA AAC GAG GTC TGC TTA AAC CCC AAG 
113 (217) 
IL-10 Forw CCA AGC CTT GTC GGA AAT GA 
IL-10 Rev GTT CAC GTG CTC CTT GAT GTC A 
TaqMan® probe AGC CTG TGG CAT CAC CTC TTC CAG GTA A 
91 
Moussay 
et al., 
(submitted) 
IFN-γ Forw CAG CTC TGA GAA ACT GGA GGA CTT 
IFN-γ Rev TGG CTT TGC GCT GGA TCT 
TaqMan® probe AGC TGA TTC AAA TTC CGG TGG ATG ATC T 
77 (405) 
TGF-β Forw GGC CCT GCC CTT ACA TCT G 
TGF-β Rev CGG GTT GTG CTG GTT GTA CA 
TaqMan® probe CCT GGA TAC ACA GTA CAG CAA GGT CCT GG 
74 
Moussay 
et al., 
(submitted) 
TNF-α Forw TCT TCT CAA GCC TCA AGT AAC AAG T 
TNF-α Rev CCA TGA GGG CAT TGG CAT AC 
TaqMan® probe AGC CCA CGT TGT AGC CGA CAT CAA CTC C  
103 (387) 
IP-10 Forw AAG TCA TTC CTG CAA GTC AAT CCT 
IP-10 Rev TTG ATG GTC TTA GAT TCT GGA TTC AG 
TaqMan® probe CCA CGT GTC GAG ATT ATT GCC ACA ATG A 
103 (388) 
MCP-1 Forw CGC TCA GCC AGA TGC AAT TA 
MCP-1 Rev GCC TCT GCA TGG AGA TCT TCT T 
TaqMan® probe CCC AAG TCG CCT GCT GCT ATA CAT TCA A 
77 
 
(388) 
GAPDH Forw GCG ATA CTC ACT CTT CTA CCT TCG A 
GAPDH Rev TCG TAC CAG GAA ATG AGC TTG AC 
TaqMan® probe CTG GCA TTG CCC TCA ACG ACC ACT T 
 
82 
(388) 
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(which was set as 100 %) after normalizing the samples referring to the housekeeping gene 
GAPDH. PCR data are presented in the results section as relative percentage of expression 
compared to the medium control. The calculation procedure was performed as follows: 
Step 1: Calculate the arithmetic mean of the Ct duplicate values (mCt) 
Step 2: Normalize the values by using a housekeeping gene (GAPDH): 
 ∆Ct = mCt (target gene) – mCt (housekeeping gene) 
Step 3: Normalize the values by using a calibrator (= condition “Medium”): 
 ∆∆Ct = ∆Ct (lymphocytes incubated with Stx1) – ∆Ct (lymphocytes incubated with Medium) 
Step 4: Calculate the relative quantity of the target gene: 
 Relative quantity = 2 (- ∆∆Ct) 
Step 5: Transform the relative quantity in relative percentage of expression: 
 Relative % of expression = Relative quantity × 100 
 
In addition to this calculation based on the ∆∆Ct values used to compare the mRNA 
expression of one cytokine in different conditions (Med vs Stx1), an alternative calculation 
method was used to compare the amount of several chemokine mRNA in iIEL incubated in 
the same condition. To do so, the step 3 was omitted; thus allowing to directly compare 
mRNA amounts (GAPDH values set to 100 %). 
 
3.5.4. IL-4 splice variants PCR 
 
Ileal IEL were isolated as previously described, and incubated 6 hrs with 2.5 µg/ml of PHA-P. 
The cells were harvested, washed once in PBS and mRNA was isolated from 2 × 107 IEL 
using the RNeasy Mini Kit (QIAGEN). The same procedure was also performed for freshly 
isolated iIEL. Reverse  transcription  and  semi-quantitative  PCR were performed to detect 
the production of IL-4 mRNA. GAPDH was used as a housekeeping gene for constitutive 
gene expression. The presence  of  IL-4  full  length  (408  bp)  and  splice  variants  (IL-4δ2  
[360  bp]  and  IL-4δ3  [282  bp])  was investigated by RT-PCR in iIEL incubated in the 
presence or absence of Stx1 and with or without anti-StxB1 antibody by using the following 
primers published by Waldvogel et al. ((406), Forward 5’- ATG GGT CTC ACC TAC CAG 
CTG -3’ and Reverse 5’- CAC TTG GAG TAT TTC TCC TTC ATA ATC G -3’). 
Complementary DNA was amplified by 35 cycles (15 sec at 94°C, 30 sec at 60°C, 1 min at 
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72°C) followed by a final post-elongation step for 5 min at 72°C. The PCR product were 
analyzed on a 2 % agarose gel. 
 
 
3.6. Analysis of the blast transformation and of the expression of Gb3/CD77 of iIEL 
 
The impact of Stx1 on several parameters of iIEL biology was investigated by flow 
cytometry. Ileal IEL were seeded (5 × 106 per well) in 6-well plates (Nunc, Wiesbaden, 
Germany) in 2.5 ml of IEL-medium. For stimulation, the culture medium was supplemented 
with phorbol-12-myristate-13-acetate (PMA, Phagoburst® Kit, ORPEGEN Pharma; 
Heidelberg, Germany, 50 ng/ml), with ionomycin (Sigma, 1 µg/ml), and the cells were 
cultivated in the absence or presence of purified Stx1 (200 CD50/ml). For neutralization the 
latter was pre-incubated for 90 min at 37°C with purified anti-StxB1 antibody 13C4 
(1.5 µg/ml). The iIEL were then incubated for 6 or 18 hrs at 37°C in 5 % CO2 and 95 % 
humidity. At the end of the incubation time, iIEL were harvested, washed twice by 
centrifugation with 10 ml of PBS 1X (202 × g, 7 min, 20°C), and then transferred to V-shaped 
microtiter plates (Greiner) at the density of 4 × 105 cells per well. 
The detection of Gb3/CD77 on the cell surface was performed by an indirect immuno-
staining. In order to quantify the total amount of Gb3/CD77 present in the cells, iIEL in some 
wells were fixed for 10 min in the dark with paraformaldehyde (PFA 1 % in PBS 1X, Merck, 
Darmstadt, Germany), washed once by centrifugation (150 × g, 7 min, 4°C) with PBS 1X, and 
permeabilized 5 min in the dark with PBS 1X supplemented with 0.1 % of saponin (Merck) 
and 0.1 % of sodium azide (Merck). Ileal IEL in other wells were left in their native form to 
quantify the amount of the Stx1-receptor present on the cell surface. 
The cells were centrifuged (150 × g, 7 min, 4°C) and incubated then 20 min in the dark at 
room temperature with 50 µl of an anti-human CD77 antibody (Beckman-Coulter GmbH) 
diluted 1:20 in PBS 1X. As a control for the specificity of the staining, iIEL in some wells 
were also incubated with 1 µg/ml of unspecific rat IgM (CAMON, Wiesbaden, Germany). 
After two washes with PBS 1X by centrifugation (150 × g, 7 min, 4°C), the cells were 
incubated 20 min in the dark at room temperature with 50 µl of secondary antibody diluted 
1:200 in PBS 1X (anti-rat IgM (µ-chain specific)-PE conjugated antibody [Beckman-Coulter 
GmbH]). The iIEL were washed twice in PBS 1X, and transferred into 5 ml-FACS tubes 
containing 200 µl of PBS 1X. 
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The morphology of the iIEL, the total cellular content of the glycosphingolipid Gb3/CD77, 
and its expression on the cell surface were investigated with the FACSCalibur™ flow 
cytometer and the Cell Quest Pro software (BD). Five thousand events were acquired per 
sample. The data were then analyzed with the software FCS express 2 (de Novo software). 
 
 
3.7. Cytokine and chemokine protein expression by bovine PBMC and iIEL in vitro 
 
3.7.1. Intracellular detection of cytokine proteins in PBMC and iIEL by flow cytometry 
 
The intracellular detection of cytokine proteins was performed by flow cytometry concerning 
three TH-type specific cytokines. IFN-γ, IL-4, and TGF-β were chosen to represent the TH1, 
TH2, and TH3-type immune responses, respectively. Specific antibodies were purchased from 
Serotec GmbH (Düsseldorf, Germany). 
 
3.7.1.1. Titration of the anti-human TGF-β antibody 
 
In order to detect the production of TGF-β in iIEL, an anti-human TGF-β antibody was used 
because the human and the bovine forms of mature TGF-β proteins are 100 % identical (5, 
400). Before being suitable for iIEL analysis, this antibody required a titration to find an 
appropriate concentration leading to a reduced unspecific binding of the antibody to 
unstimulated cells and to a specific detection of the antigen in stimulated cells. 
Bovine PBMC were isolated as described (see 3.3) and were incubated 6 hrs or overnight 
(37°C, 5 % CO2, and 95 % humidity) with brefeldin A (10 µg/ml) in the presence or absence 
of mitogens (50 ng/ml of PMA [ORPEGEN Pharma] and 1 µg/ml of ionomycin [Sigma]). 
The brefeldin A is a fungal metabolite obtained from Penicillium brefeldianum which 
reversibly disassembles the structure and disrupts the functions of the Golgi complex and also 
stops the intracellular trafficking of vesicles (endocytosis and exocytosis)(72). In the context 
of this study, the addition of brefeldin A to the culture blocks the secretion and induces the 
storage of the cytokines in the cell cytoplasma allowing the intracellular detection of cytokine 
after fixation and permeabilization of the cells. The cells were harvested, washed twice with 
PBS 1X by centrifugation (202 × g, 7 min, 20°C), transferred to wells of V-shaped microtiter 
plates (Greiner). The cells were centrifuged (150 × g, 7 min, 4°C) and fixed by incubation in 
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100 µl of paraformaldehyde (1 % in PBS, Merck) for 10 min in the dark at room temperature. 
The cells were next washed with 100 µl of the “washing buffer” (PBS supplemented with 
0.1 % saponin [Merck] and 0.1 % sodium azide [Merck]) and then permeabilized 5 min at 
room temperature in 100 µl of “washing buffer”. The cells were stained in duplicates for 
20 min on ice in the dark with several dilutions of the anti-human TGF-β antibody (from 1:50 
to 1:2050 in “Ab-buffer” [PBS supplemented with 1 % bovine serum albumin, 0.1 % saponin, 
and 0.1 % sodium azide]). A goat anti-mouse IgG (heavy and light chain specific)-FITC 
conjugated purchased from Dianova (Hamburg, Germany), was used diluted 1:400 (final 
concentration: 3.4 µg/ml) in “Ab-buffer”. 
As seen on the titration curve (Fig. 2A), the utilization of a high concentration of antibody 
(dilutions 1:50 to 1:400) led to a strong binding to unstimulated cells comprised between 61.3 
and 17.3 % respectively. Reduced concentrations of antibody (dilutions 1:600 to 1:1400) led 
to a reduced binding (7.6 to 1.1 %). 
The second part of the titration performed with mitogen-stimulated PBMC (Fig. 2B) showed a 
plateau when the dilutions of the antibody between 1:600 and 1:900 were used. This titration 
led to choose the dilution 1:800 as a working dilution for the intracellular detection of this 
cytokine in iIEL. 
 
3.7.1.2. Intracellular detection of cytokine proteins in bovine PBMC and iIEL 
 
The cells (5 × 106) were seeded in 6-well plates (Nunc) in 2.5 ml of PBMC-medium or IEL-
medium, stimulated by mitogens (see 3.7.1.1), and incubated in the absence or presence of 
200 CD50/ml Stx1. For neutralization the latter was pre-incubated for 90 min at 37°C with 
purified anti-StxB1 antibody 13C4. The cells were then incubated 6 or 24 hrs at 37°C in 5 % 
CO2 and 95 % humidity, in the presence of brefeldin A (Sigma, 10 µg/ml) which was added 
1 h or 8 hrs after the beginning of the incubation, respectively. 
At the end of the incubation period, cells were resuspended, transferred to a 50 ml-
centrifugation tube and washed once with 10 ml PBS-EDTA 1X by centrifugation (202 × g, 
7 min, 20°C), and once with 10 ml PBS 1X (202 × g, 7 min, 20°C). The cells were then 
resuspended in PBS at the density of 4 × 105 cells per 100 µl and transferred to V-shaped 
microtiter plates (Greiner) for immunostaining. Briefly, the cells were centrifuged (150 × g, 
7 min, 4°C), fixed and then permeabilized. The antibodies listed in the table 6 directed against 
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bovine IL-4 (Serotec), bovine IFN-γ (Serotec) and human TGF-β (Serotec) were diluted in 
“Ab-buffer”. 
 
A 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Dilution of the anti-TGF-β antibody  
B 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. Titration of the anti-human TGF-β antibody with unstimulated (A) and 
mitogen-stimulated (B) bovine PBMC. Cells were incubated 6 hrs or overnight with 
brefeldin A (10 µg/ml), then harvested, washed, fixed, permeabilized, and stained 20 min 
on ice with several dilutions of the antibody. Five thousand events were acquired by a 
FACSCalibur™ flow cytometer. 
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The cells were also incubated with irrelevant antibodies (1F9 and 2-4A5 C5D7) directed 
against Clostridium perfringens phospholipase C and β2-toxin as IgG isotype controls. These 
antibodies were produced in the supernatant of hybridoma cell lines cultured in RPMI 1640 
supplemented with 2 % Ultroser® HY (CYTOGEN, Sinn, Germany), 100 IU/ml of penicillin, 
and 100 µg/ml of streptomycin (PAA Laboratories GmbH). Five thousand events were 
acquired for each sample. The gates were defined according to the negative control (PBS) and 
the respective isotype controls defining less than 2 % of the cells as positive. 
 
Table 6. Antibodies used for intracellular detection of cytokines by flow cytometry 
 
Specificity Bovine IL-4 Bovine IFN-γ Human TGF-β 
PLC of           
C. perfringens 
β2-toxin of    
C. perfringens 
Clone CC 303 CC 302 TB 21 1F9 2-4A5 C5D7 
Dilution 1:400 1:800 1:800 1:4 1:4 
Isotype IgG2a IgG1 IgG1 IgG2a IgG1 
   
   C. pefringens = Clostridium perfringens, PLC= phospholipase C  
 
 
The intracellular detection of cytokines was also performed in bovine PBMC which were 
isolated as described, and incubated 8.5 or 21 hrs at 37°C with 5 % CO2 in the absence or 
presence of Stx1 (33 CD50/ml). Brefeldin A (10 µg/ml f.c.) was added respectively 1 h or 
9.5 hrs after the beginning of the incubation and then the cells were cultivated for 7.5 or 
11.5 additional hours, respectively. The PBMC were then harvested, washed, fixed, 
permeabilized, and the cytokines were intracellularly immunodecorated as described for iIEL. 
 
3.7.2. Establishment of a polymorphonuclear neutrophil (PMN) migration assay 
 
In order to assess whether Stx1 modifies the release by iIEL of total chemoattractant 
substances for PMN, a biological assay was performed with bovine PMN. Dyed cells were 
used to count migrating PMN by flow cytometry. 
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3.7.2.1. Generation of a positive control supernatant 
 
Bovine peripheral blood lymphocytes were isolated as previously described (see 3.3) and 
were seeded in 5 ml of PBMC-medium at the density of 1 × 107 per well into 6-well plates. 
The cells were stimulated with 5 µg/ml of concanavalin A (Sigma) and 200 IU/ml of 
recombinant-human interleukin-2 (rhIL-2). The cells were split every 3 days during three 
weeks and the cell-culture supernatants were saved in 50 ml-centrifugation tubes (Greiner), 
centrifuged (202 × g, 7 min, room temperature) to eliminate dead cells and debris and then 
stored at 4°C. Fresh culture medium supplemented with 100 units of rhIL-2 per ml was then 
added to the cultures to continue the proliferation and activation of the lymphocytes. This 
supernatant was later used as a positive control for induction of the migration of bovine PMN 
in the system. 
 
3.7.2.2. Comparison of two calibrators to count bovine leukocytes 
 
Isolation of bovine leukocytes 
Bovine leukocytes were prepared from 4 ml-aliquots of whole blood by lysis of erythrocytes 
with 18 ml of bi-distilled water 50 seconds at room temperature. The osmolarity was restored 
by adding 2 ml of 10 X-concentrated PBS-EDTA. The leukocytes were washed once with 
PBS 1X by centrifugation (202 × g, 7 min, at 20°C) and counted by trypan blue exclusion 
after dilution 1:10. The cells were finally resuspended in PBS supplemented with 1 % of BSA 
at the density of 1 × 106/ml. 
 
Preparation of fluorescent beads 
Fifty microliters of a commercial suspension of Fluoresbrite calibration grade 3.0-micron YG 
microspheres (Polysciences Europe GmbH, Eppelheim, Germany) were washed twice in 
1.450 µl of PBS 1X by centrifugation (16,000 × g, 3 min, at 20°C) in 2 ml-reaction tubes and 
finally resuspended in PBS 1X. 
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Staining of BL-3 cells 
The bovine B lymphoma BL-3 cells (ECACC 86062401) were counted by trypan blue 
exclusion. The density of 1 × 106 cells per ml of suspension was adjusted by addition of BL-3 
medium (RPMI 1640 with 2 mM of stabilized glutamin, 15 % of Lebowitz 15 medium, 10 % 
of FCS, 100 IU/ml of penicillin, 100 µg/ml of streptomycin, 1 mM of β-Mercaptoethanol. The 
dye 3-3´dioctadecyloxacarbocyanine perchlorate (DiO, Molecular Probes, Leiden, 
The Netherlands) was added to the cell suspension at a final concentration of 1.5 µg/ml. After 
1 h of incubation at 37°C in the dark under constant shaking (100 rpm/min), the cells were 
centrifuged (202 × g, 7 min, 20°C) and then washed twice in PBS 1X. The DiO-BL-3 cells 
were counted again and resuspended in a certain volume of PBS 1X to establish a 
concentration of 1 × 106 cells per ml. The DiO-BL-3 cells were fixed with the same volume of 
paraformaldehyde 4 % (dilution 1:2; final concentration 2 %), and incubated for 30 min in the 
dark at 20°C. Until the end of the procedure, DiO-BL-3 cells were protected from light and 
stored on ice. Finally, the cells were centrifuged (202 × g, 7 min at 20°C), wash once in 
PBS 1X and resuspended in PBS 1X. 
The morphology and the fluorescence of cells were checked by flow cytometry. Twenty 
microliters of stained cells were added to 80 µl PBS 1X and acquired with the 
FACSCalibur™ flow cytometer and the acquisition software Cell Quest Pro (Becton-
Dickinson). After verifying the morphology and fluorescence, the cells were frozen at –20°C 
in PBS 1X supplemented with 10 % of FCS at the density of 1.25 × 106 cells/ml in 2 ml-
reaction tubes for later use. Data were analyzed with the software FCS Express 2. 
 
Counting of leukocytes 
Different quantities of leukocytes to be counted and of counting particles were mixed in 5 ml-
FACS tubes and 1,000 fluorescent events were acquired by the flow cytometer. In order to 
compare the efficiency of the counting with the two systems, in some cases, the number of 
leukocytes was kept constant (5 × 105) and variable numbers of counting particles were added 
per tube (1.56 to 50 µl of bead suspension, or 12.5 to 500 µl of DiO-BL-3 cell suspension). In 
other cases, the number of counting particles was kept constant (12.5 µl of beads or 100 µl of 
DiO-BL-3 cell suspension) and the number of leukocytes to be counted varied (2.5 to 
7.5 × 105 leukocytes). The acquisition by FACS stopped after 1,000 fluorescent particles were 
counted in R5. Each sample was acquired in triplicates. The arithmetic mean of these three 
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determinations was considered as the number of leukocytes counted per 1,000 beads or DiO-
BL-3 cells.  
Figure 4 shows the comparison of the counting of leukocytes performed by flow cytometry by 
using fluorescent beads (Fig. 4A, C) or stained DiO-BL-3 cells (Fig. 4B, D). The counting of 
bovine leukocytes with BL-3 cells stained with the fluorescent dye DiO was found to be as 
precise as with the beads. Consequently, the release of chemoattractants for PMN by iIEL in  
supernatants was assessed by using DiO-BL-3 cells in the subsequent experiments. 
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Fig. 3. Morphology (A) and fluorescence (B) of DiO-BL-3 cells. The cells were 
stained for 1 h with DiO, fixed with PFA 2 %, washed with PBS 1X and were 
analyzed by flow cytometry. One thousand events were acquired using a 
FACSCalibur™ flow cytometer. 
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A                     B 
 
 
 
 
 
 
 
 
 
        
 
 
 
 
 
 
 
 
 
C       D 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4. Counting of bovine leukocytes by flow cytometry. A suspension of 
fluorescent beads (A, C) or in house-stained DiO-BL-3 cells (B, D) were used as a 
calibrator. The acquisition stopped after 1,000 fluorescent events were acquired by 
the FACSCalibur™. 
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3.7.2.3. Isolation of bovine PMN from whole blood 
 
PMN were prepared from whole blood by density gradient centrifugation, as described for 
PBMC (see 3.3). After centrifugation (45 minutes, 800 × g at 20°C), the plasma and the 
interphase PBMC-Ficoll-Paque™ Plus were removed and discarded. Around half of the red 
sediment (≈ 4 ml), containing erythocytes and PMN, was then recovered with a plastic pipette 
and distributed to two 50 ml-centrifugation tubes (≈ 2 ml per tube). This sediment was diluted 
with 2 ml PBS-EDTA 1X and erythrocytes were lysed. Bi-distilled water was added (27 ml 
per tube) and mixed by intense swivelling. After 50 seconds, 3 ml of 10X-concentrated PBS-
EDTA solution were added and mixed intensively to restore osmolarity. The tubes were next 
filled with RPMI 1640 (PAN™ BIOTECH GmbH) and were centrifuged 7 minutes at 202 × g 
at 20°C. The pellet was once washed with PBS-EDTA 1X and the PMN were finally 
resuspended in 2 ml of PBMC-medium. 
The purity of PMN preparations was confirmed by flow cytometry. Fifty microlitres of cell 
suspensions were diluted with 500 µl of PBS and transferred into 5 ml-plastic tubes, and were 
analyzed by the FACSCalibur™ flow cytometer with help of the Cell Quest Pro software 
(acquisition software). Five thousand events were acquired and then preparations with purity 
greater than 90 % PMN were pooled. Data were treated with the analysis software FCS 
Express 2 (plot presented in figure 5). PMN constituted a dense and homogenous population 
located in the region R3, as defined in the FSC (size of cells) vs SSC plot (granularity of 
cells). In the example given (Fig. 5.), PMN represented 97 % of the events acquired by FACS; 
mononuclear cells located in R1 represented 0.2 %, debris located in R2 1.6 %. Around 1 % 
of the cells did not fit into the defined regions. 
The cell number was next estimated by live-dead exclusion with trypan blue solution in a 
Neubauer chamber. 
 
Materials and methods 
 - 55 - 
SSC-H
0 256 512 768 1024
FS
C
-
H
0
256
512
768
1024
R1
R3
R2
97,1 %
1,6 %
0,2 %
FS
C
-
H
 
 
 
Fig. 5. Morphology of bovine PMN after the procedure of isolation. 
After a density gradient centrifugation and lysis of erythrocytes, the cells 
were washed, and analyzed by flow cytometry. Five thousand events were 
acquired by a FACSCalibur™ flow cytometer (BD). 
 
3.7.2.4. Bovine PMN migration assay 
 
A cell culture non-conditioned IEL-medium (1.5 ml) was used as a negative control and a 
supernatant of stimulated-PBMC cultures (see 3.7.2.1) (1.5 ml) was used as a positive control to 
induce the migration of bovine PMN. 
Culture supernatants of iIEL to be tested (agonists, see 3.4) were centrifuged 10 min at 10,000 × g 
(Centrifuge Eppendorf 5804R) to eliminate dead cells and debris and then 1.5 ml was transferred 
to the wells of a 12 well-flat bottom plates (the lower compartment of the migration system). The 
upper compartment, cell culture inserts with 3 µm pores (12 mm diameter, Transwell clear, 
Corning Costar, Germany), were carefully placed in the wells and immediately filled with 500 µl 
of PBMC medium containing 5 × 105 neutrophils. The multiwell-plates were incubated 1 h 45 min 
at 37°C. After the incubation, the plate was placed 15 minutes at 4°C to stop the migration. During 
this time, DiO-BL-3 cells were thawed, centrifuged 5 min at 350 × g and washed once in PBS 1X, 
counted by trypan blue exclusion, and the cell concentration was established at 1.5 × 104 per 50 µl 
of PBS 1X. During the whole procedure, DiO-BL-3 cells were protected from light and stored on 
ice. 
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The filters were carefully removed from the wells, placed in free wells and the upper surface was 
washed with 500 µl of PBS-EDTA 1X. This cell suspension was transferred to 5 ml-tubes 
containing 55 µl of PBS 1X-EDTA 10X. The tubes which were placed on ice to decrease the cell 
adhesion. 
The cell suspensions of the lower compartments (migrating PMN) (1.5 ml) were transferred to 
FACS tubes and the wells were washed with 166 µl PBS 1X-EDTA 10X. The cells were 
resuspended by pipetting and 500 µl of these suspensions from the lower compartment were 
transferred to 5 ml plastic FACS-tubes placed on ice. To avoid the adhesion of neutrophils to the 
wall of the tubes, 55 µl of PBS 1X-EDTA 10X were added per tube. 
In order to count the PMN, 1.5 × 104 DiO-dyed BL-3 cells in 50 µl of PBS-1X were added per 
tube. A specific document for acquisition was created with the acquisition software Cell Quest Pro 
to discriminate the different populations of DiO-BL-3 cells, PMN and lymphocytes. Each sample 
was measured in triplicates. 
Data were exported and analysed with the analysis software FCS Express 2. The plots 
presented in figure 6 originate from a single neutrophils’ preparation. The gating strategy 
displayed on the following FACS plots discriminate the different cell types in presence. The 
DiO-BL-3 cells are displayed in R1. As the neutrophils’ preparation could contain up to 10 % 
of mononuclear cells and debris (R1 and R2), the gating strategy was not elaborated based on 
the morphology of the cells. As seen on the plot 6B, the BL-3 cells were dyed and were the 
only fluorescent events (R5). Consequently, the acquisition stopped exactly after 1,000 DiO-
BL-3 cells were counted in the region R5. 
The plots A and C (Fig. 6) also demonstrate that the lymphocytes present in the preparation 
do not migrate in this system and stay in the upper compartment. These lymphocytes are 
found in the region R4, as they have a low granularity and express a low fluorescence. 
Polymorphonuclear eosinophils were identified as a granulocytic subpopulation displaying a 
high autofluorescence (54). In absence of any evidence, it can be hypothesized that the cells 
located in the region R8 (right part of R6) are some eosinophils. 
In order to calculate the percentage of migration induced by IEL culture supernatants of each 
condition, the number of migrating PMN incubated with non-conditioned IEL medium was 
used as a reference and defined as 100 %. 
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C       D 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6. Counting of PMN of both upper (A, B) and lower (C, D) compartments 
with DiO-BL-3 cells by a FACSCalibur™ flow cytometer. The cell counting 
stopped after 1,000 DiO-BL-3 cells were acquired by the cytometer. The figures 
display the morphology (A, C) and the fluorescence (B, D) of the different cell types 
in presence (migration induced by the positive control). The gating strategy allowed 
the discrimination of the different cell types. R1: DiO-BL-3 cells, R2: debris, R3: 
Neutrophils, R4: Lymphocytes, R5: DiO-BL-3 cells (1,000 events acquired), R6: 
Neutrophils to be counted. 
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3.8. Analysis of the importance of the enzymatic activity of Stx1 and induction of 
apoptosis of iIEL 
 
3.8.1. Cultivation of bovine PBMC, Daudi and Ramos cells 
 
Daudi and Ramos cells were used as positive controls for Stx1- and StxB1-induced apoptosis 
and to confirm the suitability of the detection systems. Daudi cells obtained from the 
European Collection of Cell Cultures (ECACC Nr. 85011437) and Ramos cells (ATCC. Nr 
91030710, RA1 cells), a kind gift of Prof. Dr. M. Oppermann (Georg-August University, 
Göttingen, Germany), were cultured in RPMI 1640 supplemented with 2 mM of glutamine 
(PAN™ Biotech GmbH), 100 U/ml of penicillin, 100 µg/ml of streptomycin (PAA 
Laboratories GmbH), and 10 % of FCS (Biowest).  
Ramos and Daudi cells were incubated 20 or 24 hrs, respectively, in the presence of the 
components listed in the table 7. 
 
Table 7. Conditions of incubation for the study of apoptosis. 
 
Substance Concentration Origin / Manufacturer 
Actinomycin D 2 µg/ml Sigma 
Stx1 200 CD50/ml In house-prepared 
Stx1 + anti-StxB1 MAb 200 CD50/ml; 1.5 µg/ml Both in house-prepared 
rStxB1 subunit 10 µg/ml In house-prepared 
rStxB1 subunit + anti-StxB1 MAb 10 µg/ml; 1.5 µg/ml Both in house-prepared 
anti-CD77 antibody (clone 38.13)1) 50 µg/ml Dr. J. Wiels, France 
LPS 1 ng/ml Sigma 
Brefeldin A 10 µg/ml Sigma 
Brefeldin A + Stx1 10 µg/ml; 200 CD50/ml Sigma; In house-prepared 
1) pre-incubated 90 min at 37°C with a goat anti-rat IgM (µ-chain specific)(Dianova, 10 µg/ml)  
 
The recombinant rStxB1 subunit was prepared in our institute by Dr. I. Stamm from the 
E. coli DH5α [pSU108] strain as described in Stamm et al. (2002). The preparation was 
purified by affinity chromatography (FPLC®, Amersham Biosciences Europe GmbH), passed 
through a Detoxi-Gel™ column (Pierce) to reduce endotoxin contaminants. The analysis by 
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MALDI-TOF mass spectrometry was performed by Dr. M. Wuhrer (Institute for 
Biochemistry, Justus-Liebig University, Giessen). The rStxB1 subunit preparation was mainly 
composed of monomers containing the signal peptide (9750.3 m/z) and dimers (19468.0 m/z) 
(Fig. 7) which could also multimerize in vitro. The StxB1-subunit preparation was analyzed 
by SDS-PAGE, and titrated (162 µg/ml) with the BCA protein assay® (Pierce, Old 
Beijerland, The Netherlands). The Limulus amoebocyte lysate assay indicated a concentration 
of 0.93 ng of endotoxin per ml. 
For functional assays, the 38.13 antibody was kindly provided by Dr J. Wiels (Institut 
Gustave Roussy, CNRS, Villejuif, France), as sodium azid-free ascites. 
In addition to Burkitt’s lymphoma cell lines, the apoptosis was also induced on primary 
cultures of bovine PBMC. The cells were isolated as previously described and incubated 6 hrs 
in 9 ml of PBMC-medium (2 × 107), supplemented with either actinomycin D (2 µg/ml, 
Sigma), or 200 CD50/ml of purified Stx1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7. Mass spectrometric analysis of the StxB1 subunit preparation. 
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3.8.2. Cultivation of bovine iIEL 
 
For stimulation, the IEL-medium was supplemented with 2.5 µg/ml of PHA-P. The iIEL were 
isolated as previously described, and 2.5 × 107 iIEL were cultivated 6 or 20 hrs at 37°C and 
5 % CO2 in 9 ml of IEL-medium supplemented with the components described above (see 
table 7). As a control, apoptosis was also quantified in iIEL freshly isolated from the intestinal 
mucosa. 
At the end of the 6 or 20 hrs of cultivation, iIEL were centrifuged for 5 min at 350 × g at 
20°C. In the meanwhile, the wells were washed with 5 ml of ice-cold PBS-EDTA 1X. This 
suspension was then used to resuspend the cell pellet in the 50 ml-centrifugation tubes. The 
lymphocytes were washed once with PBS 1X. The isolation of mRNA from 2 × 107 iIEL was 
performed by using the RNeasy Mini Kit (QIAGEN). Reverse transcription and real-time-
PCR were performed to detect the production of IL-4 mRNA, as previously described. The 
remaining iIEL (5 × 106) were used for investigation of apoptosis by flow cytometry as 
described beneath. 
 
3.8.3. Detection of mitochondrial membrane potential 
 
In order to quantify the mitochondrial membrane potential, 2 × 105 Daudi cells, Ramos cells, 
bovine PBMC or iIEL were seeded per well in a 96 U-shaped plates, centrifuged at 400 × g, 
3 min and 20°C, resuspended in 100 µl of JC-1 dye (Biocarta Europe GmbH, Hamburg, 
Germany, diluted 1:400 in JC-1 buffer 1 X), and incubated for 15 min in the dark at 37°C. For 
analysis, the lymphocytes were washed once in JC-1 buffer 1X and transferred into 200 µl of 
PBS. JC-1 is a cationic dye that exhibit potential-dependent accumulation in mitochondria, 
indicated by a fluorescence emission shift from green (monomer detected in FL-1 channel) to 
red (aggregates detected in FL-2 channel) in the conventional flow cytometer channels, 
respectively. According to the manufacturer protocol, the cells showing a decreased red 
fluorescence and/or an increased green fluorescence were considered as apoptotic and/or 
necrotic. Consequently, mitochondrial depolarization is indicated by a decrease in the 
red/green fluorescence intensity ratio. 
Five thousand events were acquired by a FACSCalibur™ flow cytometer and the acquisition 
software Cell Quest Pro. An appropriate layout was created with the analysis software FCS 
Express 2 which allowed the discrimination of cell populations with different viability (Fig. 8 
and 9). Viable cells were localized in the region 4 (R4), while cells with altered mitochondrial 
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potential were located in R5, R6, and R7. The percentages of cells located in R5, R6, and R7 
were summed and this number represented the percentage of cells with altered mitochondrial 
potential (see results’ section). The same gating strategy, using four distinct regions, was 
utilized to analyse bovine PBMC (data not shown). 
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Fig. 8. Bi-colour JC-1 analysis of mitochondrial membrane potential in Daudi 
and Ramos cells by flow cytometry. Daudi (A, B) and Ramos (C, D) cells were 
incubated 20 and 24 hrs respectively in culture medium (A, C) or in medium 
supplemented with 2 µg/ml of actinomycin D (B, D). Daudi and Ramos cells were 
stained with the JC-1 dye and 5,000 events were acquired with a FACSCalibur™ 
flow cytometer. 
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Concerning iIEL, the gating strategy was different because the cells did not fit into the four 
regions described for the investigation with Daudi and Ramos cells. Consequently, only two 
regions were created with the analysis software FCS Express 2 (Fig. 9). The viable cells could 
be visualised in the upper region (R4) while subvital, apoptotic and necrotic cells were 
localised in the lower region (R5). 
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Fig. 9. Bi-colour JC-1 analysis of mitochondrial membrane potential in iIEL by 
flow cytometry. The cells were incubated 6 hrs in culture medium (A) or in medium 
supplemented with 2 µg/ml of actinomycin D (B). Ileal IEL were stained with the 
JC-1 dye, washed and analyzed with a FACSCalibur™ flow cytometer. 
 
 
3.8.4. Detection of phosphatidyl serine exposure and staining of DNA 
 
Phosphatidylserine redistribution from the internal to the external side of the cellular 
membrane of cells is a sign of early apoptosis that triggers specific recognition and removal of 
lymphocytes by macrophages (95). A vascular anticoagulant ubiquitous protein capable of 
binding phospholipids in the presence of calcium called annexin (403) was used for this 
assay. PE-conjugated human recombinant Annexin-V was purchased from Caltag 
Laboratories (Hamburg, Germany). The iIEL incubated in different conditions (Table 7) were 
seeded in 96 U-shaped plates at the density of 2.5 × 105 per well, centrifuged at 400 × g for 
3 min and 20°C and incubated 20 min in the dark at 20°C in 5 µl of Annexin-V-PE (diluted 
1:10 in PBS) and 100 µl of Ca2+-containing Annexin-V binding buffer 1X containing 1 µg/ml 
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of  7-amino actinomycin D (7-AAD, Sigma). The cells were centrifuged, washed once in 
100 µl of Annexin-V binding buffer, and transferred to test tubes containing 200 µl PBS. 
Single positive (Annexin-V+) cells were considered as apoptotic while double-positive 
(Annexin-V+, 7-AAD+) cells were considered as necrotic. Five thousand events were acquired 
by a FACSCalibur™ flow cytometer (Becton Dickinson). An appropriate analysis-plot was 
created with the software FCS Express 2 (De Novo software) which allowed the 
discrimination of cell population viability (Fig. 10 and 11). 
 
A       B 
 
 
 
 
 
 
 
 
 
 
C       D 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 10. Investigation of Daudi (A, B) and Ramos (C, D) cells viability by staining 
with Annexin-V and 7-AAD. The cells were incubated 20 (Daudi) or 24 hrs (Ramos) 
in culture medium only (A, C) or in medium supplemented with 2 µg/ml of 
actinomycin D (B, D). The cells were stained with Annexin-V-PE and 7-AAD, and 
analyzed with a FACSCalibur™ flow cytometer. Viable cells were localized in the 
lower left quadrant, early apoptotic cells in the lower right quadrant, and late apoptotic 
and necrotic cells in the upper right quadrant. 
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Fig. 11. Investigation of iIEL viability by staining with Annexin-V and 7-AAD. 
Cells were incubated 6 hrs (A, B) or 20 hrs (C, D) in culture medium (A, C) or in 
medium supplemented with 2 µg/ml of actinomycin D (B, D). Ileal IEL were stained 
with Annexin-V-PE and 7-AAD, and analyzed with a FACSCalibur™ flow cytometer. 
 
3.9. Statistical analysis 
 
All data presented in the results part of this  study, the tables 8, 9 and the figure 17, 18, 28 
excepted, were statistically analysed by Student’s t-test for normally distributed data and by 
Mann-Whitney Rank Sum test for non-normally distributed data by using the SigmaStat 
(version 2.03 and 3.11) software (SPSS Inc., USA). Results evaluated as highly significant 
(P ≤ 0.001, ***), significant (P ≤ 0.01, **), or weakly significant (P ≤ 0.05, *), are depicted 
on the figures. Results were evaluated as not significant if P > 0.05. 
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4. Results 
 
4.1. Immunophenotyping of iIEL 
 
The results presented here are the average of duplicate determinations from iIEL isolated from 
4 different animals. Most of freshly isolated viable iIEL (absence of staining by 7-AAD) were 
found to express the CD8α antigen (51.4 ± 11.7 %, Mean ± SD), less cells were CD4+ 
(19.4 ± 11.6 %), and only a low number of cells expressed the specific B cell marker CD21 
(6.4 ± 4.0 %). The γδ TCR (TcR N12) was expressed by 25.1 ± 4.2 % of the cells and 
11.1 ± 7.1 % also expressed the WC1 antigen specific of some γδ TCR T cell subsets. The 
glycosphingolipid Gb3/CD77, the receptor of Stx1, was found on the surface of 8.1 ± 1.8 % of 
the iIEL. As 61.1 ± 10.4 % of the cells expressed CD25, the majority of the iIEL showed an 
activated state in vivo. 
 
4.2. Morphology of mitogen-stimulated iIEL 
 
After isolation, the iIEL were seeded in IEL-medium, incubated 6 or 18 hrs and stimulated by 
mitogens in order to investigate their potential to transform to blast cells. The figure 12 
depicts a representative analysis of mitogen-stimulated iIEL  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 12. Morphology of iIEL stimulated 6 hrs by PMA and ionomycin. Five thousand 
events were acquired with the FACSCalibur™ flow cytometer. The side scatter indicates 
the granularity of the cells and the forward scatter indicates the size of the cells. 
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Viable but not yet transformed cells can be observed in the region R1, while debris and 
subvital cells are localized in the region R2. The stimulation of iIEL with mitogens for 6 hrs 
did also induce the transformation of certain subsets of cells and the presence of blast cells 
could be consequently observed in the region R3. 
 
4.3. Effect of Stx1 on the blast transformation of iIEL 
 
In order to assess whether the effect of Stx1 on the iIEL activation previously reported (31, 
248) could be reproduced, the blast transformation was quantified by flow cytometry. Ileal 
IEL were incubated in culture medium supplemented with mitogens, in the absence or 
presence of Stx1, and for the latter with or without anti-StxB1 antibody. As shown by the 
figure 13, iIEL treated with Stx1 showed a significant decrease in the proportion of blast cells 
(P ≤ 0.01), accompanied by a significant increase in the percentage of untransformed viable 
cells (P ≤ 0.01) in comparison to the cells incubated with medium. 
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Fig. 13. Effect of Stx1 on the blast transformation of iIEL. Ileal IEL were stimulated 
with PMA and ionomycin and incubated 18 hrs in absence or presence of 200 CD50/ml 
Stx1 and with or without 1.5 µg/ml anti-StxB1 antibody. Data are arithmetic means and 
standard deviations of 4 independent experiments with duplicates. Five thousand events 
were acquired by the flow cytometer. Significant effect of Stx1 was determined by 
Student’s t-test and depicted if P ≤ 0.001 (***), P ≤ 0.01 (**), or P ≤ 0.05 (*). 
Viable untransformed 
iIEL 
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This effect of Stx1 was neutralized by the anti-StxB1 antibody which restored the number of 
blast cells (P ≤ 0.001) to a level comparable though slightly different (P ≤ 0.05) from the 
medium control. 
 
 
4.4. Effect of Stx1 on the expression of Gb3/CD77 by iIEL 
 
As a consequence of treatment with Stx1, a decrease in the number of iIEL expressing 
Gb3/CD77 was reported (31). Consequently, the effect of Stx1 on iIEL was investigated here 
on 18 hrs-mitogen-stimulated cells to determine whether this observation was due to the 
elimination of the cells from the culture or from a redistribution of the receptor from the cell 
surface to the intracellular compartments. The analysis of native iIEL indicated that Stx1 
slightly reduced both the percentage of blast cells expressing Gb3/CD77 (Fig. 14A) and the 
level of its expression per cell (i.e. the fluorescence intensity of Gb3/CD77 detection, Fig. 
14B). However, this effect could not be blocked by the anti-StxB1 antibody. In contrast to 
blast iIEL, both the percentage of expressing cells and the level of Gb3/CD77 expression were 
increased in subvital cells, from 6.7 to 8.0 % and from 39.1 to 69.0 A.U. (arbitrary units), 
respectively. The expression of the toxin receptor by viable cells was not affected by the 
toxin. 
However, evidence was provided that native and fixed/permeabilized cells showed an 
important difference in Gb3/CD77 expression. While not all iIEL expressed the receptor on 
the cell surface, after permeabilization of the cells, Gb3/CD77 became detectable in an higher 
number of iIEL. Both the percentage of cells expressing Gb3/CD77 and the level of 
expression increased. As only 7.4 ± 1.6 % of the viable iIEL expressed the receptor on the cell 
surface, 30.7 ± 2.2 % of viable iIEL incubated with medium possess Gb3/CD77 
intracellularly. This tendency was also true concerning the other iIEL populations (blast and 
subvital iIEL). In addition, Stx1 had a moderate effect on the percentage of subvital iIEL 
expressing Gb3/CD77 (Fig. 14C, from 22.2 to 28.2 %) but no effect on viable and blast cells 
was observed (Fig. 14C and D). The total content in Gb3/CD77 of the cells was not changed.  
Taken together, the data indicate that, upon treatment with Stx1, the receptor is redistributed 
from the surface to the intracellular compartments but Stx1-affected cells appear to remain 
present (viable) in the culture, a prerequisite for further investigations on the effect of Stx1 on 
the molecular level. 
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Fig. 14. Effect of Stx1 on the expression of Gb3/CD77 by iIEL. PMA and ionomycin-
stimulated cells were incubated 18 hrs in presence or absence of 200 CD50/ml of Stx1 or 
with Stx1 and 1.5 µg/ml of anti-StxB1 antibody. The quantitation of the percentage (A 
and C) and intensity of fluorescence (B and D) of Gb3/CD77 detection by iIEL was 
performed by flow cytometry (5,000 events) on native (A and B) or fixed and 
permeabilized cells (C and D). Data are arithmetic means and SEM of 4 determinations 
with duplicates. Significant effect of Stx1 was determined by Student’s t-test or by Mann-
Whitney Rank Sum test, and depicted if P ≤ 0.001 (***), P ≤ 0.01 (**), or P ≤ 0.05 (*). 
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Figure 14 (continued). 
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4.5. Cytokine and chemokine mRNA expression by freshly isolated bovine iIEL 
 
In order to evaluate the relative amounts of transcripts specific for cytokines and chemokines 
present in bovine iIEL after isolation and prior to any further stimulation in vitro (addition of 
mitogens or Stx1), the mRNA profile of freshly isolated iIEL was assessed by semi-
quantitative RT-PCR. The figure 15 is a representative picture of what was observed in 
determinations with iIEL originating from 3 different animals. Freshly isolated iIEL were 
found to harbour transcripts for the chemokines (IL-8, IP-10, and MCP-1) and for the TH1 
(IL-2, IFN-γ), TH2 (IL-4, IL-10), and TH3-type (TGF-β) cytokines of the selected panel. In 
addition, transcripts for the proinflammatory TNF-α were also detected in the cells. 
 
 
 
 
 
Fig. 15. Cytokine and chemokine mRNA profile of freshly isolated iIEL. 
Products of semi-quantitative RT-PCR were loaded into a 2 % agarose gel 
(M = GeneRuler™ 100 bp Marker, Fermentas GmbH). PCR products from a single 
representative iIEL preparation (n=3). 
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4.6. Chemokine expression in iIEL in the absence or presence of Stx1 
 
4.6.1. Chemokine mRNA expression 
 
After incubation of iIEL in medium supplemented with PHA-P for 6 hrs, the use of the real-
time PCR ∆Ct values brought information concerning the amounts of chemokine transcripts 
present in the cells relative to gapdh transcripts. IP-10 mRNA was very rare in the iIEL 
(≈ 0.01 % of the gapdh transcript content), while transcripts of mcp-1 were the most abundant 
(≈ 3 %). Transcripts of il-8 were constantly harboured by the cells at a moderate level 
(≈ 1 %). 
In order to evaluate whether Stx1 has an impact on the production of chemokines, the 
respective mRNA was quantified in mitogen-stimulated cells incubated in presence or 
absence of the toxin. As shown in figures 16A and 16B, the gene transcription of the three 
chemokines investigated (IL-8, IP-10, and MCP-1 mRNA) was not significantly altered by 
200 CD50/ml of Stx1 (P > 0.05) after several hours of incubation (up to 24 hrs). 
 
4.6.2. Release of chemoattractant factors by iIEL 
 
To rule out that Stx1 did not induce any post-transcriptional modifications and to assess 
whether the incubation of iIEL with Stx1 could influence the release of other chemokines not 
investigated by RT-PCR, a functional assay was performed (Fig. 17). The chemoattractant 
activity of culture supernatants was tested with bovine polymorphonuclear neutrophils. Used 
as a positive control, concanavalin A plus rhIL-2-stimulated PBMC culture supernatant 
efficiently induced the attraction of neutrophils to the lower part of the migration system 
(P ≤ 0.01). The release of chemoattractive substances by iIEL into the culture supernatant was 
lower than in the PBMC control (P ≤ 0.05).  
Nevertheless, the migration rate of neutrophils towards iIEL-conditioned media was always 
significantly superior to the non-conditioned-medium control (P ≤ 0.01), indicating that 8 and 
18 hrs PHA-P-stimulated iIEL released chemoattractant factors in the culture. However, no 
variation could be observed in the migration rate of neutrophils between the different 
conditions indicating that Stx1 failed to influence the total release of chemoattractants by iIEL 
after 8 or 18 hrs of cultivation. 
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Fig. 16. Relative amounts of chemokine gene transcripts harboured by iIEL upon 
cultivation in presence of purified Stx1. PHA-P-stimulated cells were incubated 6 and 
24 hrs (A), or 4, 6, and 8 hrs (B) with Stx1 (200 CD50/ml as determined on Vero cells). 
After RT and quantitation by real-time PCR, the transcription of the housekeeping gene 
gapdh was used for normalization of the samples. Cells incubated with medium were 
used as a control (=100 % as visualized by the black line). Data presented are arithmetic 
means, minimal and maximal values of results obtained with iIEL preparations from 5 
(A) and 6 (B) different animals. 
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Fig. 17. Migratory activity of bovine neutrophils towards supernatants obtained 
from iIEL cultures incubated in absence or presence of Stx1. Bovine neutrophils were 
allowed to migrate for 13/4 h at 37°C towards the lower compartment containing agonists 
(iIEL supernatants; stimulated PBMC supernatant as positive control), then harvested and 
counted. The results are expressed using a non-conditioned medium as a reference 
(=100 % as visualized by the black line). Data represent means ± SEM of values from 
migration assays with 6 independently obtained iIEL culture supernatants. Statistical 
analysis revealed that all conditions were significantly different from the non-conditioned 
medium (P ≤ 0.01, **). 
 
 
4.7. Effect of Stx1 on cytokine gene transcription in bovine lymphocytes 
 
4.7.1. Investigations with bovine iIEL 
 
To assess whether the toxin modified the production of cytokine transcripts after both short 
and long term incubations, iIEL were stimulated with mitogens in vitro and treated with Stx1 
for 6 and 24 hrs. Real-time PCR indicated that Stx1 had no influence on the amounts of 
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transcripts of both pro-inflammatory TH1-cytokines IL-2 and IFN-γ after both incubation 
times (P > 0.05, Fig. 18A). The level of the anti-inflammatory TH3-cytokine TGF-β was as 
well not influenced by the toxin after the incubation times. Stx1 also did not affect the relative 
amounts of the il-10 transcripts (Fig. 18A), even though they were detectable in only small 
numbers (Ct values 39-40) compared to other cytokines (data not shown). However, Stx1 
significantly influenced the level of transcripts of the TH2-type cytokine IL-4 within 6 hrs of 
cultivation (P < 0.05). This enhancement of il-4 transcripts on iIEL was not detectable in cells 
incubated 24 hrs with the toxin (Fig. 18A). A more detailed analysis (Fig. 18B) with iIEL 
incubated for 4 to 8 hrs revealed that, despite the variability of sensitivity between different 
iIEL preparations, Stx1 enhanced the level of il-4 transcripts as early as after 4 hrs of 
incubation (4.5 fold compared to the medium control) and this effect was dramatically 
increased in the next hours to reach a maximum after 8 hrs of incubation (42 fold compared to 
the medium control). As described above for 6 and 24 hour-incubations, the amounts of the 
other cytokine transcripts were not altered by 4-to-8 hour-incubations with the toxin. 
 
This effect of Stx1 on bovine iIEL could be efficiently neutralized by pre-incubating the toxin 
90 min at 37°C with 1.5 µg/ml of anti-StxB1 13C4 antibody (Fig. 19). In contrast to the effect 
of Stx1 on the Gb3/CD77 surface expression, even the effect of 180 CD50/ml could be 
perfectly neutralized by pre-incubation of the toxin with the anti-StxB1 antibody. 
In addition, even if iIEL preparations from several animals strikingly differed in their 
sensitivity to the toxin, minute concentrations of Stx1 (7, 22, and 66 CD50/ml), corresponding 
to the low range of picograms per millilitre, still induced a prominent enhancement of the 
amount of il-4 transcripts in iIEL within 6 hrs of cultivation (Fig. 20). 
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Fig. 18. Relative amounts of cytokine gene transcripts harboured by iIEL upon 
cultivation in presence of purified Stx1. PHA-P-stimulated cells were incubated 6 and 
24 hrs (A), or 4, 6, and 8 hrs (B) with Stx1 (200 CD50/ml as determined on Vero cells). 
After RT and quantitation by real-time PCR, the transcription of the housekeeping gene 
gapdh was used for normalization of the samples. Cells incubated with medium were 
used as a control (=100 % as visualized by the black line). Data presented are arithmetic 
means, minimal and maximal values of results obtained with iIEL preparations from 5 
(A) and 6 (B) different animals. Statistically significant differences were determined by 
Mann-Whitney Rank Sum test and depicted if P ≤ 0.05 (*) or ≤ 0.01 (**). 
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Fig. 19. Neutralization of the Stx1-induced enhancement of il-4 transcript’s level on 
iIEL. PHA-P-stimulated (2.5 µg/ml) cells were incubated 6 hrs with different 
concentrations of Stx1 (7.5, 15, 30, 90 and 180 CD50/ml) or 180 CD50/ml of Stx1 and 
1.5 µg of anti-StxB1 antibody. After RT and quantitation by real-time PCR, the 
transcription of the housekeeping gene gapdh was used for normalization of the samples. 
Cells incubated with medium were used as a control (= 100 % as visualized by the black 
line). N=1 determination analysed in duplicates. 
 
 
Bovine iIEL produced small amounts of transcripts encoding the IL-4δ2 splice variant 
(360 bp), as described in bovine peripheral lymphocytes (406). A shown by the figure 21, the 
IL-4δ2 splice variant was produced by both freshly isolated iIEL (lane 2) and by 6 hrs-
mitogen-stimulated iIEL as well (lanes 3 to 5). Although the production of il-4 full length 
(408 bp) transcripts was strongly increased by a 6 hrs-incubation with Stx1 (lane 4), semi-
quantitative RT-PCR analysis did not provide evidence that Stx1 influenced the production of 
the splice variant δ2 when the cells were cultivated in presence of 200 CD50/ml of the toxin. 
The splice variant δ3 could not be detected in iIEL. 
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Fig. 20. Effect of purified Stx1 on the amounts of IL-4-specific mRNA in bovine iIEL 
cultures. PHA-P-stimulated (2.5 µg/ml) cells from 3 different animals were incubated for 
6 hrs with different concentrations of Stx1 (7, 22, 66, and 200 CD50/ml as determined on 
Vero cells) or with 200 CD50/ml of Stx1 and 1.5 µg/ml of anti-StxB1 antibody 13C4. 
Subsequently, mRNA was reversely transcribed and quantified by real-time PCR. 
GAPDH mRNA expression was used as a standard. Cells incubated with medium only 
were used as a control (= 100 % as visualized by the black line). N=3. 
 
 
4.7.2. Investigations with bovine PBMC 
 
This enhancement of IL-4 mRNA cell content by Stx1 was specific for iIEL. Bovine PBMC 
incubated 6 hrs with the toxin (33 CD50/ml of Stx1) did not produce more IL-4 transcripts 
than cells incubated with medium only. Stx1 influenced only slightly the cytokine and 
chemokine mRNA transcription compared to the medium control (lower than 2 fold, no 
statistical significance, P > 0.05) (Fig. 22). 
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Fig. 21. Production of il-4 full length (408 bp) and il-4δ2 (360 bp) splice variants mRNA by iIEL. 
PHA-P-stimulated (2.5 µg/ml) cells were incubated 6 hours with 200 CD50/ml of Stx1 (as determined 
on Vero cells) or with 200 CD50/ml of Stx1 and 1.5 µg of anti-StxB1 13C4 antibody. IL-4 mRNA was 
detected by semi-quantitative RT-PCR and PCR products were analyzed on a 2 % agarose gel (A). 
gapdh was used as a housekeeping gene for constitutive gene expression (B). Data presented are 
representative of 3 repetitions with different iIEL preparations. 
 
Lane 1: GeneRuler™ 100 bp Marker 
Lane 2: Amplification of cDNA from freshly isolated iIEL 
Lane 3: Amplification of cDNA from iIEL incubated 6 hrs with IEL-medium 
Lane 4: Amplification of cDNA from iIEL incubated 6 hrs with 200 CD50/ml of Stx1 
Lane 5: Amplification of cDNA from iIEL incubated 6 hrs with 200 CD50/ml of Stx1 and 1.5 µg/ml of 
anti-StxB1 antibody 13C4 
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Fig. 22. Effect of purified Stx1 on chemokine and cytokine gene transcription by 
PBMC. PHA-P-stimulated (5 µg/ml) cells were incubated 6 hrs with 33 CD50/ml of Stx1. 
mRNA were subjected to reverse transcription and cDNA to real-time-PCR. The 
transcription of the housekeeping gene gapdh was used for normalization of the samples. 
Cells incubated with medium were used as a control (= 100 % as visualized by the black 
line). Data presented are the arithmetic means, the minimal and maximal values of 5 
different animals with duplicates. Statistical analysis did not show any significant 
difference between cells incubated in absence or presence of Stx1. 
 
 
4.8. Cytokine synthesis in the absence or presence of Stx1 
 
4.8.1. Investigations with bovine iIEL 
 
In order to confirm the PCR results at the protein level, the intracellular production of selected 
cytokine proteins was investigated by flow cytometry on the single cell level. Ileal IEL were 
unstimulated or stimulated with the mitogens PMA/Ionomycin and cultured for 1 h or 8 hrs 
with 200 CD50/ml of Stx1 and then incubated additional 5 or 16 hrs, respectively, in the 
presence of brefeldin A. The figures 23 and 24 show the percentage of cells expressing the 
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cytokines IL-4, IFN-γ and TGF-β, and the intensity of this expression after a total incubation 
time of 6 hrs (Fig. 23A and 24A) and 24 hrs (Fig. 23B and 24B). 
The IL-4 protein was shown to be produced by only a small portion of iIEL within 6 hrs of 
incubation (nearly 3 %). Moreover, Stx1 did not affect the percentage of iIEL expressing IL-4 
protein at this time points (P > 0.05). Concerning TGF-β, the production was low and Stx1 
did not influence the protein level too (P > 0.05). After 6 hrs of cultivation, IFN-γ-producing 
cells were the most abundant among iIEL. However, Stx1 did not influence the percentage of 
cells producing IFN-γ. The mitogenic stimulation dramatically increased the proportion of 
IFN-γ-producing cells but Stx1 still did not affect this production in vitro. The percentage of 
cells producing IL-4 and TGF-β was not altered upon cultivation with Stx1. The mean 
fluorescence intensity (average protein content/cell) was identical for the three tested 
cytokines after 6 hrs of cultivation, independently of the stimulation by mitogens or 
cultivation with Stx1 (Fig. 24A). 
After 24 hrs of incubation, independently of the incubation with mitogens or with Stx1, the 
number of IL-4-producing cells was low (Fig. 23B). Similarly, even if a slight increase after 
overnight cultivation could be observed, the production of TGF-β was still low. Upon 
mitogenic stimulation, the number of cells producing IFN-γ increased after 24 hrs of 
cultivation. Nevertheless, no statistical significant differences of IL-4 and TGF-β protein 
production were found between cells incubated in absence or presence of Stx1 (P > 0.05). 
Even though PMA and ionomycin-stimulated iIEL produced dramatically increased amounts 
of IFN-γ protein, the toxin did not have an effect on this TH1-type cytokine production after 
24 hrs of incubation (P > 0.05). 
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Fig. 23. Percentage of iIEL synthesizing certain cytokines in vitro in absence or 
presence of Stx1. Cells were left unstimulated or stimulated with PMA (50 ng/ml) and 
ionomycin (10 µg/ml) for 6 hrs (A) and 24 hrs (B). Brefeldin A (10 µg/ml) was added 1 h 
and 8 hrs, respectively, after the incubation begun. The cells were fixed, permeabilized, 
and intracellular cytokines were immunodecorated. Data presented are arithmetic 
means ± SEM of percentage of cytokine producing cells of 5 independent experiments 
with duplicate determinations. 
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Fig. 24. Fluorescence intensity for the detection of cytokine proteins in iIEL in vitro 
in absence or presence of Stx1. Cells were left unstimulated or stimulated with PMA 
(50 ng/ml) and ionomycin (10 µg/ml) for 6 hrs (A) and 24 hrs (B). Brefeldin A 
(10 µg/ml) was added 1 h and 8 hrs, respectively, after the incubation begun. The cells 
were fixed, permeabilized, and intracellular cytokines were immunodecorated. Data 
presented are arithmetic means ± SEM of fluorescence intensities (arbitrary units) of 
cytokine detection of 5 independent experiments with duplicate determinations. 
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4.8.2. Investigations with bovine PBMC 
 
In addition to iIEL, the intracellular production of cytokines was investigated in bovine 
peripheral lymphocytes. Upon cultivation with mitogens, PBMC produced both IL-4 and 
IFN-γ proteins within 7 and 21 hrs. After 7 hrs of incubation, half of the cells had produced 
IFN-γ while only 20.9 ±5.5 % (mean ±SEM) of the cells had synthesized IL-4. After 21 hrs of 
incubation, the percentage of cells producing IL-4 decreased while the average amount of 
cytokine produced per cell increased (19.0 ±2.1 A.U. and 36.2 ±10.2 A.U. after 7 and 21 hrs, 
respectively). Concerning IFN-γ, both the proportion of PBMC producing the cytokine and 
the amount of cytokine produced per cell (27.4 ±1.3 A.U. and 53.9 ±10.2 A.U. after 7 and 
21 hrs, respectively) increased. 
Stx1, at the concentration of 33 CD50/ml, slightly decreased the production of IFN-γ by 
PBMC after 21 hrs of incubation. Stx1 reduced both the total percentage of cells (Fig. 25A) 
and the average amount of cytokine produced per cell (Fig. 25B). PBMC preparations from 
several animals strikingly differed in their sensitivity but always showed the same effect of 
Stx1. 
Similarly to what was observed with IFN-γ, the toxin had an effect on the production of IL-4 
by PBMC only after 21 hrs of incubation (Fig. 25B), as the average amount of cytokine 
produced per cell was significantly decreased (P < 0.05). 
The figure 26 shows the example of a PBMC preparation particularly affected by the toxin. 
The percentage of cell producing IFN-γ (defined by the range M1) was reduced from 69.9 to 
55.5 % after 21 hrs of cultivation with Stx1. The addition of anti-StxB1 antibody restored the 
IFN-γ production. No effect was observed on the IFN-γ production for this PBMC preparation 
after 7 hrs of incubation (data not shown). In addition, a detailed examination revealed that 
Stx1 also reduced the percentage of cells which produced high amounts of IFN-γ (defined by 
the range M2) after 21 hrs of incubation. This IFN-γ-high-producing population of PBMC 
was reduced from 13.6 % to 7.0 % in presence of the toxin. An additional pre-incubation of 
Stx1 with the anti-StxB1 antibody 13C4 restored and even increased the production of IFN-γ. 
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Fig. 25. Effect of Stx1 on intracellular protein expression of IL-4 and IFN-γ by 
PBMC. The cells were stimulated with PMA (50 ng/ml) and ionomycin (10 µg/ml) for 7 
or 21 hrs with or without 33 CD50/ml of Stx1. Brefeldin A (10 µg/ml) was added 
respectively 1 h or 8 hrs after the incubation begun. Data presented are arithmetic 
means ± SEM of percentages of cytokine-expressing cells (A) and intensities of 
fluorescence (B, normalized by setting the condition Medium as 100 %) obtained from 3 
independent experiments with duplicate determinations. 
Results 
 - 85 - 
A      B 
FL1-H
010 110 210 310 410
Co
u
n
t
45
40
35
30
25
20
15
10
5
0
M1
M2
69.9%
13.6%
Co
u
n
t
 
FL1-H
010 110 210 310 410
Co
u
n
t
45
40
35
30
25
20
15
10
5
0
M1
M2
55.5%
7.0%
Co
u
n
t
 
C 
FL1-H
010 110 210 310 410
Co
u
n
t
40
35
30
25
20
15
10
5
0
M1
M2
77.2%
20.5%
Co
u
n
t
 
Fig. 26. Effect of Stx1 on the production of IFN-γ by PBMC. Cells were incubated 
21 hrs with either medium (A), with 33 CD50/ml of Stx1 (B), and with 33 CD50/ml 
Stx1 plus 1.5 µg/ml anti-StxB1 antibody (C). FACS analysis plots present the 
intensity of the fluorescence (FL-1 channel) after a specific staining with an anti-
IFN-γ antibody (Ctrl represents the isotype control). 
 
 
4.9. Investigation of Stx1-induced apoptosis in several cell types 
 
Stx1 and StxB1 were previously shown to induce apoptosis in several cell types as monocyte-
like THP-1 cells (138) or Burkitt’s lymphoma cell lines (240). The triggering of Gb3/CD77 by 
monoclonal antibodies also induces apoptosis in Burkitt’s lymphoma cell line (382, 391). In 
addition, mistletoe lectins (plant toxins) induce apoptosis in CD8+ T cells and this coincided 
with an increase in IL-4 production (364). Consequently, as most of Gb3/CD77
+ iIEL express 
the CD8 co-receptor (248), the hypothesis emerged that the enhancement of il-4 transcripts 
Ctrl Ctrl 
Ctrl 
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induced by Stx1 could be linked with the induction of apoptosis in iIEL by the toxin or by the 
triggering of Gb3/CD77 by the rStxB1 subunit. 
In order to establish the method of investigation of apoptosis induction, Burkitt’s lymphoma 
cells (Daudi and Ramos cells) were used as positive controls for Stx1- and StxB1-induced 
apoptosis. As shown in table 8, Daudi cells were found to be relatively resistant to induction 
of apoptosis either by actinomycin D or by Stx1. The effect of Stx1 could be neutralized by a 
90 min-pre-incubation of the toxin with 1.5 µg/ml of the anti-StxB1 antibody. The StxB1 
subunit alone did not induced apoptosis neither did the cross-linking of the Stx1 receptor by 
an anti-CD77 antibody. The addition of the Golgi-inhibitor brefeldin A reduced the effect of 
the toxin, indicating the importance of the processing of the toxin intracellularly in this cell 
model. The relative low level of Stx1-induced apoptosis in Daudi cells led to the use of 
another cell line to obtain an efficient induction of apoptosis. The presence of Gb3/CD77 on 
Ramos cells surface was assessed by flow cytometry. All Ramos cells expressed Gb3/CD77 
on their cell surface at a relatively high level, as shown in the figure 27. 
 
Table 8. Induction of apoptosis in Daudi cells 
 
Condition 
of incubation 
Early 
apoptotic 
Late 
apoptotic 
and necrotic 
 
Altered mitochondrial 
membrane potential 
     Medium 11.8 6.4  15.5 
     Actinomycin D 31.2 11.6  31.0 
     Stx1 29.2 19.8  47.2 
     Stx1 + anti-StxB1 13C4 MAb 16.9 8.6  26.0 
     Anti-StxB1 13C4 MAb 11.3 4.9  20.6 
     rStxB1 17.0 7.3  31.2 
     rStxB1 + 13C4 Ab 15.5 7.0  32.4 
     CD77 cross-linking 14.9 7.7  30.9 
     Brefeldin A 12.9 4.8  37.9 
     Brefeldin A + Stx1 13.8 5.0  34.4 
 
Daudi cells were incubated 24 hrs at 37°C. Apoptosis and necrosis levels were 
assessed by detection of Annexin-V binding to phosphatidylserine, staining of DNA 
by 7-AAD, and modification of the mitochondrial membrane potential (JC-1 assay). 
Data presented are the arithmetic means of percentages obtained from duplicates 
from 1 experiment. 
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Fig. 27. Expression of CD77 on the surface of Ramos cells. The FACS plot 
presents the intensity of the fluorescence (FL-2 channel) after a specific staining 
with an anti-human CD77 antibody. The grey line depicts the isotype control (Ctrl). 
 
 
 
 
As shown in table 9, the addition of 200 CD50/ml of Stx1 to Ramos cell cultures very 
efficiently induced apoptosis after 20 hrs of cultivation as detected by the exposure of 
phosphatidylserine on the cell surface and by the loss of mitochondrial membrane potential. 
The anti-StxB1 13C4 antibody neutralised this effect by considerably reducing the apoptosis 
to a level comparable to the medium control. Moreover, the addition of a high concentration 
of the StxB1 subunit (10 µg/ml) also induced apoptosis, confirming a role of the Gb3/CD77 
signaling pathway in Ramos cells. However, the latter effect could not be neutralized by pre-
incubation with the anti-StxB1 antibody 13C4. The addition of the Golgi inhibitor brefeldin A 
slightly reduced the effect of the toxin suggesting that both toxin processing and triggering of 
the receptor are important in this cell system. However, no apoptosis was observed by cross-
linking Gb3/CD77 by the 38.13 antibody and an anti-rat IgM in Ramos cells. 
 
Before assessing whether Stx1 induced the apoptosis of iIEL, the JC-1 assay was applied to 
bovine PBMC incubated 6 hrs with 2 µg/ml of actinomycin D or with 200 CD50/ml of Stx1. 
In comparison to the medium control (apoptosis 7.1 % and necrosis 37.1 %), actinomycin D 
efficiently reduced the cell viability (Fig. 28), mainly by inducing necrosis of PBMC 
Ctrl 
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(69.8 %). In contrast, a 6 hrs-incubation with Stx1 had no effect on PBMC apoptosis (7.8 %) 
and necrosis levels (37.9 %). 
Upon staining with Annexin-V and 7-AAD, 41.9 % of iIEL were detected as apoptotic and/or 
necrotic after the isolation procedure from the ileum. Even in the presence of the mitogen 
PHA-P, a 6 h-incubation in medium increased this level to 65.2 % (table 9). In contrast to 
Ramos cells, neither Stx1 holotoxin nor the StxB1 subunit induced apoptosis in iIEL after 
6 hrs of incubation. 1 ng/ml of LPS also failed to induce any apoptosis and the cross-linking 
of Gb3/CD77 with antibodies did not have any effect on the cell viability. The RNA-synthesis 
inhibitor actinomycin D, used as a positive control, did not induce iIEL apoptosis after short 
term-incubation but very efficiently did after 20 hrs of incubation. Not any other substance of 
the panel did induce any iIEL apoptosis after 20 hrs of incubation at 37°C. 
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Fig. 28. Induction of apoptosis in bovine PBMC. Cells were incubated 
6 hrs at 37°C. Apoptosis and necrosis levels were assessed by FACS by 
detecting any modification of the mitochondrial membrane potential (JC-1 
assay). Five thousand events were acquired per sample with a FACSCalibur™ 
flow cytometer. Data presented are the arithmetic means of percentages 
obtained from one PBMC preparation with duplicate determinations. 
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Table 9. Induction of apoptosis in Ramos cells and bovine iIEL 
             6 h incubation             20 h incubation 
Cell type and condition 
of incubation 
Early apoptotic 
Late apoptotic 
and necrotic 
 
Altered mitochondrial 
potential 
 Early apoptotic 
Late apoptotic 
and necrotic 
Altered mitochondrial 
potential 
Ramos cells         
     Medium n.t n.t  n.t  17.9 ±8.7 3.3 ±1.4 20.2 ±11.8 
     Actinomycin D n.t n.t  n.t  77.2 ±2.5 15.8 ±2.0 98.0 ±0.8 
     Stx1 n.t n.t  n.t  78.8 ±4.1 14.5 ±4.0 98.2 ±0.4 
     Stx1 + anti-StxB1 Ab n.t n.t  n.t  21.2 ±9.1 3.5 ±1.2 20.8 ±11.0 
     Anti-StxB1 MAb n.t n.t  n.t  20.2 ±8.6 4.0 ±2.0 26.8 ±17.5 
     rStxB1 n.t n.t  n.t  52.7 ±7.2 8.2 ±4.3 65.7±12.0 
     rStxB1 + anti-StxB1 Ab n.t n.t  n.t  59.2 ±13.1 7.3± 3.7 61.8±12.7 
     CD77 cross-linking n.t n.t  n.t  17.6 ±9.2 5.2 ±3.1 22.3 ±12.2 
     Brefeldin A n.t n.t  n.t  34.0 ±15.0 11.0 ±6.1 65.5 ±15.1 
     Brefeldin A + Stx1 n.t n.t  n.t  43.3 ±18.0 13.1 ±7.7 77.3 ±12.0 
Bovine iIEL         
     Medium 29.7 ±11.4 35.5 ±5.4  74.1 ±1.8  34.4 16.2 n.t 
     Actinomycin D 30.2 ±10.4 41.0 ±4.1  72.7 ±4.2  49.9 44.6 n.t 
     Stx1 26.3 ±9.4 40.9 ±5.8  74.3 ±4.5  32.8 17.9 n.t 
     Stx1 + anti-StxB1 Ab 29.1 ±10.3 39.2 ±7.4  76.7 ±3.2  32.0 17.9 n.t 
     rStxB1 26.8 ±12.5 37.6 ±5.9  75.7 ±2.7  32.8 19.0 n.t 
     rStxB1 + anti-StxB1 Ab 27.6 ±10.7 39.4 ±5.2  73.7 ±4.2  33.4 20.4 n.t. 
     CD77 cross-linking 27.1 ±8.9 38.3 ±5.7  75.6 ±4.2  35.8 17.8 n.t 
     LPS 30.1 ±9.1 36.3 ±4.9  75.4 ±4.1  35.4 16.3 n.t 
     Brefeldin A 27.4 ±6.4 36.4 ±6.3  75.5 ±4.4  39.5 30.8 n.t 
     Brefeldin A + Stx1 25.2 ±7.6 37.5 ±7.7  78.6 ±2.2  39.7 29.4 n.t 
Ramos cells, used as positive control for Stx1- and StxB1-induced apoptosis, were incubated 20 hrs at 37°C (for concentrations, see Table 7). Data are means ± SD of 3 
determinations with duplicates. Bovine iIEL were incubated 6 or 20 hrs at 37°C. Apoptosis and necrosis levels were assessed by flow cytometry by Annexin-V binding, 
staining of DNA by 7-AAD, and modification of the mitochondrial membrane potential. Data presented are arithmetic means ± SD of percentages obtained from duplicate 
determinations with 3 (6 hrs) or 1 (20 hrs) preparation.  “n.t.” for “not tested”. 
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4.10. Contribution of the enzymatic activity of Stx1 to the enhancement of il-4 
transcripts 
 
In order to assess whether the enzymatic activity of the toxin was required to induce the 
increase in il-4 transcripts, iIEL were incubated with the substances listed in table 7. Stx1 
holotoxin induced a very strong increase in the amount of il-4 transcripts within 6 hrs of 
cultivation in PHA-P-stimulated iIEL (Fig. 29). This effect was perfectly neutralized by 
1.5 µg/ml of anti-StxB1 antibody 13C4. However, StxB1 alone did not induce any increase in 
il-4 transcripts level, indicating the preponderant role of the enzymatic activity of Stx1 in 
bovine iIEL. The Golgi inhibitor brefeldin A almost completely removed the effect due to 
Stx1, confirming the importance of the uptake and processing of the toxin into the cells. 
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Fig. 29. Effect of different agents on the amount of IL-4-specific mRNA in bovine 
iIEL cultures. PHA-P-stimulated (2.5 µg/ml) cells were incubated for 6 hrs in 
presence of different agents (for concentrations, see table 7). After RT and quantitation 
by real-time PCR, the transcription of the housekeeping gene gapdh was used for 
normalization of the samples. Cells incubated with medium were used as a control 
(=100 % as visualized by the black line). Data presented are arithmetic means, minimal 
and maximal values from 3 preparations from different animals. Significant cytokine 
production was determined by Student’s t-test and depicted if P ≤ 0.01 (**) or 
P ≤ 0.05 (*). 
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The endotoxin LPS from E. coli, used at an overdose to what was present in the Stx1 
preparation, did not induce any IL-4 mRNA transcription in iIEL, neither did the cross-
linking of Gb3/CD77 by specific antibodies. The treatment with Actinomycin D induced a 
decrease in the overall mRNA quantity in iIEL (data not shown), and also reduced the relative 
amount of il-4 specific transcripts. 
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5. Discussion 
 
 Shiga toxins (Stxs) affect the cytokine production of several cell types involved in 
inflammatory processes in the course of human infections with Stx-producing E. coli (STEC) 
(139, 140, 317, 392, 393). In adult cattle, the chronic carriage of STEC in the intestine 
coincides with the ability of Stx1 to affect the immune response by acting on bovine 
lymphocytes from both systemic compartment and intestinal mucosa. Stx1 blocks the 
activation and proliferation of blood lymphocytes without inducing cell death (249, 254). It 
equally affects the lymphoblast transformation of iIEL in vitro (248) and partially depletes the 
bovine ileal mucosa of CD8+ iIEL in vivo (251). Ileal IEL, the first immune cells to gain 
contact with the toxin, are therefore considered the main target cells of Stx1 in cattle (248). 
These observations prompted to hypothesize that Stx1 may disturb the mucosal cytokine 
regulatory network in the bovine´s intestine. Therefore, the objectives of the present study 
were to investigate the cytokine and chemokine gene transcript and protein expression 
profiles of bovine iIEL upon cultivation in the absence and presence of purified Stx1. 
Although peripheral blood mononuclear cells (PBMC) and iIEL transcribed a number of 
different cytokine and chemokine genes, the effect of Stx1 at minute concentrations was 
considerably specific in that it was restricted to il-4 and occurred in iIEL only. It is tempting 
to speculate that, by secreting Stx1, STEC trigger the immune response in the intestine of the 
bovine host towards a TH2-like pattern.  
 
5.1. Chemokine production by bovine iIEL cultured in presence and absence of Stx1 
 Human IEL are a potent source of chemokines (IL-8, MIP-1α, -1β, RANTES and 
lymphotactin) (35, 227) and are thought to induce the attraction of cells of the innate immune 
response (monocytes, neutrophils) as well as of lymphocytes. The present study showed, for 
the first time, that bovine iIEL also produce chemokines mRNA and proteins, indicating that 
iIEL in this species also actively contribute to the migration of immune cells to the mucosa. 
 In contrast to preliminary observations with bovine iIEL (248), investigations by real-time 
PCR proved that the iIEL chemokine mRNA levels were not altered by incubation of the cells 
with Stx1. This finding was further supported by results from a neutrophil migration assay to 
investigate the overall release of chemoattractant proteins. While a ConA-stimulated PBMC 
culture supernatant efficiently induced the migration of neutrophils, supernatants of PHA-P-
stimulated iIEL cultures induced migration to a lower extent. No difference could be 
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observed, however, between the supernatants of iIEL incubated with or without Stx1. Stx1 
strongly induces the production of several chemokine´s mRNA and proteins in human 
intestinal epithelial cells (IEC) (392, 393). During human STEC infections, the subsequent 
recruitment of PMN, as part of an inflammatory process, leads to an increased uptake of Stx1 
which is thought to be the most important prerequisite for significant organ damage to occur 
(155). Although comparative experiments with human IEL are pending, the results presented 
here clearly show that Stx1 does not represent a proinflammatory factor for bovine iIEL. 
Thereby, these results supplement the observation that bovine IEC are as well not stimulated 
by Stx1 to release chemoattractants for neutrophils in vitro (M. Mohr, I. Stamm, E. Schröpfer, 
G. Baljer, and C. Menge, manuscript in preparation). Together with the observation that Stx1 
is not involved in the induction of intestinal inflammation in vivo in experimentally STEC-
infected calves (368), these in vitro findings help to understand why STEC are able to 
colonize their bovine host without disturbing the intestinal homeostasis. 
 
5.2. Cytokine mRNA and proteins profiles of bovine iIEL 
 By producing a broad range of cytokines, IEL are involved in the regulation of the 
mucosal homeostasis in various species (106). Bovine iIEL freshly isolated from the intestinal 
mucosa and iIEL incubated with PHA-P-supplemented culture medium were also found to 
produce a number of different cytokine mRNAs. Although tgf-β transcripts were found more 
abundantly than other transcripts, all TH-type cytokine transcripts from the panel selected for 
the investigation were found in bovine iIEL. These findings are consistent with previous 
observations that human freshly isolated IEL harbour cytokine mRNAs and underline the 
activated state of the mucosal lymphocytes (227). 
 PHA-P stimulation was unable to induce a detectable IFN-γ and IL-4 protein production 
in bovine iIEL (data not shown). Bovine γδ T cells (15), as well as CD4+ and CD8+ T cells 
from bovine blood and mesenteric lymph nodes (341, 359), were previously reported to 
produce IFN-γ protein upon stimulation. PHA-P is a T-cell activator through CD2, however, 
and bovine γδ T cells do not express CD2 (229), partially explaining the lack of 
responsiveness upon PHA-P stimulation. Even if the treatment of the human monocytic cell 
line THP-1 with PMA decreases the membrane expression of the Stx-receptor Gb3/CD77 
(317), stimulation of bovine iIEL with PMA/ionomycin does not abrogate the cells´ 
sensitivity for the activation-inhibiting effect of Stx1(248). The mitogenic stimulation of iIEL 
in the present study was changed, therefore, in favour of PMA, a PKC activator, 
supplemented by ionomycin, a Ca2+ ionophore, which activate non-specifically T cells. 
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Indeed, IFN-γ protein was very strongly synthesised by more than 40 % of the iIEL upon this 
kind of stimulation. 
 Although both CD4+ IEL and murine primed CD8αβ IEL can secrete TGF-β (150, 255), 
the TGF-β protein was detected in only a minority of bovine iIEL and at a low level 
independently of the application of mitogens. Moreover, the constant presence of high 
numbers of mRNA led to speculate that iIEL constitutively generate tgf-β transcripts and 
probably stock them, as NK T cells can do, waiting for an eventual activation (242, 367). 
Similarly to TGF-β, the IL-4 protein was produced by the cells at a low level, independently 
of the stimulation of the cells.  
 A TH1 vs. TH2 bias is rarely observed in cattle (44, 45) and bovine T cells can express the 
cytokines IL-2, IFN-γ, and IL-4, independently and in combination, indicating possible 
intermediate patterns of cytokine production (43). The incubation of bovine iIEL with 
mitogens in the present study also led to different mRNA and protein TH-profiles, with 
predominance of TGF-β mRNA and of IFN-γ protein, respectively. The simultaneous 
production of IL-4, IFN-γ, and TGF-β protein points to an unrestricted TH0-like pattern or to a 
mixed TH profile in the unsorted preparations of bovine iIEL. Although it must be considered 
that the various iIEL subpopulations in the preparations have responded differently, a 
simultaneous production of these cytokines was also observed in human intestinal IEL (53, 
110) and in activated human peripheral blood CD4+ and CD8+ T cells (7, 295). The 
predominant production of IFN-γ by bovine iIEL (35.0 ± 4.0 % positive cells after 6 hrs, 
45.4 ± 8.8 % after 24 hrs) is in accordance with recent results that normal human IEL mainly 
produced IFN-γ (43 ± 18 %) and only small amounts of IL-4 (< 1 %) after 12 hrs of 
stimulation with PMA and ionomycin (215). Although mucosal immune responses are often 
TH2 dominated (145, 278), IEL, therefore, do not appear to be generally restricted to a certain 
TH profile. 
 
5.3. TGF- β production by bovine iIEL cultured in the presence of Stx1 
 TGF-β represents a cytokine significantly implicated in mucosal homeostasis. Produced 
by IEL (19, 227), TGF-β is an important growth factor for IEC (18). It had been shown 
previously, that prolonged STEC shedding by cattle correlates with a decreased proliferation 
rate of the intestinal epithelial cells (232). It appeared plausible to hypothesize, therefore, that 
Stx1 may have decreased the production of TGF-β by bovine iIEL in these experiments. 
However, Stx1 did not modify both tgf-β transcript and TGF-β protein levels, suggesting that 
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STEC may alter the epithelial proliferation rate (232) by a mechanism independent of the 
TGF-β production by iIEL.  
 
5.4. Effect of Stx1 on the TH1/TH2 balance in bovine iIEL 
 In this study, freshly isolated iIEL were found to express a low quantity of il-4 transcripts. 
This finding is in agreement with the literature concerning other species which indicated that 
il-4 transcripts were undetectable (107) or present only in low numbers in human IEL (53, 
397). No il-4 transcripts could be detected in IEL of calves by Canals et al. (51) and by Wyatt 
et al. (426). In extension of preliminary observations (248), the present study unequivocally 
confirmed that Stx1 significantly increased the number of il-4 transcripts in iIEL as early as 
after 4 hrs of cultivation to levels even easily detectable by semi-quantitative PCR. The 
analysis of real-time PCR Ct values further revealed that after incubation with Stx1, il-4 
transcripts became rapidly predominant in the cells (data not shown), even exceeding the tgf-β 
transcripts’ level which was not modified by the toxin. The il-4 transcripts represented the 
majority of the analysed transcripts after 4, 6, and 8 hrs of incubation but declined to baseline 
levels after overnight culture. While the protein machinery of iIEL was not affected by 
incubation with 200 CD50/ml of Stx1, the increase in il-4 transcripts was inducible with 
concentrations of toxin even as low as 7 CD50/ml. Furthermore, Stx1 predominantly affected 
the amount of full-length il-4 transcripts. Waldvogel et al. (406) suggested an important role 
of splice variants in the regulation of IL-4 production, although the biological significance of 
the IL-4δ2 variant is not fully elucidated yet. However, the il-4δ2 splice variant was equally 
detected in iIEL incubated in absence or presence of Stx1, strongly implying that bovine iIEL 
are remarkably sensitive to a Stx1-induced rapid and highly specific increase of IL-4 
translation templates. 
 PBMC respond differently from iIEL with the production of cytokines after stimulation by 
different bacterial superantigens underscoring differences in activation requirements (361). 
The results presented in this study are other examples for these differences. PBMC did not 
display significant modifications of the cytokine mRNA profile after cultivation with Stx1. 
Moreover, again in contrast to what was observed in iIEL, cultivation of bovine PBMC with 
Stx1 (33 CD50/ml) slightly decreased the production of IFN-γ protein. The effect of Stx1 was 
not found to be statistically significant due to the variability between the PBMC preparations 
from several animals. Nevertheless, the findings resemble those made with Stx2 at 
30 CD50/ml, which as well reduced the IFN-γ synthesis in bovine PBMC (Menge and Dean-
Nystrom, personal communication). Despite the differences in the immunomodulatory effects 
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Stxs exert on bovine PBMC and iIEL, the results led to conclude, that Stxs induce an overall 
shift of the bovine immune response towards a TH2-like pattern. 
 Further investigations are required to identify the iIEL subtype which is stimulated by 
Stx1 to produce il-4 transcripts. The expression of Gb3/CD77 by CD4
+ cells can be induced in 
vitro and these cells are equally sensitive as CD8α+ cells to Stx1 then (248). CD4+ IEL can 
produce IL-4 and provide help for B cells (110). Nonetheless, preliminary data indicate that 
the magnitude of il-4 transcripts’ level fails to correlate with the percentage of CD4+ cells in 
the iIEL preparations tested (data not shown). It was reported that rat splenic CD8+ T cells 
produce 4 times more il-4 transcripts than CD4+ T cells and that IL-4 regulates the 
differentiation and the growth of cytotoxic CD8+ T cells (283). Under some circumstances, 
CD8+ T cells can increase the proliferation of and provide help to B cells, mainly by 
producing IL-4 (65). Since murine CD8+ T cells also can be primed in vitro to produce IL-4 
(341), the cellular source of Stx1-induced il-4 transcripts within bovine iIEL preparations may 
not be restricted to the CD4+ population. 
 
5.5. Possible mechanisms underlying the Stx1-induced increase in il-4 transcripts 
 In addition to the cytosolic effects of the Stxs, many cellular functions are known to be 
affected by triggering Gb3/CD77, as MHC-II-mediated functions related to B cell-antigen 
presentation. The cross-linking of Gb3/CD77 in Ramos cells leads to the activation of the 
BCR signaling cascade (261) and binding of the StxB1 subunit induces an increase in 
cytosolic calcium concentration and release of ceramide. The activation of the Stx-receptor 
and the release of second messengers eventually induces apoptosis (382). However, high 
concentrations of rStxB1 induced neither an increase in il-4 transcripts nor apoptosis of 
bovine iIEL (containing few B cells). This confirms previous results (432, 433) indicating that 
the Stx1 holotoxin must enter the cells and that the enzymatic activity is indispensable to 
induce cytokine transcripts’ production in target cells. 
 In this context it needs to be considered that the Stxs holotoxins may affect the numbers of 
cytokine gene transcripts even prior to or in the absence of a complete abolishment of protein 
synthesis (393). Stx1 can increase selected transcripts’ levels within 12-24 hrs in bovine 
endothelial cells at concentrations of toxins that have no effects on protein synthesis (26). In 
THP-1 cells (140), the Stx1-induced elevation of transcript levels is associated with a 
ribotoxic stress response involving JNK and p38 MAP (Mitogen-activated protein) kinases 
(50, 108, 357) and the activation of NF-κB (329). The activation of p38 in monocytes is 
associated with an enhanced stability of cytokine transcripts (407) and Stx1 in fact induces the 
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accumulation of certain mRNA transcripts within 4-8 hrs by increasing the half-life of mRNA 
(alteration of decay rates). It may also be that Stx1 modulates the translation-dependent 
mRNA degradation in a transcript-specific fashion (165, 326). It remains to be determined 
whether Stx1 increased the il-4 transcript numbers in bovine iIEL as well by inhibiting the 
degradation of pre-existing transcripts. Since Grogan et al. (130) showed that stimulated 
murine T cells transcribe il-4 within hours, it also appears plausible that the Stx1-induced 
increase in il-4 transcripts is the result of an elevated transcriptional activity. 
 
 Ribosome-inhibiting proteins (as mistletoe lectins) stimulate the intracellular expression 
of IL-4 in human PBMC after 24 hrs of cultivation in coincidence with an increased 
expression of the mitochondrial marker Apo2.7, and with a decreased level of the anti-
apoptotic Bcl-2 protein. This has prompted the interpretation that the toxins simultaneously 
induced the production of IL-4 and apoptosis in these cells (364). IL-4 in turn is known to 
induce apoptosis in human eosinophils (410) and in stimulated monocytes (239) by activating 
the proteolytic caspases cascade (96). These findings raised the possibility that the increase in 
il-4 transcripts in bovine iIEL could be a side effect of Stx1-induced apoptosis.  
 The ability of Stx1 holotoxin or rStxB1 subunit to induce apoptosis has been extensively 
studied on several Burkitt’s lymphoma cell lines (182, 189, 240, 241, 261, 382, 391). 
Consequently, two lymphoma cell lines were used in a first approach to prove the ability of 
the holotoxin and B subunit preparations used in the present study for their capability to 
induce apoptosis. The Stx1 preparation had a moderate effect on Daudi cells. Daudi cells are 
infected with Epstein-Barr virus (EBV) and this may alter the phenotype of the cells leading 
to a decreased expression of Gb3/CD77 on the cell surface and an over-expression of the anti-
apoptotic Bcl-2 protein. Daudi cells are consequently less sensitive to apoptosis induced by 
the Shiga toxins than Ramos cells (241) which are not subject to EBV-mediated phenotypic 
drift (193). Indeed, Ramos cells proved to be particularly sensitive to the Stx1 preparation 
after 20 hrs of incubation. The effect was completely neutralized by the anti-StxB1 antibody, 
and partially reduced by pre-incubation of the toxin with brefeldin A as already reported in 
THP-1 cells (196). The rStxB1 subunit preparation also efficiently induced apoptosis in 
Ramos cells. This effect could not be neutralized by the anti-StxB1 antibody but this can 
likely be explained by the considerable high concentration of rStxB1 subunit used which, on a 
molar basis, exceeded the concentration of the antibody by several magnitudes.  
 When applied to bovine iIEL, Stx1 reduced the percentage of cells that transformed to 
blast cells within 18 hrs of incubation. Stx1 thus affects the biology of bovine iIEL more 
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profoundly as assumed before, when it was discovered that Stx1 exerted this inhibitory effect 
within 72 hrs of incubation (248). Within 18 hrs, Stx1 particularly lowered the percentage of 
blast cells that expressed Gb3/CD77 on their surface. However, this effect vanished when the 
cells were permeabilized prior to Gb3/CD77 detection, indicating that the toxin induced a 
redistribution of the receptor from the cell surface to intracellular compartments rather than 
eliminating Gb3/CD77-expressing cells from the cultures. The possibility that Stx1 induces 
apoptosis in bovine iIEL cultures could be finally ruled out when the Stx1-treated cells were 
submitted to staining with Annexin-V and 7-AAD. Although Actinomycin D efficiently 
induced apoptosis in bovine iIEL, Stx1 failed to induce apoptosis in bovine iIEL within 6 or 
20 hrs of incubation. These results are in line with previous reports that Stx1 did not induce 
apoptosis in bovine PBMC (254) and bovine colonic epithelial cells (149) (M. Mohr, I. 
Stamm, E. Schröpfer, G. Baljer, and C. Menge, Manuscript in preparation). In conclusion, the 
Stx1-induced elevation in il-4 transcripts does not seem to be linked to the induction of 
apoptosis in bovine iIEL. Even if the underlying mechanism is not yet known (for a 
preliminary model of the Stx1´s cellular activity see fig. 30), bovine iIEL, which show an 
enhanced quantity of il-4 transcripts in response to Stx1, are fully viable in vitro and 
presumably remain well integrated in the mucosal network in vivo.  
 
5.6. IL-4 production by bovine iIEL cultured in the presence and absence of Stx1 
 After incubation with PMA and ionomycin, a strong synthesis of IFN-γ protein was 
detected by flow cytometry. This IFN-γ response was not modified by additional 
supplementation of the medium with Stx1. As iIEL therefore generally retained their ability to 
produce cytokines in response to mitogens even in the presence of Stx1, the protein 
machinery of targeted cells seemed not to be significantly affected by a 6-to-24h-incubation 
with 200 CD50/ml of Stx1. Nevertheless, the Stx1-induced increase in the numbers of il-4 
transcripts in iIEL was not followed by a detectable increase of the corresponding protein. A 
number of different factors may account for this obvious discrepancy. 
 Although Stx1 strongly stimulated the increase in il-4 transcripts in PHA-P-stimulated 
iIEL within 8 hours, no IL-4 could be detected in the corresponding culture supernatants even 
after 18 hrs (data not shown). IL-4 protein only became detectable when it was detected 
intracellularly on a single cell level by flow cytometry. Upon strong mitogenic stimulation 
(PMA and ionomycin) and blocking of the protein secretion pathway (brefeldin A, BFA), 
IL-4 could be detected and only a relative low number of cells was found to be positive 
(≈ 3 %). As the cellular source of the increased amounts of il-4 transcripts in Stx1-treated 
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iIEL cultures remains to be discovered, it cannot be excluded that the population of Stx1-
responding cells is identical to this small population of IL-4-producing cells. Even if this is 
not the case, the correlation between IL-4 mRNA production and secretion of the protein has 
already been reported by several groups to be difficult to establish (43, 184). Similarly, an 
increase of the transcript levels specific for il-8 and gro-α by 100 fold due to Stx1 can lead to 
an increase of the protein to a much lower extent (393). 
 The detection of small increases in IL-4 are particularly difficult when it is considered that 
iIEL may express IL-4 receptors (IL-4R) that rapidly remove newly produced IL-4 from the 
cultures. Indeed, a mitogenic stimulation of T cells, comparable to that in the present study, 
was shown to increase the accumulation of IL-4R mRNA (73). Notably, binding of IL-4 to 
IL-4R does not solely result in consumption of the ligand but also induces a negative feed-
back mechanism. Naive T cells produce IL-4 and then undergo further TH2 differentiation 
(282). This differentiation in turn requires IL-4-induced Stat6 signalling and involves an 
increase in intracellular-Ca2+ concentration. Thereby the autocrine release of IL-4 results in a 
down-regulation of the IL-4 promoter establishing a self regulation of the IL-4 production 
(75). It is tempting to assume that similar events occurred in the iIEL cultures investigated in 
the present study. Since the ionomycin used to stimulate the cells also induces an intracellular 
increase in Ca2+, the addition of this reagent may even have potentiated the negative feedback 
signal induced by IL-4 itself. 
 The lack of an increased IL-4-production in Stx1-treated iIEL cultures may be, at least in 
part, also due to the fact that stimulation of the mixed iIEL preparations caused a significant 
production of IFN-γ by a considerable number of cells. Although protein secretion was 
blocked by addition of BFA at a later time point, the cells were left for up to 8 hrs in the 
presence of Stx1 before BFA was added. It is highly likely therefore, that IFN-γ was initially 
secreted into the cell culture medium causing a rapid reciprocal down-regulation of TH2-cell 
proliferation, further depleting an already low level of IL-4 producing cells (325). 
 Consequently, although a direct proof is missing, the results presented in this study argue 
in favour of the possibility that bovine iIEL do produce IL-4 protein in response to Stx1. 
 
5.7. Biological significance of an increased IL-4 synthesis by bovine iIEL 
 In several murine models of infection that eventually result in clinical manifestations of 
the infection, IEL were shown to produce IFN-γ after parasitic (205) or bacterial stimulations 
(429, 431). IEL from calves infected with Cryptosporidium parvum also expressed increased 
levels of IFN-γ mRNA while no difference was noted for IL-10, IL-2, and IL-4 (51). Babesia 
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bovis-specific CD4+ T cell clones from immune cattle expressed either the TH0 or TH1 profile 
of cytokines (45). By contrast, CD4+ T-cell clones obtained from cattle chronically infected 
with Fasciola hepatica and specific for adult worm antigen displayed both unrestricted and 
TH2 cytokine profiles (43). While TH1 profiles apparently are more oftenly found in acute 
inflammation and protective immunity, the induction of TH2 cytokines in bovines hinders the 
immune clearance of many microbial pathogens (101). Accordingly, an enhanced 
pathogenicity of bovine tuberculosis may be linked to an increased ratio of TH0 (IL-4
+ 
IFN-γ+) versus TH1 (IL-4
- IFN-γ+) T cells (414) since the extend of chronic lung pathology 
positively correlates with the production of IL-4 by PBMC in response to Mycobacterium 
bovis antigen in vitro (411). With further respect to the prominent role of IL-4 in the 
maintenance of intestinal homeostasis (64, 415) it is tempting to assume that a Stx1-induced 
IL-4 secretion by bovine iIEL also contributes to the prolonged survival of STEC in the 
intestine of cattle. 
 Indeed, several bacterial antigens are involved in immunomodulatory mechanisms 
presumably leading to a host immunosuppression (101). Some bacterial toxins have 
immunomodulatory effects on T cells and IEL similar to the effect of Stx1 in bovine iIEL 
cultures. The staphylococcal enterotoxin C (SEC1) inhibits the full activation of bovine 
T cells, and induces the production of il-4 and il-10 transcripts (100, 101). A production of 
IL-4, but not IFN-γ, was also induced by minute concentrations (1 ng/ml) of TSST-1 (Toxic-
shock syndrome toxin-1) and SEB (Staphylococcal enterotoxin B) in human PBMC, LPL, and 
IEL after 48 hrs (361). Ferens et al. therefore suggest that superantigens induce TH2 responses 
and facilitate immunosuppression in cattle and contribute to the chronicity of infections (101). 
IL-4 is potentially an early player in the events that determine whether the infection 
progresses or becomes latent. IL-4 down-regulates the inducible nitric oxide synthase (iNOS) 
(173) and TLR-2 expression (200) in bovine macrophages, and hinders the activation of the 
cells (126). In mice, IL-4 induces the production of IL-4, IL-10 and TGF-β by iIEL (120). IL-
4 is further known to inhibit the secretion of IL-8 by human intestinal epithelial cells (225), 
thus altering the recruitment of immune cells and contributing to the absence of inflammatory 
processes in the enterocytes’ monolayer. IL-4 also diminishes the epithelial barrier function 
and increases the paracellular permeability of human intestinal epithelial monolayers (330, 
444), which then potentially leads to an increased uptake of toxins from the intestinal lumen 
(155), thereby establishing a positive feedback circuit. Notably, IL-4 particularly down-
regulates the responsiveness of human CD8+ iIEL without affecting the proliferation of 
CD8+ T cells from the peripheral blood (82), suggesting a very localized immunomodulation 
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of the gut immune cells. In the light of these considerations, further investigations are strongly 
encouraged to elucidate whether the depletion of CD8α+ iIEL from the bovine mucosa in the 
course of experimental STEC infections (251) can be traced back to a Stx1-induced 
production of IL-4.  
 
5.8. Conclusions and outlook 
 The molecular mechanisms leading to a long-term colonization of the bovine intestine by 
STEC are still not fully understood. Most STEC strains possess an array of virulence 
determinants (417) that allow them to interact with intestinal cells (24). Although it appears 
unlikely that none of these factors is recognized as a danger signal that activates mucosal 
defences (353, 369), STEC are not reported to induce inflammation in the intestine of 
ruminating cattle. Consequently, STEC must have evolved strategies to actively suppress the 
immune response and to allow a persistent colonisation of the intestine. Lymphostatin, 
encoded by the gene lifA in enteropathogenic E. coli (which is similar to efa-1 in non-O157 
STEC) inhibits the proliferation of human and bovine lymphocytes, and the mitogen-induced 
IFN-γ and IL-2 synthesis of human PBMC, LPL (190-192), and murine IEL (238). 
Lymphostatin seems to modulate the gut mucosal immunity and favours the intestinal 
colonization by STEC O5 and O111 strains in cattle (371). However, the homologous factors 
in STEC O157:H7 (products of toxB and a truncated form of efa-1) fail to influence the 
intestinal colonization in sheep and cattle (370). The data presented here support the notion 
that in adult cattle, Stx1 acts in a subtle way as an immunomodulatory factor by perturbing 
cytokine production. Even if the functional consequences of such disturbance are not fully 
known yet, it can be assumed that Stx1, probably in concert with other STEC factors (51, 62), 
favours the establishment of a TH2 response allowing the development of an asymptomatic 
and persistent STEC infection (Fig. 31). In that, Stxs are the only immunomodulatory STEC 
factors recognized to date, that, by definition, are common to all STEC strains. Stxs, 
therefore, are highly interesting targets to be included in vaccination strategies aimed at 
limiting intestinal colonization by STEC.  
 It was recently hypothesized that STEC have evolved strategies to permit a commensal-
like lifestyle (356). By increasing the amount of il-4 transcripts, STEC might generate a 
particular ecological niche. Interestingly, oral treatment of pigs with the probiotic E. coli 
Nissle 1917 also reportedly led to an increase in il-4 transcripts in the duodenum (76). This 
raises the possibility that other bacteria might be able to compete with the STEC for the same 
niche. Such a strategy, known as competitive exclusion, has been succesfully applied to 
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E. coli O157 infections in cattle, as feeding of cattle with L. acidophilus decreased the faecal 
shedding of O157:H7 (41). Probiotic strains, such as L. rhamnosus, tested in animal or cell 
models, inhibited the adhesion of E. coli O157:H7 on Caco-2 cells (147) and reduced the 
mortality of mice by 50 % after infection (385). In the economic environment of modern 
animal production, such strategies can be considered a realizable alternative (or complement) 
to vaccination measures in order to lower the STEC prevalence in adult cattle. 
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Fig. 30. Proposed cellular model depicting the effects of E. coli Shiga toxin 1 on bovine ileal 
intraepithelial lymphocytes (iIEL) (original cellular frame from Stamm et al. (363)) 
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Fig. 31. Proposed model depicting the effects of E. coli Shiga toxin 1 on bovine PBMC and iIEL from the intestinal mucosa (adapted from the 
original mucosa scheme from Menge C. (246)) 
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6. Summary 
 
Escherichia coli Shiga toxin 1 (Stx1) blocks the activation of bovine peripheral (PBMC) and 
ileal intraepithelial lymphocytes (iIEL). The objectives of the study were to assess the impact 
of Stx1 on the expression of selected chemokine and cytokine genes in bovine lymphocytes 
(iIEL and PBMC) in vitro by real-time RT-PCR and by quantitation of intracellular cytokine 
proteins by flow cytometry. 
Freshly isolated iIEL were shown to harbour transcripts of chemokines and of TH1, TH2, and 
TH3 cytokines. While Stx1 did not alter the amount of mRNA specific for IL-2, IL-10, IFN-γ, 
TGF-β, IL-8, IP-10, and MCP-1 in cultured iIEL, minute concentrations of Stx1 led to an up 
to 40-fold increase of il-4 transcripts within 6-8 hrs of incubation. In addition, the effect of 
Stx1 on il-4 transcripts was specified to require the enzymatic activity of the holotoxin, as the 
StxB1 subunit alone did not affect iIEL. Nevertheless, in the presence of Stx1, iIEL retained 
their ability to synthesize proteins: 40 % of iIEL could be mitogen-stimulated to synthesize 
IFN-γ while less than 10 % of the cells expressed IL-4 or TGF-β proteins. The enhancement 
of il-4 transcripts in iIEL was not accompanied by apoptosis. Although Stx1 significantly 
impaired the iIEL blast transformation induced by mitogens in vitro and induced a marked 
redistribution of the Stx- receptor from the cell surface to intracellular compartments, Stx1-
treated iIEL neither showed an increased exposure of phosphatidylserine on the cell surface 
nor an altered mitochondrial membrane potential. Comparative experiments with PBMC 
revealed that the effect on il-4 transcripts was specific for iIEL. Moreover, Stx1 hindered the 
translation of IFN-γ in PBMC within 21 hrs. 
Mucosal immune cells in cattle were found to be considerably sensitive to a cytokine-
stimulating effect of Stx1. The results led to assume that the distinct induction of il-4 
transcripts contributes to the establishment of a commensal-like colonization of the bovine 
intestinal mucosa by STEC. 
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7. Zusammenfassung 
 
Escherichia coli Shiga toxin 1 (Stx1) blockiert die Aktivierung boviner peripherer (PBMC) 
und ilealer intraepithelialer Lymphozyten (iIEL). Ziel dieser Untersuchung war es, den 
Einfluss von Stx1 auf die Expression ausgewählter Chemokin- und Zytokin-Gene in vitro mit 
Hilfe der „real-time RT-PCR“ und der intrazellulären Quantifizierung zweier Zytokin-
Proteine in der Durchflusszytometrie zu bestimmen. 
Frisch isolierte iIEL enthielten sowohl Transkripte für eine Reihe von Chemokin-Genen als 
auch von Genen für TH1-, TH2- und TH3-Zytokine. Während Stx1 den Gehalt an mRNA für 
IL-2, IL-10, IFN-γ, TGF-β, IL-8, IP-10 und MCP-1 in kultivierten iIEL nicht veränderte, 
führten bereits kleinste Konzentrationen von Stx1 zu einer bis zu 40-fachen Steigerung der 
Zahl der il-4-Transkripte innerhalb von 6-8 Stunden. Dieser Effekt des Stx1 war von der 
enzymatischen Aktivität des Holotoxins abhängig, da die rezeptorbindende StxB1-
Untereinheit nicht die gleiche Wirkung entfaltete. Trotzdem war auch in Anwesenheit von 
Stx1 die Fähigkeit der iIEL zur Proteinsynthese erhalten. Vierzig Prozent der iIEL konnten 
durch Mitogene zur Synthese von IFN-γ stimuliert werden, wohingegen weniger als 10 % der 
Zellen IL-4- oder TGF-β-Proteine bildeten. Die Stx1-induzierte Vermehrung der il-4-
Transkripte in iIEL war nicht von Apoptose begleitet. Stx1 beeinträchtigte zwar erheblich die 
Fähigkeit der iIEL zur Blastentransformation in vitro und induzierte eine deutliche 
Umverteilung der Stx-Rezeptoren von der Zelloberfläche in intrazelluläre Kompartimente. 
Stx1-behandelte iIEL zeigten aber weder eine verstärkte Exposition von Phosphatidylserin auf 
der Zelloberfläche noch war ihr mitochondriales Membranpotential verändert. Bei 
vergleichenden Untersuchungen mit PBMC zeigte sich, dass der Effekt des Stx1 auf il-4-
Transkripte spezifisch für iIEL ist. Im Gegensatz zur Wirkung des Stx1 auf iIEL reduziert 
Stx1 bei PBMC innerhalb von 21 Stunden die Translation von IFN-γ. 
Schleimhautimmunzellen des Rindes sind damit aussergewöhnlich sensibel gegenüber einem 
Zytokin-stimulierenden Effekt des Stx1. Dies lässt vermuten, dass die gezielte Induktion von 
il-4-Transkripten zur Kolonisierung der bovinen Mukosa durch STEC in einer Saprophyten 
ähnlichen Weise beiträgt. 
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8. Reagents, media, and buffers 
 
8.1. Reagents 
 
 
Reagents Company Catalogue number 
1,4 Dithiothreitol (DTT) Carl Roth GmbH 6908.2 
3,3’-Dioctadecyloxacarbocyanin-
Perchlorate (DiO) 
Molecular Probes D-275 
7-Aminoactinomycin D Sigma-Aldrich A-9400 
Actinomycin D Sigma-Aldrich A-1410 
Agarose D-1 Low EEO Serva Electrophoresis GmbH 8016 
Amplitaq® DNA Polymerase, 10X 
buffer and 25mM MgCl2 
Applied Biosystem N808-0161 
Anti-bovine CD8β VMRD BAT82A 
Anti-human CD77, Clone 38.13 Coulter Immunotech Diagnostic IM0175 
Anti-bovine TcR-N12 VMRD CACT61A 
Anti-bovine IFN-γ Serotec GmbH Clone 303 
Anti-bovine IL-4 Serotec GmbH Clone 302 
Anti-human TGF-β Serotec GmbH Clone TB21 
BSA Serva Electrophoresis GmbH 11930 
Brefeldin A Sigma-Aldrich B-6542 
Collagenase (Type 1 CLS) Biochrom AG C 1-22 
Concanavalin A Sigma-Aldrich C-2010 
DNase I and 10X buffer Amersham Biosciences 27-0514-02 
dNTP (4 nmol each) PAN™ BIOTECH GmbH 739026 
EDTA Serva Electrophoresis GmbH 11280 
Ethanol 99 % Merck 1.00983.1011 
Ethidium bromide Serva 21251 
Fetal calf serum Biowest S1810 
Ficoll-Paque™ Plus Amersham Pharmacia Biotech 17-0840-03 
GeneRuler™ 100 bp DNA ladder MBI Fermentas SM0241 
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Gentamycin Biochrom AG A2710 
Goat anti-mouse IgG (H+L) –  
FITC conjugated 
Dianova 115-095-062 
Goat anti-rat IgM (µ-chain specific) Dianova 112-005-075 
Ionomycin calcium salt Sigma-Aldrich I-0634 
Lambda DNA/EcoRI+HindIII marker MBI Fermentas SM0191 
Leibowitz’s L-15 medium Life Technologies GmbH 41300-021 
Lipolysaccharide Sigma-Aldrich L-4130 
Mercaptoethanol PlusOne 98 % Amersham Biosciences 17-1317-01 
M-MLV RTase (H-) Promega M 3683 
M-MLV RTase Buffer Pack Promega M 5313 
Nylon wool Biotest AG, Dreieich 830034 
Oligo d(T)16 primer Applied Biosystems N808-0128 
Paraformaldehyde Merck 104005 
PCR tubes Nerbe 04.022.1100 
PCR primers MWG Biotech AG - 
PCR TaqMan™ probe Eurogentec - 
Penicillin / Streptomycin (100X) PAA GmbH P11-010 
Percoll® Sigma-Aldrich P-1644 
Phorbol-Myristat-Acetat (PMA) Orpegen-Pharma 34008480 
Phytohematogglutinin P (PHA-P) Sigma-Aldrich L-8754 
Rat IgM Kappa myeloma protein CAMON PRP08 
qPCR ™  MasterMix Eurogentec RT-QP2X-03 
Recombinant human Annexin-V- 
PE conjugated 
Caltag ANNEXINV04 
Ribonuclease Inhibitor (RNasin) MBI Fermentas E00312 
RNase-free DEPC-treated water Carl Roth GmbH T 143.2 
Rnase-free DNase Set QIAGEN 79254 
RNeasy® Mini Kit QIAGEN 74106 
RPMI 1640 medium with 2mM 
stabilized L-glutamin and 2.0 g/l 
NaHCO3 
PAN™ BIOTECH GmbH P04-18500 
Saponin Merck 7695 
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Sodium azide Merck 106688 
Tris-Hydroxymethyl-Aminomethan Carl Roth GmbH 4855 
Ultroser® HY CYTOGEN 66029-018 
 
 
8.2. Buffers and solutions 
 
Annexin-V binding buffer 10X-concentrate 
Hepes/NaOH (pH=7.4)                  2.283 g 
NaCl                    8.182 g 
CaCl2                    0.277 g 
Bi-distilled water                100.0 ml 
 
Annexin-V binding buffer 1X 
Annexin-V binding buffer 10X-concentrate               10.0 ml 
Bi-distilled water                  90.0 ml 
 
Erythocytes lysis buffer 
NH4Cl                      8.26 g 
NaHCO3                     1.09 g 
Na2-EDTA * 2H2O                  0.037 g 
Bi-distilled water                 1,000 ml 
Sterilization by filtration  (Millipore 0.22 µm) 
 
Electrophoresis loading-dye 
Bromophenol blue (Sodium salt)                  0.25 g 
Xylene Cyanole FF                    0.25 g 
Glycerin                        30 g 
Bi-distilled and autoclaved water                 100 ml 
Aliquoted (1 ml) and stored at –20°C 
 
NaCl solution 
NaCl                       0.89 g 
Bidistilled water                 100.0 ml 
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10X-concentrated PBS  buffer (pH= 7.4) 
Na2HPO4 * 2 H2O                    18.0 g 
KH2PO4                       2.5 g 
KCl                        2.5 g 
NaCl                    100.0 g 
Bi-distilled water                 1,000 ml 
 
PBS 1X buffer (pH= 7.4) 
PBS 10X-concentrate buffer               100.0 ml 
Bi-distilled water                900.0 ml 
Sterilization by filtration  (Millipore 0.22 µm) 
 
PBS 1X – 1 % BSA  buffer (pH 7.4) 
Bovine serum albumine (Fraction V)                 10.0 g 
1X PBS (pH 7.4)                1,000 ml 
Sterilization by filtration  (Millipore 0.22 µm)  
Storage at 4°C  
 
10X-concentrated PBS – EDTA  buffer (pH= 7.4) 
Na2HPO4 * 2H2O                    14.2 g 
KH2PO4                       2.0 g 
KCl                        2.0 g 
NaCl                      80.0 g 
Na2-EDTA * 2H2O                               20.0 g 
Bi-distilled water                 1,000 ml 
Sterilization by filtration  (Millipore 0.22 µm) 
 
PBS – EDTA 1X buffer (pH= 7.4) 
PBS – EDTA 10X concentrate buffer             100.0 ml 
Bi-distilled water                 900.0 ml 
Sterilization by filtration  (Millipore 0.22 µm) 
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PBS 1X – EDTA 10X buffer (pH 7.4) 
Na2-EDTA * 2H2O                    20.0 g 
PBS 1X                 1,000 ml 
Sterilization by filtration  (Millipore 0.22 µm) 
 
PBS-EDTA-AB buffer (pH 7.4) 
Na2HPO4 * 2H2O                    1.42 g 
KH2PO4                     0.20 g 
KCl                      0.20 g 
NaCl                      8.00 g 
Na2-EDTA * 2H2O                    0.75 g 
Glucose                     1.00 g 
Penicillin / Streptomycin                 100000 U Penicillin; 100 g Streptomycin 
Gentamycin (20 mg/ml)                  500 µg 
Bi-distilled water                 1,000 ml 
Sterilization by filtration  (Millipore 0.22 µm) 
 
PBS – PFA 4 % (paraformaldehyde) 
Paraformaldehyde                      4.0 g 
1X PBS (pH 7.4)                100.0 ml 
Allow to dissolve 30 min in water-bath at 75-80°C. Shake every 5 min. Store at 4°C. 
 
Saponin solution 5 % 
Saponin                                                                                                             5.0 g 
Bidistilled water                                                                                                      100.0 ml 
Sterilize by filtration (0.2 µm), store at 4 °C. 
 
Sodium azide solution (10 %) 
NaN3                        5.0 g 
NaCl solution (150 mM)                 50.0 ml 
Sterilize by filtration (0.2 µm), store at 4 °C. 
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Sodium citrate solution (3,8%) 
Na-citrate x 2 H2O                     3.80 g 
Bidistilled water                 100.0 ml 
Sterilize by filtration (0.2 µm), aliquot (100 ml), store at RT 
 
Trypan blue solution 
Trypan blue                     0.20 g 
NaCl solution                 1,000 ml 
 
 
8.3. Cell culture media 
 
BL-3 medium 
RPMI 1640 with stabilized glutamin              617.0 ml 
Lebowitz 15 medium                150.0 ml 
Fetal calf serum                100.0 ml 
Penicillin / Streptomycin                    1000 IU / 1.0 g in 10.0 ml 
β-Mercaptoethanol (1 mM)                   3.0 ml 
Sterilization by filtration  (Millipore 0.22 µm) 
 
Gentamycin 
Gentamycin-sulfat                                10.0 g 
Bi-distilled water                    500 ml 
Sterilization by filtration  (Millipore 0.22 µm) 
 
IEL-medium 
RPMI 1640 with stabilized glutamin              780.0 ml 
Fetal calf serum                200.0 ml 
Penicillin (10,000 U/ml)/ Streptomycin (10,000 µg/ml)                                             10.0 ml 
Amphotericin B (250 µg/ml)                 10.0 ml 
Gentamycin (20 mg/ml)                        2.5 µg/ml 
Sterilization by filtration  (Millipore 0.22 µm) 
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PBMC-medium 
RPMI 1640 with stabilized glutamin              897.0 ml 
Fetal calf serum                100.0 ml 
β-Mercaptoethanol (1 mM)                   3.0 ml 
Sterilization by filtration  (Millipore 0.22 µm) 
 
Ramos cell-medium 
RPMI 1640 with stabilized glutamine             890.0 ml 
Fetal calf serum                100.0 ml 
Penicillin (10,000 U/ml)/ Streptomycin (10,000 µg/ml)             10.0 ml 
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